8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934

Date of Report (Date of earliest event reported): June 16, 2009 (May 21, 2009)

Vermillion, Inc.

(Exact name of registrant as specified in its charter)

Commission File Number: 000-31617

Delaware	33-059-5156
(State or other jurisdiction of incorporation)	(IRS Employer Identification No.)

47350 Fremont Blvd., Fremont, CA 94538
(Address of principal executive offices, including zip code)

510.226.2800
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

	Item 8.01. Other Events.
	Item 9.01. Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
EX-99.1
EX-99.2
EX-99.3

Item 8.01. Other Events.

FDA Response

Vermillion, Inc. (the “Company”) currently has a 510(k) pre-market notification pending before the FDA. In Feb 2009, and in March 2009, the FDA asked Vermillion for additional information regarding the submission. Following a number of constructive substantive discussions between Vermillion and the FDA, on June 11, 2009, Vermillion submitted information to the FDA that it believes responds to all questions raised by the FDA to date.

This statement regarding Vermillion’s response to the FDA may contain forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion’s plans, objectives, expectations and intentions and risks and uncertainties. Such risks are discussed in Vermillion’s latest Form 10-K and Vermillion’s periodic reports on Form 10-Q and Form 8-K. These forward-looking statements are based on Vermillion’s current expectations. Vermillion is providing this information as of the date of the filing of this Current Report on Form 8-K and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise. Forward-looking statements cannot be guaranteed and actual results may differ materially from Vermillion’s current expectations.

Monthly Operating Reports

On May 21, 2009, Vermillion, Inc. (the “Company”) filed its financial statements included in the Monthly Operating Report for the period from March 30, 2009 to April 30, 2009 (the “Monthly Operating Report”) with the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) (Case No. 09-11091). A copy of the Monthly Operating Report is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated in this report by reference.

Under the Exchange Act, the SEC issued Exchange Act release 9660 providing guidance for Exchange Act reporting companies in bankruptcy. Consistent with that release, in light of limitations on the Company’s liquidity and personnel, the Company is unable to continue filing periodic reports under the Exchange Act without unreasonable effort and expense because (i) the Company’s regular accounting staff has been reduced as a result of the bankruptcy filing and (ii) the cost of having an independent registered public accounting firm perform the requisite reviews and audits coupled with the cost of complying with the requirements of the Sarbanes-Oxley Act of 2002 is prohibitive. As a result, the Company hereafter intends to file with the SEC, under cover of current reports on Form 8-K, in lieu of filing Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, copies of the Company’s monthly operating reports required to be submitted to the Bankruptcy Court. In accordance with General Instructions B.2 and B.6 of Form 8-K, the Monthly Reports are, and any future such monthly operating reports will be, furnished for informational purposes only and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor will such information be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act, except as expressly set forth by specific reference in such a filing. The information set forth in this Item 9 also will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Monthly Operating Report, which was not prepared for the purpose of providing the basis for an investment decision relating to any of the securities of the Company. The Monthly Operating Report is limited in scope, covers a limited time period and has been prepared solely for the purpose of the Company’s compliance with the monthly reporting requirements of the Bankruptcy Court. The financial information in the Monthly Operating Report was not audited or reviewed by independent registered accountants and is not presented in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and is in a format prescribed by applicable bankruptcy laws and is subject to future adjustment and reconciliation. There can be no assurance that, from the perspective of an investor or potential investor in the Company’s securities, the Monthly Operating Report is complete. The Monthly Operating Report also contains information for periods which may be shorter or otherwise different from those contained in reports required pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such information is likely not indicative of Company’s financial condition or operating results for the period that

would be reflected in the periodic reports pursuant to the Exchange Act. The Monthly Operating Report does not include footnotes that would ordinarily be contained in the financial statements in our quarterly and annual reports pursuant to the Exchange Act. In addition, the income tax provision in the Monthly Operating Reports is difficult to ascertain as a result of many factors, including, among other things, our inability to predict taxable income that may be generated as a result of any cancellation of indebtedness that might occur as a result of the bankruptcy proceeding involving the Company. Results set forth in the Monthly Operating Reports should not be viewed as indicative of future results.

Bankruptcy Materials

On June 11, 2009, the Company filed a Statement of Financial Affairs and Schedules of Assets and Liabilities, which included Global Notes and Statement of Limitations, Methodology and Disclaimer Regarding Debtor’s Statements of Financial Affairs with Schedules (the “Global Notes”), a Statement of Financial Affairs (the “Statement”) and certain Schedules of Assets and Liabilities (the “Schedules” and with the Global Notes and Statement, the “Bankruptcy Materials”) with the Bankruptcy Court. The Bankruptcy Materials contain unaudited summary financial information relating to the Debtors’ assets and liabilities in the form required under the Bankruptcy Code and the rules and regulations thereunder. A copy of the Bankruptcy Reports is attached to this Current Report on Form 8-K as Exhibit 99.2 and incorporated in this report by reference.

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Bankruptcy Materials, which were not prepared for the purpose of providing the basis for an investment decision relating to any of the securities of the Company. The Bankruptcy Materials contain financial information that has not been audited or reviewed by independent registered accountants and is not presented in accordance with U.S. GAAP. The information contained in the Bankruptcy Materials has been prepared in accordance with the Bankruptcy Code and the rules and regulations thereunder and was not prepared for the purpose of providing a basis for an investment decision relating to any securities of the Company. The Bankruptcy Materials also contain information for periods that are shorter or otherwise different from those required by the periodic reporting requirements of the Exchange Act, and the rules and regulations thereunder, and such information may not be indicative of the Company’s financial condition or operating results for the period that would be reflected in its financial statements or in its reports pursuant to the Exchange Act or the rules and regulations thereunder. Results set forth in the Bankruptcy Materials should not be viewed as indicative of future results. There can be no assurance that the Bankruptcy Materials are complete. The Company may amend, supplement or otherwise change the information contained in the Bankruptcy Materials at a future date.

Cash Budget Through December, 2009

On June 16, 2009 the Board of Directors of the Company approved the Company’s Cash Budget through December, 2009 (the “Cash Budget”). A copy of the Cash Budget is attached to this Current Report on Form 8-K as Exhibit 99.3 and incorporated in this report by reference.

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Cash Budget, which was not prepared for the purpose of providing the basis for an investment decision relating to any of the securities of the Company. The Cash Budget contains financial information that has not been audited or reviewed by independent registered accountants and is not presented in accordance with U.S. GAAP. The information contained in the Cash Budget was not prepared for the purpose of providing a basis for an investment decision relating to any securities of the Company. The Cash Budget also contains information for periods that are shorter or otherwise different from those required by the periodic reporting requirements of the Exchange Act, and the rules and regulations thereunder, and such information may not be indicative of the Company’s financial condition or operating results for the period that would be reflected in its financial statements or in its reports pursuant to the Exchange Act or the rules and regulations thereunder. Results set forth in the Cash Budget should not be viewed as indicative of future results. There can be no assurance that the Cash Budget is complete. The Company may amend, supplement or otherwise change the information contained in the Cash Budget at a future date.

Forward-Looking Statements

Certain matters discussed in this Current Report on Form 8-K and the exhibits hereto contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. These forward-looking statements may relate to, among other things, expectations of the business environment in which the Company operates, projections of future performance and projections of future expenses. These forward-looking statements are based upon current management expectations and may therefore involve risks and uncertainties. Certain of these forward-looking statements are only estimates of the anticipated cash and expenses of the Company, and of the operating requirements of the Company through December, 2009. The Company’s actual expenses may be affected by a wide range of factors, including, but not limited to: anticipated expenses may significantly increase; unanticipated or unforeseen expenses may arise; changes to FDA regulations, and any delay by or failure of the FDA to approve any of Vermillion’s diagnostic tests submitted to the FDA, may result in unanticipated expenses; the overall financial situation and needs of the Company or its research could change; and unanticipated litigation could arise and could result in increased expenses. The Company’s Chapter 11 filing may disrupt and distract management. Moreover, the Chapter 11 filing could result in unanticipated expenses or increases to estimated expenses, including respecting possible financing, sale of assets and/or a plan of reorganization, any one or all of which could be substantial. The Company’s actual results or performance may differ materially from those suggested, expressed, or implied by forward-looking statements due to a wide range of factors, and although the Company believes that its expectations and beliefs are based on reasonable assumptions, it can give no assurance that its goals will be achieved. The Company disclaims any obligation to subsequently revise or update any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Item 9.01. Financial Statements and Exhibits.

(d)	Exhibit No.	Description.
	99.1	Monthly Operating Report for the Period March 30, 2009 — April 30, 2009.
	99.2	Statement of Financial Affairs and Schedules of Assets and Liabilities.
	99.3	Cash Budget for Vermillion, Inc. through December, 2009.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vermillion, Inc.
Date: June 16, 2009	By:	/s/ Gail S. Page
		Gail S. Page
		Executive Chair of the Board of Directors

EXHIBIT INDEX

Exhibit No.	Description
99.1	Monthly Operating Report for the Period March 30, 2009 — April 30, 2009.
99.2	Statement of Financial Affairs and Schedules of Assets and Liabilities.
99.3	Cash Budget for Vermillion, Inc. through December, 2009.

EX-99.1

Exhibit 99.1

Monthly Operating Report for the period April 1, 2009 — May 31, 2009

UNITED STATES BANKRUPTCY COURT
                     DISTRICT OF                     

In re: Vermillion, Inc. Case No. 09-11091 (CSS)
Reporting Period: March 30, 2009 — April 30, 2009

MONTHLY OPERATING REPORT
File with Court and submit copy to United States Trustee within 20 days after end of month.

Submit copy of report to any official committee appointed in the case.

		Document	Explanation	Affidavit/Supplement
REQUIRED DOCUMENTS	Form No.	Attached	Attached	Attached
Schedule of Cash Receipts and Disbursements	MOR-1
Bank Reconciliation (or copies of debtor’s bank reconciliations)	MOR-1a	exhibit 1&2
Schedule of Professional Fees Paid	MOR-1b
Copies of bank statements		X
Cash disbursements journals		exhibit 3
Statement of Operations	MOR-2	exhibit 4
Balance Sheet	MOR-3	exhibit 5 & 6
Status of Postpetition Taxes	MOR-4	exhibit 7
Copies of IRS Form 6123 or payment receipt
Copies of tax returns filed during reporting period
Summary of Unpaid Postpetition Debts	MOR-4	Exhibit 8
Listing of aged accounts payable	MOR-4
Accounts Receivable Reconciliation and Aging	MOR-5	N/A
Debtor Questionnaire	MOR-5	X

I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.

/s/ Gail S. Page
Signature of Debtor	Date: May 21, 2009
Signature of Joint Debtor	Date
Signature of Authorized Individual*	Date
Printed Name of Authorized Individual	Title of Authorized Individual

* Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.

MOR
(04/07)

Vermillion, Inc. MOR-1

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 — April 30, 2009

SCHEDULE OF CASH RECEIPTS AND DISBURSEMENTS

Amounts reported should be per the debtor’s books, not the bank statement. The beginning cash should be the ending cash from the prior month or, if this is the first report, the amount should be the balance on the date the petition was filed. The amounts reported in the “CURRENT MONTH - ACTUAL” column must equal the sum of the four bank account columns. The amounts reported in the “PROJECTED” columns should be taken from the SMALL BUSINESS INITIAL REPORT (FORM IR-1) . Attach copies of the bank statements and the cash disbursements journal. The total disbursements listed in the disbursements journal must equal the total disbursements reported on this page. A bank reconciliation must be attached for each account. [See MOR-1 (CON’T)]

	BANK ACCOUNTS						CURRENT MONTH			CUMULATIVE FILING TO DATE
	OPER.		PAYROLL		TAX	OTHER	ACTUAL		PROJECTED	ACTUAL	PROJECTED
CASH BEGINNING OF MONTH		640,301.97		0				610,214.31
RECEIPTS
CASH SALES								0.00
ACCOUNTS RECEIVABLE								0.00
LOANS AND ADVANCES								0.00
SALE OF ASSETS								0.00
OTHER (ATTACH LIST) -Outstanding checks for old operating account								149.75
Rebate check from American Express Card								21.92
Check from Conexis for COBRA premium								2,214.48
Refund check from Stericycle (toxic waste mgmt)								461.94
TRANSFERS (FROM DIP ACCTS)		642,968.81						0.00
TOTAL RECEIPTS								2,848.09
DISBURSEMENTS
NET PAYROLL								16,043.38
PAYROLL TAXES								9,641.01
SALES, USE, & OTHER TAXES								3,200.00
INVENTORY PURCHASES								0.00
SECURED/ RENTAL/ LEASES
INSURANCE
ADMINISTRATIVE
SELLING
OTHER (ATTACH LIST)
Bank charge								783.74
ADP payroll processing fee								101.90
OWNER DRAW *
TRANSFERS (TO DIP ACCTS)
PROFESSIONAL FEES								44,300.00
U.S. TRUSTEE QUARTERLY FEES
COURT COSTS
TOTAL DISBURSEMENTS								74,070.03
NET CASH FLOW								-71,221.94
(RECEIPTS LESS DISBURSEMENTS)
CASH — END OF MONTH								538,992.37

* COMPENSATION TO SOLE PROPRIETORS FOR SERVICES RENDERED TO BANKRUPTCY ESTATE

FORM MOR - - 1
(04/07)

THE FOLLOWING SECTION MUST BE COMPLETED

DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES: (FROM CURRENT MONTH ACTUAL COLUMN)

TOTAL DISBURSEMENTS		74,070.03
LESS: TRANSFERS TO DEBTOR IN POSSESSION ACCOUNTS	$	0.00
PLUS: ESTATE DISBURSEMENTS MADE BY OUTSIDE SOURCES (i.e. from escrow accounts)	$	0.00
TOTAL DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES	$	74,070.03

FORM MOR - - 1
(04/07)

Vermillion Inc. MOR-1

Vermillion Inc.
Outstanding Checks as of 3/31/09

CHECK
NUMBER	DATE S		RC	REFERENCE	PAYEE NAME	AMOUNT		CLR
52		10/5/2007	AP	00CONWA02	CONWAY, KENNETH		64	N
1501		12/15/2008	AP	00NATIO15	NATIONAL ONCOLOGY ALLIANCE IN		25,000.00	N
20502		4/28/2006	AP	00HSABA00	HSA BANK		25	N
22771		2/16/2007	AP	00ELITE01	ELITE NETWORK		4,244.63	N
22779		2/16/2007	AP	00IRONM00	IRON MOUNTAIN		149.75	N
22812		2/16/2007	AP	00WELLS01	WELLS FARGO AUTO FINANCE, INC		604.28	N
				TOTAL			30,087.66

Vermillion, Inc. MOR-1a

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 — April 30, 2009

BANK RECONCILIATIONS
Continuation Sheet for MOR-1
A bank reconciliation must be included for each bank account. The debtor’s bank reconciliation may be substituted for this page.

Operating

Payroll

Tax

Other

#3300661008

#3300661012

#

#

BALANCE PER BOOKS

See exhibit 1

See exhibit 2

BANK BALANCE

(+) DEPOSITS IN TRANSIT (ATTACH LIST)

(-) OUTSTANDING CHECKS (ATTACH LIST)

OTHER (ATTACH EXPLANATION)

ADJUSTED BANK BALANCE *

* Adjusted bank balance must equal balance per books

DEPOSITS IN TRANSIT

Date

Amount

Date

Amount

Date

Amount

Date

Amount

CHECKS OUTSTANDING

Ck. #

Amount

Ch. #

Amount

Ck. #

Amount

Ck. #

Amount

OTHER

FORM MOR - - 1a
(04/07)

Vermillion, Inc. MOR-1a

Exhibit 1

VERMILLION INC.
Silicon Valley Bank -Checking Account 3300661008
As of April 30, 2009

Closing Ledger Per Statement	568,930.28
Sweep In Transit Per Statement	0.00
Checks outstanding	0.00
Deposit in transit	0.00
	568,930.28
Balance per general ledger: Account 1010	568,930.28
Variance	—

Exhibit 2

Vermillion, Inc. MOR-1a

VERMILLION, INC
Silicon Valley Bank Payroll Account 3300661012 — GL Account #1016
As Of April 30, 2009

Balance per bank statement:	0.00
Less outstanding checks: ck #     Check Date     Name
	0.00
Balance per general ledger: Account 1016	0.00
Variance	—

Confidential

Vermillion, Inc. MOR-1b

In re: Vermillion, Inc.	Case No.09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 - April 30, 2009

SCHEDULE OF PROFESSIONAL FEES AND EXPENSES PAID
This schedule is to include all retained professional payments from case inception to current month.

Amount

Check

Amount Paid

Year-To-Date

Payee

Period Covered

Approved

Payor

Number

Date

Fees

Expenses

Fees

Expenses

Applied Clinical Intelligence

Apr-09

34,300.00

200

04/23/09

34,300.00

Franchise Tax Board

2009

3,200.00

1000

04/15/09

3,200.00

BMC Group, Inc.

Retainer fee

10,000.00

301471

04/09/09

10,000.00

FORM MOR - - 1b
(04/07)

Vermillion, Inc. MOR-1b

Exhibit 3

Exhibit 3 to the Monthly Operating Report containing a check history report and copies of checks, as filed with the U.S. Bankruptcy Court of Delaware, is available through the Federal Court filing system PACER at http://pacer.psc.uscourts.gov/ in the Company’s document section.

Vermillion, Inc. MOR-1b

The portion of the Monthly Operating Report containing copies of bank statements, as filed with the U.S. Bankruptcy Court of Delaware, is available through the Federal Court filing system PACER at http://pacer.psc.uscourts.gov/ in the Company’s document section.

Vermillion, Inc. MOR-2

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: Mach 30, 2009 — April 30, 2009

STATEMENT OF OPERATIONS
(Income Statement)

The Statement of Operations is to be prepared on an accrual basis. The accrual basis of accounting recognizes revenue when it is realized and expenses when they are incurred, regardless of when cash is actually received or paid.

			Cumulative
REVENUES	Month		Filing to Date
Gross Revenues	$	0.00	$
Less: Returns and Allowances
Net Revenue	$	0.00	$
COST OF GOODS SOLD
Beginning Inventory
Add: Purchases
Add: Cost of Labor
Add: Other Costs (attach schedule)
Less: Ending Inventory
Cost of Goods Sold
Gross Profit	$	0.00
OPERATING EXPENSES	See Exhibit 4
Advertising
Auto and Truck Expense
Bad Debts
Contributions
Employee Benefits Programs
Insider Compensation*
Insurance
Management Fees/Bonuses
Office Expense
Pension & Profit-Sharing Plans
Repairs and Maintenance
Rent and Lease Expense
Salaries/Commissions/Fees
Supplies
Taxes — Payroll
Taxes — Real Estate
Taxes — Other
Travel and Entertainment
Utilities
Other (attach schedule)
Total Operating Expenses Before Depreciation
Depreciation/Depletion/Amortization
Net Profit (Loss) Before Other Income & Expenses
OTHER INCOME AND EXPENSES	See Exhibit 4
Other Income (attach schedule)
Interest Expense
Other Expense (attach schedule)
Net Profit (Loss) Before Reorganization Items
REORGANIZATION ITEMS	See Exhibit 4
Professional Fees
U. S. Trustee Quarterly Fees
Interest Earned on Accumulated Cash from Chapter 11 (see continuation sheet)
Gain (Loss) from Sale of Equipment
Other Reorganization Expenses (attach schedule)
Total Reorganization Expenses
Income Taxes
Net Profit (Loss)	$		$

* “Insider” is defined in 11 U.S.C. Section 101(31).

FORM MOR - - 2
(04/07)

Vermillion, Inc. MOR-2

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 — April 30, 2009

STATEMENT OF OPERATIONS — continuation sheet

		Cumulative
BREAKDOWN OF “OTHER” CATEGORY	Month	Filing to Date
Other Costs
Other Operational Expenses
Other Income
Other Expenses
Other Reorganization Expenses

Reorganization Items — Interest Earned on Accumulated Cash from Chapter 11:

Interest earned on cash accumulated during the chapter 11 case, which would not have been earned but for the bankruptcy proceeding, should be reported as a reorganization item.

FORM MOR - - 2 COND
(04/07)

Vermillion, Inc.	MOR-2
VERMILLION INC.	Exhibit 4
MOR 2 — INCOME STATEMENT — APRIL 2009
OPERATING EXPENSES

GL ACCT	DESCRIPTION	AMT
8009	SAFETY SUPPLIES		109.95
8023	LAB SUPPLIES - GENERAL: SURF-U		691.97
8030	TOXIC WASTE DISPOSAL: SURF-UNS		39.44
8081	SAMPLE ACQUISITION COSTS		22,710.00
8110	SALARIES: SURF-UNSP		24,302.78
8210	PAYROLL TAXES: OATOF-UNSP		1,814.43
8212	PAID TIME OFF: OATOF-UNSP		327.46
8220	WORKERS’ COMP INS.: OATOF-UNSP		(11,843.50	)
8240	HEALTH INSURANCE: OATOF-UNSP		3,779.72
8304	TEMPORARY HELP: SURF-UNSP		(4,244.63	)
8310	CONSULTING FEES: OATOF-UNSP		(7,175.71	)
8311	OTHER OUTSIDE SERVICES: SURF-U		8,823.54
8313	INVESTOR RELATIONS		1,060.50
8321	LEGAL FEES - INTELLECTUAL PROP		14,963.76
8325	LEGAL FEES - LAWSUIT		4,075.98
8330	ACCOUNTING FEES		101.90
8331	AUDIT FEES		2,500.00
8360	COLLABORATION COSTS: OATOF-UNS		146,173.90
8375	ROYALTY/LICENSE FEES		5,916.56
8383	BOARD FEES		1,666.67
8437	EQUIPMENT RENTALS: SURF-UNSP		1,356.85
8452	DEPRECIATION: SURF-UNSP		31,156.10
8465	AUTO AND TRUCK LEASES: SURF-UN		759.49
8610	AIRFARE: SURF-UNSP		1,407.79
8620	HOTELS / LODGING: SURF-UNSP		489.07
8630	BUSINESS MEALS & ENTERTAINMENT		356.79
8640	GROUND TRANSPORTATION: SURF-UN		(52.50	)

GL ACCT	DESCRIPTION	AMT
8710	OFFICE AND COMPUTER SUPPLIES		26.95
8716	INSURANCE - D&O		8,916.67
8731	SOFTWARE LICENSES &MAINTENANCE		864.50
8750	BANK, CHARGE CARD AND LOAN FEES		783.74
8765	FEES, PERMITS: OATOF-UNSP		300.00
8775	POSTAGE AND SHIPPING: OATOF-UN		232.22
8810	OFFICE RENT: OATOF-UNSP		9,279.10
8812	STORAGE		328.10
8813	PROPERTY TAXES: OATOF-UNSP		2,545.25
8815	BUSINESS INSURANCE		5,631.58
8820	UTILITIES: OATOF-UNSP		2,738.07
8825	OFFICE MAINTENANCE AND REPAIRS		329.00
8830	OFFICE TELEPHONE AND FAXES		1,292.83
	TOTAL OPERATING EXPENSES		(284,536.32	)
OTHER INCOME AND EXPENSES
9110	INTEREST INCOME-MONEY MARKET		(2,086.03	)
9215	AMORTIZATION OF DEBT DISCOUNT		14,945.34
9230	INTEREST EXPENSE - CONVERTIBLE NOTES		105,625.00
9250	INTEREST EXPENSE-QUEST LOAN		30,821.92
9314	OFFERING COSTS AMORTIZATION		4,125.17
9360	FRANCHISE TAXES		3,200.00
	TOTAL OTHER INCOME AND EXPENSES		156,631.40
NET PROFIT (LOSS)			(441,167.72	)

Vermillion, Inc. MOR-3

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 — April 30, 2009

BALANCE SHEET

The Balance Sheet is to be completed on an accrual basis only. Pre-petition liabilities must be classified separately from postpetition obligations.

	BOOK VALUE AT END OF	BOOK VALUE ON
	CURRENT REPORTING MONTH	PETITION DATE
ASSETS
CURRENT ASSETS
Unrestricted Cash and Equivalents	See exhibit 5	See exhibit 6
Restricted Cash and Cash Equivalents (see continuation sheet)
Accounts Receivable (Net)
Notes Receivable
Inventories
Prepaid Expenses
Professional Retainers
Other Current Assets (attach schedule)
TOTAL CURRENT ASSETS	$	$
PROPERTY AND EQUIPMENT
Real Property and Improvements
Machinery and Equipment
Furniture, Fixtures and Office Equipment
Leasehold Improvements
Vehicles
Less Accumulated Depreciation
TOTAL PROPERTY & EQUIPMENT	$	$
OTHER ASSETS
Loans to Insiders*
Other Assets (attach schedule)
TOTAL OTHER ASSETS	$	$
TOTAL ASSETS	$	$

	BOOK VALUE AT END OF	BOOK VALUE ON
	CURRENT REPORTING MONTH	PETITION DATE
LIABILITIES AND OWNER EQUITY
LIABILITIES NOT SUBJECT TO COMPROMISE (Postpetition)
Accounts Payable
Taxes Payable (refer to FORM MOR-4)
Wages Payable
Notes Payable
Rent / Leases — Building/Equipment
Secured Debt / Adequate Protection Payments
Professional Fees
Amounts Due to Insiders*
Other Postpetition Liabilities (attach schedule)
TOTAL POSTPETITION LIABILITIES	$	$
LIABILITIES SUBJECT TO COMPROMISE (Pre-Petition)
Secured Debt
Priority Debt
Unsecured Debt
TOTAL PRE-PETITION LIABILITIES	$	$
TOTAL LIABILITIES	$	$
OWNER EQUITY
Capital Stock
Additional Paid-In Capital
Partners’ Capital Account
Owner’s Equity Account
Retained Earnings — Pre-Petition
Retained Earnings — Postpetition
Adjustments to Owner Equity (attach schedule)
Postpetition Contributions (Distributions) (Draws) (attach schedule)
NET OWNER EQUITY	$	$
TOTAL LIABILITIES AND OWNERS’ EQUITY	$	$

* “Insider” is defined in 11 U.S.C. Section 101(31).

FORM MOR-3
(04/07)

Vermillion, Inc. MOR-3

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 — April 30, 2009

BALANCE SHEET — continuation sheet

	BOOK VALUE AT END OF	BOOK VALUE ON
ASSETS	CURRENT REPORTING MONTH	PETITION DATE
Other Current Assets
Other Assets

	BOOK VALUE AT END OF	BOOK VALUE ON
LIABILITIES AND OWNER EQUITY	CURRENT REPORTING MONTH	PETITION DATE
Other Postpetition Liabilities
Adjustments to Owner Equity
Postpetition Contributions (Distributions) (Draws)

Restricted Cash is cash that is restricted for a specific use and not available to fund operations. Typically, restricted cash is segregated into a separate account, such as an escrow account.

FORM MOR-3 CONTD
(04/07)

Vermillion, Inc. MOR-3

Exhibit 5

Vermillion Inc.

For the Four Months Ending April 30, 2009

Assets:
Cash and cash equivalents	$	575,568.31
Employee receivables
Prepaids and other		662,848.09
Intercompany — IllumeSys		222,159.97
Intercompany — CTI		10,318.48
Intercompany — Denmark		354,966.56
Intercompany — Germany		(370,347.39	)
Intercompany — UK		20,888.89
Intercompany — France		(128,360.30	)
Intercompany — Ciphergen Int’l		2,507,898.82
Intercompany — Japan		1,261,994.85
Intercompany — Italy		10,504.77
Intercompany — China		(527,039.97	)
Fixed assets		2,962,643.96
Accumulated depreciation		(2,478,361.99	)
Investment in IllumeSys		1,699,988.35
Investment in UK		17,569.28
Investment in Denmark		65,413.35
Investment in China		618,339.92
Investment in Germany		266,480.00
Investment in Japan		(1,008,058.87	)
Investment in Italy		9,112.44
Investment in France		9,314.25
Other long-term assets		3,404,899.22
Total assets		10,168,740.99
Liabilities:
Accounts payable		2,511,537.17
Accrued liabilities		931,488.15
Accrued payroll and related		130,687.69
Intercompany accounts
Deferred rent — current		2,030.40
Other current liabilities, net of discount		2,500,000.00
Convertible senior notes, net of discounts		16,438,225.85
Long-term debt to related party		9,999,999.84
Total liabilities		32,513,969.10
Stockholders’ equity:
Common stock		6,383.92
Additional paid in capital		225,430,142.83
Deferred stock-based compensation		3,152,300.93
Accum. comprehensive income
Retained earnings — prior		(248,699,448.32	)
Retained earnings — current		(2,234,607.46	)
Total stockholders’ equity		(22,345,228.10	)
Total liabilities and equity		10,168,741.00

Vermillion, Inc. MOR-3

Exhibit 6

Vermillion Inc.
For the Three Months Ending March 31, 2009

Assets:
Cash and cash equivalents	$	613,916.89
Employee receivables
Prepaids and other		677,399.16
Intercompany — IllumeSys		222,159.97
Intercompany — CTI		10,318.48
Intercompany — Denmark		354,966.56
Intercompany — Germany		(370,347.39	)
Intercompany — UK		20,888.89
Intercompany — France		(128,360.30	)
Intercompany — Ciphergen Int’l		2,507,898.82
Intercompany — Japan		1,261,994.85
Intercompany — Italy		10,504.77
Intercompany — China		(527,039.97	)
Fixed assets		2,962,643.96
Accumulated depreciation		(2,447,205.89	)
Investment in IllumeSys		1,699,988.35
Investment in UK		17,569.28
Investment in Denmark		65,413.35
Investment in China		618,339.92
Investment in Germany		266,480.00
Investment in Japan		(1,008,058.87	)
Investment in Italy		9,112.44
Investment in France		9,314.25
Other long-term assets		3,407,960.89
Total assets		10,255,858.41
Liabilities:
Accounts payable		2,206,843.54
Accrued liabilities		898,295.11
Accrued payroll and related		129,997.44
Intercompany accounts
Deferred rent — current		1,827.36
Other current liabilities, net of discount		2,500,000.00
Convertible senior notes, net of discounts		16,423,280.51
Long-term debt to related party		9,999,999.84
Total liabilities		32,160,243.80
Stockholders’ equity:
Common stock		6,383.92
Additional paid in capital		225,430,142.83
Deferred stock-based compensation		3,152,300.93
Accum. comprehensive income
Retained earnings — prior		(248,699,448.32	)
Retained earnings — current		(1,793,764.74	)
Total stockholders’ equity		(21,904,385.38	)
Total liabilities and equity		10,255,858.42
05/14/09

Vermillion, Inc. MOR-4

In re: Vermillion, Inc.	Case No. 09-11091 (CSS)
Debtor	Reporting Period: March 30, 2009 — April 30, 2009

STATUS OF POSTPETITION TAXES

The beginning tax liability should be the ending liability from the prior month or, if this is the first report, the amount should be zero. Attach photocopies of IRS Form 6123 or payment receipt to verify payment or deposit of federal payroll taxes. Attach photocopies of any tax returns filed during the reporting period.

	Beginning	Amount				Ending
	Tax	Withheld or	Amount	Date	Check No.	Tax
Federal	Liability	Accrued	Paid	Paid	or EFT	Liability
Withholding			See exhibit 7
FICA-Employee
FICA-Employer
Unemployment
Income
Other:
Total Federal Taxes
State and Local
Withholding
Sales
Excise
Unemployment
Real Property
Personal Property
Other:
Total State and Local
Total Taxes

SUMMARY OF UNPAID POSTPETITION DEBTS

Attach aged listing of accounts payable.                     See exhibit 8

	Number of Days Past Due
	Current	0-30	31-60	61-90	Over 90	Total
Accounts Payable
Wages Payable
Taxes Payable
Rent/Leases-Building
Rent/Leases-Equipment
Secured Debt/Adequate Protection Payments
Professional Fees
Amounts Due to Insiders*
Other:
Other:
Total Postpetition Debts

Explain how and when the Debtor intends to pay any past-due postpetition debts.

* “Insider” is defined in 11 U.S.C. Section 101(31).

FORM MOR-4
(04/07)

Vermillion, Inc. MOR-4

(Exhibit 7)

Exhibit 7 to the Monthly Operating Report containing tax withholding statements, as filed with the U.S. Bankruptcy Court of Delaware, is available through the Federal Court filing system PACER at http://pacer.psc.uscourts.gov/ in the Company’s document section.

( )  Exhibit 7 is marked as “Exhibit 6” on the original filing

Vermillion, Inc. MOR-4

Exhibit 8

VERMILLION, INC.
ACCOUNTS PAYABLE AGED INVOICE REPORT
ALL OPEN INVOICES — AGED BY INVOICE DATE

H
VENDOR/            DATES            L INVOICE				DISCOUNT
INVOICE NO. INVOICE DUE DSCNT D BALANCE					AMOUNT	CURRENT	30 DAYS	60 DAYS	90 DAYS	120 DAYS
ACE1	ACE USA
372646	04/22/09 04/22	N	2,091.00		0	2,091.00
APPLI11	APPLIED CLINICAL INTELLIGENCE
09-122-APR	05/04/09 05/04	N	52,600.00		0	52,600.00
BAYAL01	BAY ALARM COMPANY
2263122090	04/16/09 04/16	N	339.00		0	339
BLUEC00	BLUE CROSS OF CALIFORNIA
0200904070	04/03/09 04/03	N	2,571.00		0		2,571.00
BOWNE00	BOWNE OF LOS ANGELES, INC.
090425210	04/15/09 04/15	N	2,166.00		0	2,166.00
090436080	04/22/09 04/22	N	413.00		0	413
CARRU01	CARRUTHERS, SUSAN D
043009	04/30/09 04/30	N	3,474.20		0	3,474.20
CINTA00	CINTAS CORPORATION #054
DG38044465	04/08/09 05/08	N	109.95		0		109.95
CITTE00	CIT TECHNOLOGY FIN SERV, INC
14156735	04/24/09 04/24	N	1,016.40		0	1,016.40
CRUTC00	CRUTCHER, GILLIAN
042809	04/28/09 04/28	N	159.00		0	159
CTCOR00	CT CORPORATION
042909	04/29/09 05/29	N	12,900.00		0	12,900.00
2004317668	04/01/09 05/01	N	540.00		0		540
ENDSI00	ENDSIGHT
34569	04/01/09 04/01	N	4,000.00		0		4,000.00
FACIL01	FACILITIES MAINTENANCE SVCS
28215	04/15/09 05/15	N	329.00		0	329

H
VENDOR/            DATES            L INVOICE				DISCOUNT
INVOICE NO. INVOICE DUE DSCNT D BALANCE					AMOUNT	CURRENT	30 DAYS	60 DAYS	90 DAYS	120 DAYS
FOLEY01	FOLEY & LARDNER
31028051	04/18/09 04/18	N	380.50		0	380.5
GLOBA06	GLOBAL CROSSING CONFERENCING
2180966	04/29/09 05/29	N	464.27		0	464.27
IRONM00	IRON MOUNTAIN
ADZ3038	04/30/09 05/30	N	354.29		0	354.29
JOHNS00	JOHNS HOPKINS UNIVERSITY
042409	04/24/09 04/24	N	22,710.00		0	22,710.00
043009	04/30/09 04/30	N	154,000.00		0	154,000.00
LANDR00	LAND ROVER CAPITAL GROUP
051109	04/21/09 04/21	N	1,363.77		0	1,363.77
PACIF00	AT&T
040109	04/01/09 04/01	N	828.56		0		828.56
PALLI00	PALLIS, KATHERINE C.
56	04/17/09 05/17	N	1,548.00		0	1,548.00
PGE00	P G & E
041009	04/10/09 04/10	N	407.93		0		407.93
PRAXA00	PRAXAIR DISTRIBUTION, INC.
32874091	04/20/09 05/20	N	29.80		0	29.8
PRECI09	PRECISIONMED INC.
703	04/20/09 04/20	N	5,000.00		0	5,000.00
PRNEW00	PR NEWSWIRE
100724051	04/02/09 04/02	N	1,060.50		0		1,060.50
PROLO00	PROLOGIS LIMITED PARTNERSHIP-I
050109	04/29/09 04/29	N	9,076.06		0	9,076.06
PUBLI00	PUBLIC STORAGE, INC.
050109	04/29/09 04/29	N	255.00		0	255
042109	04/21/09 04/21	N	73.10		0	73.1
PURCH00	PURCHASE POWER
042109	04/21/09 05/06	N	25.00		0	25
QUINN00	QUINN EMANUEL URQUHART
1140987	04/13/09 04/13	N	4,075.98		0	4,075.98
STERI00	STERICYCLE INC.
3000410014	04/01/09 05/01	N	501.38		0		501.38
ZHOUT01	ZHOU, QUN
043009	04/30/09 04/30	N	8,687.50		0	8,687.50

Vermillion, Inc. MOR-5

In re: Vermillion, Inc.

Debtor

ACCOUNTS RECEIVABLE RECONCILIATION AND AGING

N/A

Accounts Receivable Reconciliation	Amount
Total Accounts Receivable at the beginning of the reporting period
+ Amounts billed during the period
- Amounts collected during the period
Total Accounts Receivable at the end of the reporting period

Accounts Receivable Aging	Amount
0 - 30 days old
31 - 60 days old
61 - 90 days old
91+ days old
Total Accounts Receivable
Amount considered uncollectible (Bad Debt)
Accounts Receivable (Net)

DEBTOR QUESTIONNAIRE

Must be completed each month	Yes	No
1. Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.		X
2. Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.		X
3. Have all postpetition tax returns been timely filed? If no, provide an explanation below.	X
4. Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.	X
5. Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.	X

FORM MOR-5
(04/07)

EX-99.2

Statement of Financial Affairs and Schedules of Assets and Liabilities Exhibit 99.2

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE

	x
	:	Chapter 11
In re:	:
	:	Case No. 09-11091 (CSS)
VERMILLION, INC.,1	:
	:
Debtor.	:
	:
	:
	:
	x

STATEMENT OF FINANCIAL AFFAIRS AND
SCHEDULES OF ASSETS AND LIABILITIES

¹ The address of the Debtor’s principal executive offices is 47350 Fremont Blvd., Fremont, California 94538. The Debtor’s EIN is
33-0595156.

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE

	x
	:	Chapter 11
In re:	:
	:	Case No. 09-11091 (CSS)
VERMILLION, INC.,2	:
	:
Debtor.	:
	:
	:
	:
	x

STATEMENT OF FINANCIAL AFFAIRS AND SCHEDULES OF ASSETS
LIABILITIES DECLARATION UNDER PENALTY OF PERJURY
OF GAIL S. PAGE, ON BEHALF OF THE COMPANY

     I, Ms. Gail S. Page, Executive Chair of the Board of Directors of Vermillion, Inc., the above-captioned debtor and debtor-in-possession (the “Debtor”), declare under penalty of perjury that I have reviewed the Debtor’s Statement of Financial Affairs, Summary of Schedules, Schedule A, B, D, E, F, G, and H (collectively, the “Schedules”) and the Global Notes and Statement of Limitations, Methodology and Disclaimer Regarding Debtor’s Statements of Financial Affairs with Schedules, and that they are true and correct to the best of my knowledge, information, and belief.

     Although every effort has been taken to make the Statement of Financial Affairs and Schedules of Assets and Liabilities accurate and complete, because of the magnitude and complexity of the task, inadvertent errors or omissions may exist.

Date: June 11, 2009

Ms. Gail S. Page

Executive Chair of the Board of Directors

Vermillion, Inc.

² The address of the Debtor’s principal executive offices is 47350 Fremont Blvd., Fremont, California 94538. The Debtor’s EIN is
33-0595156.

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE

	x
	:	Chapter 11
In re:	:
	:	Case No. 09-11091 (CSS)
VERMILLION, INC.,	:
	:
Debtor.	:
	:
	:
	:
	x

GLOBAL NOTES AND STATEMENT OF LIMITATIONS, METHODOLOGY
AND DISCLAIMER REGARDING DEBTOR’S STATEMENTS OF FINANCIAL
AFFAIRS WITH SCHEDULES¹

     The Schedules of Assets and Liabilities and Statements of Financial Affairs (the “Schedules and Statements”) filed herewith by Vermillion, Inc. (“Vermillion”), the above-captioned debtor and debtor-in-possession (the “Debtor”) were prepared pursuant to section 521 of 11 U.S.C. §§ 101-1532 (as amended and applicable to this bankruptcy case, the “Bankruptcy Code”) and Rule 1007 of the Federal Rules of Bankruptcy Procedure (the “Bankruptcy Rules”) by management of the Debtor and are unaudited. While the Debtor’s management has made every effort to ensure that the Schedules and Statements are accurate and complete based on information that was available at the time of preparation, inadvertent errors or omissions may have occurred. The Schedules and Statements remain subject to further review and verification by the Debtor. Subsequent information may result in material changes in financial and other data contained in the Schedules and Statements. Except as noted in the Schedules and Statements, all asset and liability data is reported as of the close of business on March 30, 2009. The Debtor has used its best efforts to compile the information set forth in the Schedules and Statements from its books and records maintained in the ordinary course of its business. The Debtor reserves its right to amend its Schedules and Statements from time to time as may be necessary or appropriate. These Global Notes and Statement of Limitations, Methodology and Disclaimer Regarding Debtor’s Statements of Financial Affairs with Schedules (the “Global Notes”) are incorporated by reference in, and comprise an integral part of, the Schedules and Statements, and should be referred to and reviewed in connection with any review of the Schedules and Statements.

¹ A Statement of Financial Affairs and Schedule of Assets of Liabilities for the Debtor begins immediately after these Global Notes.

     1. Description of the Cases. On March 30, 2009 (the “Petition Date”), the Debtor filed its voluntary petition with the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) for reorganization under chapter 11 of the Bankruptcy Code under case numbers 09-11091 (CSS) and an order for relief was entered by the Bankruptcy Court. The Debtor is currently operating its business as a debtor in possession under the Bankruptcy Code.

     2. Basis of Presentation. For financial reporting purposes, the Debtor prepares consolidated financial statements, which include financial information for certain of the Debtor’s non-debtor subsidiaries. The Schedules and Statements are unaudited and reflect the Debtor’s best efforts to report the assets and liabilities of the Debtor on an unconsolidated basis. These Schedules and Statements neither purport to represent financial statements prepared in accordance with Generally Accepted Accounting Principles in the United States (“GAAP”), nor are they intended to fully reconcile to the financial statements.

     3. Summary of Significant Reporting Policies. The Schedules and Statements have been signed by Ms. Gail S. Page, Executive Chair of the Board of Directors of Vermillion. In reviewing and signing the Schedules and Statements, Ms Page has necessarily relied upon the efforts, statements and representations of the accounting and non-accounting personnel located at Vermillion’s headquarters. Ms. Page has not (and could not have) personally verified the accuracy of each such statement and representation, including statements and representations concerning amounts owed to creditors.

     The Debtor made its best effort to report asset, liability, disbursement, and other information on the appropriate Schedules and Statements. However, the following qualifications and limitations apply to the Schedules and Statements and the Debtor has adopted the following conventions in the preparation of the Schedules and Statements:

          (a) Reporting Date. Assets reported in the Debtor’s Schedules and Statements are prepared as of the close of business on March 30, 2009, unless otherwise noted. Liabilities are reported in the Debtor’s Schedules and Statements as of the close of business on March 30, 2009.

          (b) Book Value. Each asset and liability of the Debtor is shown on the basis of the book value of the asset or liability in the Debtor’s accounting books and records, unless otherwise noted, rather than the current market values, of such interests in property and/or liabilities.

          (c) Intellectual Property Rights. Inclusion of certain intellectual property shall not be construed as an admission that such intellectual property rights have not been abandoned, have not been terminated or otherwise expired by their terms, or have not been assigned or otherwise transferred pursuant to a sale, acquisition, or other transaction. Accordingly, the Debtor reserves all of its rights with respect to the legal status of such intellectual property rights.

          (d) Causes of Action. The Debtor has not set forth all causes of action against all third parties as assets in their Schedules and Statements. The Debtor reserves all of its

2

rights with respect to any causes of action that it may have, and neither these Global Notes nor the Schedules and Statements shall be deemed a waiver of any such causes of action.

          (e) Executory Contracts. The Debtor has not set forth executory contracts as assets in their Schedules and Statements. The Debtor’s executory contracts have been set forth in Schedule G.

          (f) Property and equipment — owned. Unless otherwise noted, owned property and equipment are stated as net book value. The estimated useful lives for the Debtor’s assets are up to eight (8) years for other fixtures and equipment and leasehold improvements are depreciated over a eight (8) year period or the life of the lease, whichever is less. The leases are identified in the Debtor’s Schedule G of Executory Contracts. For tax reporting purposes, all assets were recorded using straight line methods of depreciation. Inasmuch as the Debtor calculates depreciation and amortization monthly, the Schedules and Statements reflect monthly depreciation and amortization through March 30, 2009.

          (g) Property and equipment — leased. In the ordinary course of its business, the Debtor leases equipment and computer hardware and software from certain third-party lessors. Any such leases are set forth in the Schedules and Statements. Nothing in the Schedules and Statements is or shall be construed as an admission or determination as to the legal status of any lease (including whether any lease is a true lease or a financing arrangement), and the Debtor reserves all rights with respect to any of such issues.

          (h) Payments to Creditors and Insiders. On Statement of Financial Affairs 3c and 23, the Debtor has not scheduled payments made to employees who may be deemed officers where the employees function in a purely ministerial role and have no material inside information.

          (i) Interests in Subsidiaries and Affiliates. Vermillion owns directly or indirectly eleven subsidiaries and/or affiliates. Equity interests in subsidiaries and affiliates primarily arise from common stock ownership or partnership interests. The Debtor’s “Schedule B-Personal Property” lists the Debtor’s ownership interests, if any, in subsidiaries and affiliates. For purposes of these Schedules and Statements, the Debtor has listed the value of some ownership interests as undetermined because the fair market value of such stock or interests is dependent on numerous variables and factors and may differ significantly from the net book value.

          (j) Financial Statements. Vermillion is a publicly traded corporation whose common shares were traded as of the Petition Date on the OTC Bulletin Board under the symbol “VRML.” Prior to the Petition Date, Vermillion publicly filed periodic reports with the United States Securities & Exchange Commission.

          (k) Schedule D:

               (i) Except as otherwise agreed pursuant to a stipulation or agreed order or any other order entered by the Bankruptcy Court, the Debtor reserves its rights to dispute or challenge the validity, perfection, or immunity from avoidance of any lien purported to be granted or perfected in any specific asset to a secured creditor listed on Schedule D of the

3

Schedules and Statements. Moreover, although the Debtor has scheduled claims of certain creditors as secured claims, the Debtor reserves all rights to dispute or challenge the secured nature of any such creditor’s claim or the characterization of the structure of any such transaction, or any document or instrument related to such creditor’s claim.

               (ii) No claim set forth on Schedule D of the Schedules and Statements is intended to acknowledge claims of creditors that are otherwise satisfied or discharged by other entities. The descriptions provided in Schedule D are intended only to be a summary. Reference to the applicable loan agreements and related documents is necessary for a complete description of the collateral and the nature, extent, and priority of any liens. Nothing in the Global Notes or the Schedules and Statements shall be deemed a modification or interpretation of the terms of such agreements. Holders of secured claims by virtue of holding setoff rights against the Debtor are not included on Schedule D. To the extent that the Debtor is a party to capital leases, the Debtor has treated those leases as executory contracts, which may be shown on Schedule G. However, the Debtor reserves its rights to assert that such capital leases are secured financings, rather than unexpired leases.

          (l) Schedule F. No claim set forth on Schedule F of the Schedules and Statements is intended to acknowledge claims of creditors that are otherwise satisfied or discharged by other entities. The descriptions provided in Schedule F are intended only to be a summary. Nothing in the Global Notes or the Schedules and Statements shall be deemed a modification or interpretation of the terms of such agreements. The claims of individual creditors for, among other things, merchandise, goods, services, or taxes are listed at the amounts listed on the Debtor’s books and records and may not reflect credits or allowances due from such creditor. The Debtor reserves all of its rights respecting such credits and allowances. The dollar amounts listed may be exclusive of contingent and unliquidated amounts. The Debtor expressly incorporates by reference into Schedule F all parties to pending and potential pending litigation listed in the Debtor’s Statements as contingent, unliquidated, and disputed claims to the extent not already listed on Schedule F. All parties to executory contracts, including those listed on Schedule G, are holders of contingent and unliquidated unsecured claims arising from (i) obligations under those executory contracts and/or (ii) rejection damages in the event that such executory contract is rejected. Not all such claims are duplicated on Schedule F.

          (m) Schedule G:

               (i) While every effort has been made to ensure the accuracy of the Schedule of Executory Contracts, inadvertent errors or omissions may have occurred. The Debtor hereby reserves all of its rights to dispute the validity, status, or enforceability of any contracts, agreements, or leases set forth in Schedule G and to amend or supplement such Schedule as necessary.

               (ii) The contracts, agreements, and leases listed on Schedule G may have expired or may have been modified, amended, or supplemented from time to time by various amendments, restatements, waivers, estoppel certificates, letters, and other documents, instruments, and agreements that may not be listed therein. Certain of the real property leases listed on Schedule G may contain renewal options, guarantees of payment, options to purchase, rights of first refusal, rights to lease additional space, and other miscellaneous rights. Such

4

rights, powers, duties, and obligations are not set forth on Schedule G. Certain of the executory agreements may not have been memorialized and could be subject to dispute. Schedule G does not include stand alone purchase orders for goods or equipment or nondisclosure agreements. Additionally, the Debtor may be parties to various other agreements concerning real property, such as easements, rights of way, subordination, non-disturbance and attornment agreements, supplemental agreements, amendments/letter agreements, title documents, consents, site plans, maps, and other miscellaneous agreements. Such documents are not set forth in Schedule G. Certain of the agreements listed on Schedule G may be in the nature of conditional sales agreements or secured financings.

               (iii) The presence of a contract or agreement on this schedule does not constitute an admission that such contract or agreement is an executory contract or unexpired lease. The Debtor reserves all of its rights, claims, and causes of action with respect to the contracts and agreements listed on these Schedules.

          (n) Statement of Financial Affairs. Both questions 3c and 23 in the statement of financial affairs request information regarding payments to insiders. The Debtor has listed payroll related payments and loan repayments to its insiders in response to question 3c and 23.

     4. Employee Claims. The Bankruptcy Court entered an order (the “401K Order”) granting authority to the Debtor to pay prepetition obligations owed in connection with the Debtor’s 401K Plan. Pursuant to such 401K Order, the Debtor believes that any employee claims for prepetition amounts owed in connection with the 401K plan either have been satisfied or are in the process of being satisfied. The Debtor believes that no other prepetition employee wage, salary, benefit, or other employee claims are outstanding. Accordingly, employee claims for amounts owing as of the end of the day on March 30, 2009, that have been paid or that are intended to be paid have not been included in the Schedules and Statements. The Debtor has listed its employees on Schedules E and/or F as having unliquidated claims that cover accrued vacation and/or bonuses.

     5. Disputed, Contingent, and/or Unliquidated Claims. Schedules D, E, and F permit the Debtor to designate a claim as disputed, contingent, and/or unliquidated. A failure to designate a claim on any of these schedules as disputed, contingent, and/or unliquidated does not constitute an admission that such claim is not subject to objection. The Debtor reserves the right to dispute, or assert offsets or defenses to any claim reflected on these Schedules as to nature, amount, liability, or status or to otherwise subsequently designate any claim as disputed, contingent, or unliquidated.

     6. Insurance. Vermillion maintains general liability insurance policies, and various other insurance policies, on behalf of the Debtor. A listing of all such insurance policies is set forth on Schedule G.

5

     7. Global Notes Control. In the event that the Schedules and Statements differ from the foregoing Global Notes, the Global Notes shall control.

***END OF GLOBAL NOTES***
**SCHEDULES AND STATEMENTS BEGIN ON THE FOLLOWING PAGE**

6

B7 (Official Form 7) (12/07)

United States Bankruptcy Court
District of Delaware

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)	Chapter	11

STATEMENT OF FINANCIAL AFFAIRS

               This statement is to be completed by every debtor. Spouses filing a joint petition may file a single statement on which the information for both spouses is combined. If the case is filed under chapter 12 or chapter 13, a married debtor must furnish information for both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed. An individual debtor engaged in business as a sole proprietor, partner, family farmer, or self-employed professional, should provide the information requested on this statement concerning all such activities as well as the individual’s personal affairs. To indicate payments, transfers and the like to minor children, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. § 112; Fed. R. Bankr. P. 1007(m).

               Questions 1 — 18 are to be completed by all debtors. Debtors that are or have been in business, as defined below, also must complete Questions 19 — 25. If the answer to an applicable question is “None,” mark the box labeled “None.” If additional space is needed for the answer to any question, use and attach a separate sheet properly identified with the case name, case number (if known), and the number of the question.

DEFINITIONS

               “In business.” A debtor is “in business” for the purpose of this form if the debtor is a corporation or partnership. An individual debtor is “in business” for the purpose of this form if the debtor is or has been, within six years immediately preceding the filing of this bankruptcy case, any of the following: an officer, director, managing executive, or owner of 5 percent or more of the voting or equity securities of a corporation; a partner, other than a limited partner, of a partnership; a sole proprietor or self-employed full-time or part-time. An individual debtor also may be “in business” for the purpose of this form if the debtor engages in a trade, business, or other activity, other than as an employee, to supplement income from the debtor’s primary employment.

               “Insider.” The term “insider” includes but is not limited to: relatives of the debtor; general partners of the debtor and their relatives; corporations of which the debtor is an officer, director, or person in control; officers, directors, and any owner of 5 percent or more of the voting or equity securities of a corporate debtor and their relatives; affiliates of the debtor and insiders of such affiliates; any managing agent of the debtor. 11 U.S.C. § 101.

1. Income from employment or operation of business
State the gross amount of income the debtor has received from employment, trade, or profession, or from operation of the debtor’s business, including part-time activities either as an employee or in independent trade or business, from the beginning of this calendar year to the date this case was commenced. State also the gross amounts received during the two years immediately preceding this calendar year. (A debtor that maintains, or has maintained, financial records on the basis of a fiscal rather than a calendar year may report fiscal year income. Identify the beginning and ending dates of the debtor’s fiscal year.) If a joint petition is filed, state income for each spouse separately. (Married debtors filing under chapter 12 or chapter 13 must state income of both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)
	AMOUNT $167,539	SOURCE Service Contract Revenue

	2. Income other than from employment or operation of business
None    þ	State the amount of income received by the debtor other than from employment, trade, profession, or operation of the debtor’s business during the two years immediately preceding the commencement of this case. Give particulars. If a joint petition is filed, state income for each spouse separately. (Married debtors filing under chapter 12 or chapter 13 must state income for each spouse whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)
		AMOUNT	SOURCE

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

2

	3. Payments to creditors
None    þ	Complete a. or b., as appropriate, and c.
	a. Individual or joint debtor(s) with primarily consumer debts. List all payments on loans, installment purchases of goods or services, and other debts to any creditor made within 90 days immediately preceding the commencement of this case unless the aggregate value of all property that constitutes or is affected by such transfer is less than $600. Indicate with an (*) any payments that were made to a creditor on account of a domestic support obligation or as part of an alternative repayment schedule under a plan by an approved nonprofit budgeting and creditor counseling agency. (Married debtors filing under chapter 12 or chapter 13 must include payments by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS	DATES OF		AMOUNT STILL
OF CREDITOR	PAYMENTS	AMOUNT PAID	OWING

b. Debtor whose debts are not primarily consumer debts: List each payment or other transfer to any creditor made within 90 days immediately preceding the commencement of the case unless the aggregate value of all property that constitutes or is affected by such transfer is less than $5,475. If the debtor is an individual, indicate with an asterisk (*) any payments that were made to a creditor on account of a domestic support obligation or as part of an alternative repayment schedule under a plan by an approved nonprofit budgeting and creditor counseling agency. (Married debtors filing under chapter 12 or chapter 13 must include payments by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

		AMOUNT
	DATES OF	PAID OR
NAME AND ADDRESS OF CREDITOR	PAYMENTS/	VALUE OF	AMOUNT STILL
See attached file — Form 7, question 3-b	TRANSFERS	TRANSFERS	OWING

c. All debtors: List all payments made within one year immediately preceding the commencement of this case to or for the benefit of creditors who are or were insiders. (Married debtors filing under chapter 12 or chapter 13 must include payments by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS OF CREDITOR AND
RELATIONSHIP TO DEBTOR			AMOUNT STILL
See attached file — Form 7, question 3-c	DATE OF PAYMENT	AMOUNT PAID	OWING

4. Suits and administrative proceedings, executions, garnishments and attachments

a. List all suits and administrative proceedings to which the debtor is or was a party within one year immediately preceding the filing of this bankruptcy case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

CAPTION OF SUIT		COURT OR AGENCY	STATUS OR
AND CASE NUMBER	NATURE OF PROCEEDING	AND LOCATION	DISPOSITION
See attached file — Form 7,
question 4-a

None
   þ b. Describe all property that has been attached, garnished or seized under any legal or equitable process within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning property of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS OF PERSON FOR WHOSE BENEFIT PROPERTY WAS SEIZED DATE OF SEIZURE DESCRIPTION AND VALUE OF
PROPERTY

5. Repossessions, foreclosures and returns

None    þ

List all property that has been repossessed by a creditor, sold at a foreclosure sale, transferred through a deed in lieu of foreclosure or returned to the seller, within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning property of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS OF CREDITOR OR SELLER DATE OF REPOSSESSION, FORECLOSURE SALE,
TRANSFER OR RETURN DESCRIPTION AND VALUE OF
PROPERTY

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

3

	6. Assignments and receiverships
None þ	a. Describe any assignment of property for the benefit of creditors made within 120 days immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include any assignment by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

	DATE OF
NAME AND ADDRESS OF ASSIGNEE	ASSIGNMENT	TERMS OF ASSIGNMENT OR SETTLEMENT

None
þ b. List all property which has been in the hands of a custodian, receiver, or court-appointed official within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning property of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

	NAME AND LOCATION
NAME AND ADDRESS	OF COURT	DATE OF	DESCRIPTION AND VALUE OF
OF CUSTODIAN	CASE TITLE & NUMBER	ORDER	PROPERTY

7. Gifts

None þ

List all gifts or charitable contributions made within one year immediately preceding the commencement of this case except ordinary and usual gifts to family members aggregating less than $200 in value per individual family member and charitable contributions aggregating less than $100 per recipient. (Married debtors filing under chapter 12 or chapter 13 must include gifts or contributions by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS OF	RELATIONSHIP TO		DESCRIPTION AND
PERSON OR ORGANIZATION	DEBTOR, IF ANY	DATE OF GIFT	VALUE OF GIFT

	8. Losses
None þ	List all losses from fire, theft, other casualty or gambling within one year immediately preceding the commencement of this case or since the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include losses by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

	DESCRIPTION OF CIRCUMSTANCES AND, IF
DESCRIPTION AND VALUE	LOSS WAS COVERED IN WHOLE OR IN PART
OF PROPERTY	BY INSURANCE, GIVE PARTICULARS	DATE OF LOSS

9. Payments related to debt counseling or bankruptcy

List all payments made or property transferred by or on behalf of the debtor to any persons, including attorneys, for consultation concerning debt consolidation, relief under the bankruptcy law or preparation of the petition in bankruptcy within one year immediately preceding the commencement of this case.

	DATE OF PAYMENT,		AMOUNT OF MONEY
NAME AND ADDRESS	NAME OF PAYOR IF OTHER		OR DESCRIPTION AND VALUE
OF PAYEE	THAN DEBTOR		OF PROPERTY
Paul, Hastings, Janofsky		3/25/09	$	170,000.00
Womble Carlyle Sandridge & Rice, PLLC		3/27/09	$	30,000.00

10. Other transfers

None þ

a. List all other property, other than property transferred in the ordinary course of the business or financial affairs of the debtor, transferred either absolutely or as security within two years immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include transfers by either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS OF TRANSFEREE,		DESCRIBE PROPERTY TRANSFERRED
RELATIONSHIP TO DEBTOR	DATE	AND VALUE RECEIVED

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

4

None
þ b. List all property transferred by the debtor within ten years immediately preceding the commencement of this case to a self-settled trust or similar device of which the debtor is a beneficiary.

		AMOUNT OF MONEY OR DESCRIPTION AND
NAME OF TRUST OR OTHER	DATE(S) OF	VALUE OF PROPERTY OR DEBTOR'S INTEREST
DEVICE	TRANSFER(S)	IN PROPERTY

11. Closed financial accounts

List all financial accounts and instruments held in the name of the debtor or for the benefit of the debtor which were closed, sold, or otherwise transferred within one year immediately preceding the commencement of this case. Include checking, savings, or other financial accounts, certificates of deposit, or other instruments; shares and share accounts held in banks, credit unions, pension funds, cooperatives, associations, brokerage houses and other financial institutions. (Married debtors filing under chapter 12 or chapter 13 must include information concerning accounts or instruments held by or for either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

	TYPE OF ACCOUNT, LAST FOUR
	DIGITS OF ACCOUNT NUMBER,	AMOUNT AND DATE OF SALE
NAME AND ADDRESS OF INSTITUTION	AND AMOUNT OF FINAL BALANCE	OR CLOSING
Wells Fargo Bank	Savings account	September 29, 2008, $90,994.63

12. Safe deposit boxes

None þ

List each safe deposit or other box or depository in which the debtor has or had securities, cash, or other valuables within one year immediately preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include boxes or depositories of either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

	NAMES AND ADDRESSES
NAME AND ADDRESS OF BANK	OF THOSE WITH ACCESS	DESCRIPTION	DATE OF TRANSFER OR
OR OTHER DEPOSITORY	TO BOX OR DEPOSITORY	OF CONTENTS	SURRENDER, IF ANY

	13. Setoffs
None þ	List all setoffs made by any creditor, including a bank, against a debt or deposit of the debtor within 90 days preceding the commencement of this case. (Married debtors filing under chapter 12 or chapter 13 must include information concerning either or both spouses whether or not a joint petition is filed, unless the spouses are separated and a joint petition is not filed.)

NAME AND ADDRESS OF CREDITOR DATE OF SETOFF AMOUNT OF SETOFF

	14. Property held for another person
None þ	List all property owned by another person that the debtor holds or controls.

	DESCRIPTION AND VALUE OF
NAME AND ADDRESS OF OWNER	PROPERTY	LOCATION OF PROPERTY

15. Prior address of debtor

If the debtor has moved within three years immediately preceding the commencement of this case, list all premises which the debtor occupied during that period and vacated prior to the commencement of this case. If a joint petition is filed, report also any separate address of either spouse.

ADDRESS:	NAME USED	DATES OF OCCUPANCY
6611 Dumbarton Circle Fremont, CA 94555	Vermillion Inc	Aug, 2000 — July 2008

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

5

16. Spouses and Former Spouses

None þ

If the debtor resides or resided in a community property state, commonwealth, or territory (including Alaska, Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Puerto Rico, Texas, Washington, or Wisconsin) within eight years immediately preceding the commencement of the case, identify the name of the debtor’s spouse and of any former spouse who resides or resided with the debtor in the community property state.

NAME

	17. Environmental Information.
	For the purpose of this question, the following definitions apply:
	“Environmental Law” means any federal, state, or local statute or regulation regulating pollution, contamination, releases of hazardous or toxic substances, wastes or material into the air, land, soil, surface water, groundwater, or other medium, including, but not limited to, statutes or regulations regulating the cleanup of these substances, wastes, or material.
	“Site” means any location, facility, or property as defined under any Environmental Law, whether or not presently or formerly owned or operated by the debtor, including, but not limited to, disposal sites. “Hazardous Material” means anything defined as a hazardous waste, hazardous substance, toxic substance, hazardous material, pollutant, or contaminant or similar term under an Environmental Law
None þ	a. List the name and address of every site for which the debtor has received notice in writing by a governmental unit that it may be liable or potentially liable under or in violation of an Environmental Law. Indicate the governmental unit, the date of the notice, and, if known, the Environmental Law:

	NAME AND ADDRESS OF	DATE OF	ENVIRONMENTAL
SITE NAME AND ADDRESS	GOVERNMENTAL UNIT	NOTICE	LAW

None
þ b. List the name and address of every site for which the debtor provided notice to a governmental unit of a release of Hazardous Material. Indicate the governmental unit to which the notice was sent and the date of the notice.

	NAME AND ADDRESS OF	DATE OF	ENVIRONMENTAL
SITE NAME AND ADDRESS	GOVERNMENTAL UNIT	NOTICE	LAW

None
þ c. List all judicial or administrative proceedings, including settlements or orders, under any Environmental Law with respect to which the debtor is or was a party. Indicate the name and address of the governmental unit that is or was a party to the proceeding, and the docket number.

NAME AND ADDRESS OF
GOVERNMENTAL UNIT	DOCKET NUMBER	STATUS OR DISPOSITION

18 . Nature, location and name of business

a. If the debtor is an individual, list the names, addresses, taxpayer identification numbers, nature of the businesses, and beginning and ending dates of all businesses in which the debtor was an officer, director, partner, or managing executive of a corporation, partner in a partnership, sole proprietor, or was self-employed in a trade, profession, or other activity either full- or part-time within six years immediately preceding the commencement of this case, or in which the debtor owned 5 percent or more of the voting or equity securities within six years immediately preceding the commencement of this case.

If the debtor is a partnership, list the names, addresses, taxpayer identification numbers, nature of the businesses, and beginning and ending dates of all businesses in which the debtor was a partner or owned 5 percent or more of the voting or equity securities, within six years immediately preceding the commencement of this case.

If the debtor is a corporation, list the names, addresses, taxpayer identification numbers, nature of the businesses, and beginning and ending dates of all businesses in which the debtor was a partner or owned 5 percent or more of the voting or equity securities within six years immediately preceding the commencement of this case.

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

6

	LAST FOUR DIGITS OF
	SOCIAL-SECURITY OR
	OTHER INDIVIDUAL
	TAXPAYER-I.D. NO.			BEGINNING AND
NAME	(ITIN)/ COMPLETE EIN	ADDRESS	NATURE OF BUSINESS	ENDING DATES
Ciphergen Biosystems Inc Vermillion, Inc See attached file- Form 7, question 18-a	33-0595156	6611 Dumbarton Circle, Fremont, CA 94555 47350 Fremont Blvd., Fremont, CA 94538	Business is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients	Originally incorporated in California on December 9, 1993, filled chapter 11 on March 31, 2009

None b. Identify any business listed in response to subdivision a., above, that is “single asset real estate” as defined in 11 U.S.C. § 101.

NAME ADDRESS

     The following questions are to be completed by every debtor that is a corporation or partnership and by any individual debtor who is or has been, within six years immediately preceding the commencement of this case, any of the following: an officer, director, managing executive, or owner of more than 5 percent of the voting or equity securities of a corporation; a partner, other than a limited partner, of a partnership, a sole proprietor or self-employed in a trade, profession, or other activity, either full- or part-time.

     (An individual or joint debtor should complete this portion of the statement only if the debtor is or has been in business, as defined above, within six years immediately preceding the commencement of this case. A debtor who has not been in business within those six years should go directly to the signature page.)

19. Books, records and financial statements

a. List all bookkeepers and accountants who within two years immediately preceding the filing of this bankruptcy case kept or supervised the keeping of books of account and records of the debtor.

NAME AND ADDRESS	DATES SERVICES RENDERED
The company itself

b. List all firms or individuals who within the two years immediately preceding the filing of this bankruptcy case have audited the books of account and records, or prepared a financial statement of the debtor.

NAME	ADDRESS	DATES SERVICES RENDERED
PricewaterhouseCoopers LLP	Ten Almaden Blvd, Suite 1600, San Jose, CA 95113	Year end and quarter end

c. List all firms or individuals who at the time of the commencement of this case were in possession of the books of account and records of the debtor. If any of the books of account and records are not available, explain.

NAME	ADDRESS
The company (debtor itself)	47350 Fremont Blvd. Fremont, CA 94538

None
þ d. List all financial institutions, creditors and other parties, including mercantile and trade agencies, to whom a financial statement was issued by the debtor within two years immediately preceding the commencement of this case.

NAME AND ADDRESS DATE ISSUED

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

7

	20. Inventories
None þ	a. List the dates of the last two inventories taken of your property, the name of the person who supervised the taking of each inventory, and the dollar amount and basis of each inventory.

		DOLLAR AMOUNT OF INVENTORY
DATE OF INVENTORY	INVENTORY SUPERVISOR	(Specify cost, market or other basis)

None
þ b. List the name and address of the person having possession of the records of each of the two inventories reported in a., above.

	NAME AND ADDRESSES OF CUSTODIAN OF INVENTORY
DATE OF INVENTORY	RECORDS

	21 . Current Partners, Officers, Directors and Shareholders
None þ	a. If the debtor is a partnership, list the nature and percentage of partnership interest of each member of the partnership.

NAME AND ADDRESS NATURE OF INTEREST PERCENTAGE OF INTEREST

b. If the debtor is a corporation, list all officers and directors of the corporation, and each stockholder who directly or indirectly owns, controls, or holds 5 percent or more of the voting or equity securities of the corporation.

		NATURE AND PERCENTAGE
NAME AND ADDRESS	TITLE	OF STOCK OWNERSHIP
PAGE, Gail	Executive Chairman of the Board of
47350 Fremont Blvd, Fremont, CA 94539	Directors
Burns, James	Director
47350 Fremont Blvd, Fremont, CA 94539
HAMILTON, John	Director
47350 Fremont Blvd, Fremont, CA 94539
Highbridge International LLC	Stockholder		7.29	%
9W 57th Street, 27th Floor, New York, NY 10019
Ironwood Investment Management, LLC	Stockholder		13.13	%
21 Custom House Street, Suite 240 Boston, MA 02110
OppenheirmerFunds, Inc	Stockholder		10.08	%
225 Liberty Street, New York, NY 10281
Phronesis Partners, L.P	Stockholder		10.38	%
180 E Broad Street # 1704, Columbus, OH 43215
Quest Diagnostics, Inc.	Stockholder		13.48	%
3 Giralda Farms, Madison, NJ 07940
Falcon Technology Partners L.P	Stockholder		6.88	%
600 Dorset Road, Devon, PA 19333

	22 . Former partners, officers, directors and shareholders
None þ	a. If the debtor is a partnership, list each member who withdrew from the partnership within one year immediately preceding the commencement of this case.

NAME ADDRESS DATE OF WITHDRAWAL

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

8

b. If the debtor is a corporation, list all officers, or directors whose relationship with the corporation terminated within one year immediately preceding the commencement of this case.

NAME AND ADDRESS	TITLE	DATE OF TERMINATION
CONWAY, Kenneth J.
REDACTED	Director	March 25, 2009
DALAL, Rajen
REDACTED	Director	March 30, 2009
RATHMANN, James L.
REDACTED	Executive Chairman	March 25, 2009
YOUNG, John A
REDACTED	Lead Outside Director	March 26, 2009
PAGE, Gail
REDACTED	President, CEO	March 27, 2009
FUNG, Eric
REDACTED	Chief Scientific Officer	March 19, 2009
SHORTER, Simon
REDACTD	VP- Business Development	March 27, 2009
ZHOU, Qun
REDACTED	Interim CFO	March 27, 2009

	23. Withdrawals from a partnership or distributions by a corporation
None	If the debtor is a partnership or corporation, list all withdrawals or distributions credited or given to an insider, including compensation in any form, bonuses, loans, stock redemptions, options exercised and any other perquisite during one year immediately preceding the commencement of this case.

NAME & ADDRESS		AMOUNT OF MONEY OR
OF RECIPIENT,	DATE AND PURPOSE	DESCRIPTION AND
RELATIONSHIP TO DEBTOR	OF WITHDRAWAL	VALUE OF PROPERTY
See attached file, Form 7, question 23

	24. Tax Consolidation Group.
None þ	If the debtor is a corporation, list the name and federal taxpayer identification number of the parent corporation of any consolidated group for tax purposes of which the debtor has been a member at any time within six years immediately preceding the commencement of the case.

NAME OF PARENT CORPORATION TAXPAYER IDENTIFICATION NUMBER (EIN)

	25. Pension Funds.
None þ	If the debtor is not an individual, list the name and federal taxpayer identification number of any pension fund to which the debtor, as an employer, has been responsible for contributing at any time within six years immediately preceding the commencement of the case.

NAME OF PENSION FUND TAXPAYER IDENTIFICATION NUMBER (EIN)

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

9

DECLARATION UNDER PENALTY OF PERJURY ON BEHALF OF CORPORATION OR PARTNERSHIP

I declare under penalty of perjury that I have read the answers contained in the foregoing statement of financial affairs and any attachments thereto and that they are true and correct to the best of my knowledge, information and belief.

Date June 11, 2009	Signature	/s/ Gail S. Page
		Gail S. Page
		Executive Chairman of the Board of Directors

[An individual signing on behalf of a partnership or corporation must indicate position or relationship to debtor.]

Penalty for making a false statement: Fine of up to $500,000 or imprisonment for up to 5 years, or both. 18 U.S.C. §§ 152 and 3571

Software Copyright (c) 1996-2007 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

Form 7, question 3-b
CHECK HISTORY REPORT JANUARY 1, 2009 — MARCH 31, 2009

VENDOR NAME	ADDRESS	Payment Date	Amount Paid		Amount Still Owing		Payment Method
ABFO	P.O. BOX 2103, Fremont CA 94536-0103	1/29/2009		250		0	Check
ALAMEDA COUNTY	P.O. Box N,Alameda CA 94501-0108	1/29/2009		775		0	Check
ALLIED WASTE SERVICES #9	P.O. BOX 78829, Phoenix AZ 85062-8829	1/8/2009		1,991.14		0	Check
ALLIED WASTE SERVICES #9	P.O. BOX 78829, Phoenix AZ 85062-8829	2/13/2009		1,991.14		0	Check
ALLIED WASTE SERVICES #9	P.O. BOX 78829, Phoenix AZ 85062-8829	3/13/2009		1,991.14		0	Check
AMERICAN EXPRESS	2975 W. Corporate Lakes Blvd., Weston FL 33331-3626	1/8/2009		2,290.97		0	Check
AMERICAN EXPRESS	2976 W. Corporate Lakes Blvd., Weston FL 33331-3626	2/13/2009		7,888.01		0	Check
AMERICAN EXPRESS	2977 W. Corporate Lakes Blvd., Weston FL 33331-3626	3/13/2009		878.31		0	Check
AMERICAN EXPRESS CO.	P.O. Box 360001, Ft. Lauderdale FL 33336-0001	1/29/2009		4,969.00		0	Check
AMERICAN EXPRESS CO.	P.O. Box 360001, Ft. Lauderdale FL 33336-0001	2/13/2009		309.4		0	Check
ANTHEM BLUE CROSS	P.O. BOX 54630, Los Angeles CA 90054-0630	1/29/2009		11,427.00		0	Check
ANTHEM BLUE CROSS	P.O. BOX 54630, Los Angeles CA 90054-0630	2/27/2009		8,778.00		0	Check
ANTHEM BLUE CROSS	P.O. BOX 54630, Los Angeles CA 90054-0630	3/13/2009		6,824.00		0	Check
APPLIED CLINICAL INTELLI	225 City Avenue, Suite 15, Bala Cynwyd PA 19004	2/27/2009		5,000.00		0	Check
AT & T MOBILITY	P.O. BOX 9004, Carol Stream IL 60197-9004	1/29/2009		1,739.75		0	Check
AT & T MOBILITY	P.O. BOX 9004, Carol Stream IL 60197-9004	2/27/2009		2,119.43		0	Check
AT & T MOBILITY	P.O. BOX 9004, Carol Stream IL 60197-9004	3/13/2009		1,538.37		0	Check
AT&T	P.O. BOX 5019, Carol Stream IL 60197-5019	1/8/2009		505.75		0	Check
AT&T	PAYMENT CENTER, Sacramento CA 95887-0001	1/8/2009		100.41		0	Check
AT&T	PAYMENT CENTER, Sacramento CA 95887-0001	1/29/2009		1,185.28		0	Check
AT&T	P.O. BOX 5019, Carol Stream IL 60197-5019	2/13/2009		874.65		0	Check
AT&T	PAYMENT CENTER, Sacramento CA 95887-0001	2/13/2009		842.88		0	Check
AT&T	P.O. BOX 5019, Carol Stream IL 60197-5019	2/27/2009		404.16		0	Check
BARKHURST, DAVID	REDACTED	1/12/2009		1,136.74		0	Check
BARKHURST, DAVID	REDACTED	1/29/2009		640		0	Check
BARKHURST, DAVID	REDACTED	2/13/2009		120		0	Check
BAY ALARM COMPANY	P.O. BOX 7137,San Francisco CA 94120-7137	1/29/2009		339		0	Check
BOWNE OF LOS ANGELES, IN	P.O. Box 79358, City of Industry CA 91716-9358	2/13/2009		4,191.00		0	Check
BOWNE OF LOS ANGELES, IN	P.O. Box 79358, City of Industry CA 91716-9358	2/27/2009		1,405.00		0	Check
BOWNE OF LOS ANGELES, IN	P.O. Box 79358, City of Industry CA 91716-9358	3/13/2009		413		0	Check
CALIFORNIA BOARD OF	P.O. Box 942879, Sacramento CA 94279-6009	1/21/2009		3,098.00		0	Wire Transfer
CAREY INTERNATIONAL INC.	P.O. Box 631414, Baltimore MD 21263-1414	1/29/2009		670.77		0	Check
CARRUTHERS, SUSAN D.	REDACTED	1/15/2009		72.62		0	Direct Deposit
CARRUTHERS, SUSAN D.	REDACTED	2/27/2009		107.64		0	Direct Deposit
CARRUTHERS, SUSAN D.	REDACTED	3/13/2009		85.04		0	Direct Deposit
CHAVEZ, JESUS N.	REDACTED	1/21/2009		1,645.00		0	Check
CHAVEZ, JESUS N.	REDACTED	1/29/2009		87.5		0	Check
CHAVEZ, JESUS N.	REDACTED	2/27/2009		61.25		0	Check
CINTAS DOCUMENT MANAGEME	P.O. Box 633842, Cincinnati OH 45263-3842	1/29/2009		140.35		0	Check
CINTAS DOCUMENT MANAGEME	P.O. Box 633842, Cincinnati OH 45263-3842	2/27/2009		70		0	Check
CIT TECHNOLOGY FIN SERV,	P.O. Box 100706, Pasadena CA 91189-0706	1/8/2009		336.82		0	Check
CIT TECHNOLOGY FIN SERV,	P.O. Box 100706, Pasadena CA 91189-0706	1/29/2009		336.82		0	Check
CIT TECHNOLOGY FIN SERV,	P.O. Box 100706, Pasadena CA 91189-0706	3/13/2009		336.82		0	Check
CONEXIS	P.O. Box 5547, Orange CA 92863-5547	1/15/2009		40		0	Check
CONEXIS	P.O. Box 5547, Orange CA 92863-5547	2/13/2009		40		0	Check

VENDOR NAME	ADDRESS	Payment Date	Amount Paid		Amount Still Owing		Payment Method
CONEXIS	P.O. Box 5547, Orange CA 92863-5547	3/13/2009		40		0	Check
CONTROL SOLUTIONS	400 Amherst St. Suite 201, Nashua NH 03063	2/13/2009		13,760.00		0	Check
CREECH, WILLIAM B.	2237 Mount Vernon Lane, Auburn AL 36830	1/29/2009		6,490.41		0	Check
CREECH, WILLIAM B.	2237 Mount Vernon Lane, Auburn AL 36830	2/13/2009		3,687.50		0	Check
CREECH, WILLIAM B.	2237 Mount Vernon Lane, Auburn AL 36830	3/13/2009		4,125.00		0	Check
CRUTCHER, GILLIAN	REDACTED	3/13/2009		82.52		0	Direct Deposit
CRUTCHER, GILLIAN	REDACTED	3/31/2009		125.05		0	Direct Deposit
CT CORPORATION	P.O. Box 4349, Carol Stream IL 60197-4349	1/8/2009		618		0	Check
DELAWARE SECRETARY OF ST	Corporation Trust Center,1209 Orange Street, Wilmington DE 19801	2/26/2009		21,093.64		0	Check
DELOITTE TAX LLP	P.O. BOX 2079,Carol Stream IL 60132-2079	1/8/2009		20,000.00		0	Check
DELOITTE TAX LLP	P.O. BOX 2079,Carol Stream IL 60132-2079	2/13/2009		25,000.00		0	Check
DELOITTE TAX LLP	P.O. BOX 2079,Carol Stream IL 60132-2079	2/27/2009		5,000.00		0	Check
DELOITTE TAX LLP	P.O. BOX 2079,Carol Stream IL 60132-2079	3/13/2009		5,000.00		0	Check
DELOITTE TOUCHE TOHMATSU	8/F Office Tower W2,1 East Chang An Avenue, Beijing 100738, PRC	1/6/2009		4,204.00		0	Wire Transfer
E*TRADE FINANCIAL	P.O. Box 3512, Arlington VA 22203	2/27/2009		5,098.23		0	Check
EDWARDS & ANGELL LLP	P.O. BOX 40956, Hartford CT 06150-0956	1/8/2009		59,863.20		0	Check
ENDSIGHT	1440 Fourth Street Suite B, Berkeley CA 94710	1/29/2009		5,100.00		0	Check
ENDSIGHT	1440 Fourth Street Suite B, Berkeley CA 94710	2/13/2009		5,175.00		0	Check
ENDSIGHT	1440 Fourth Street Suite B, Berkeley CA 94710	2/27/2009		100		0	Check
EXEC-U-CARE	P.O. BOX 533204, Atlanta GA 30353-3204	1/15/2009		1,110.56		0	Check
EXEC-U-CARE	P.O. BOX 533204, Atlanta GA 30353-3204	1/29/2009		919.67		0	Check
FACILITIES MAINTENANCE S	266 Gifford Avenue, San Jose CA 95110	1/29/2009		987		0	Check
FACILITIES MAINTENANCE S	266 Gifford Avenue, San Jose CA 95110	2/27/2009		459.77		0	Check
FEDEX ERS	P.O. Box 371741, Pittsburgh PA 15250-7741	1/8/2009		349.74		0	Check
FEDEX ERS	P.O. Box 371741, Pittsburgh PA 15250-7741	1/29/2009		692.08		0	Check
FEDEX ERS	P.O. Box 371741, Pittsburgh PA 15250-7741	2/27/2009		213.33		0	Check
FEDEX ERS	P.O. Box 371741, Pittsburgh PA 15250-7741	3/13/2009		222.02		0	Check
FIDELITY INVESTMENTS	P.O. Box 73307, Chicago IL 60673-7307	2/27/2009		637		0	Check
FIDELITY MANAGEMENT TRUS	100 Crosby Parkway,Mailzone KC1F-E, Covington KY 41015-4323	1/29/2009		1,793.23		0	Check
FPRS DEPOSITORY ACCOUNT	P.O. Box 73307, Chicago IL 60673-7307	1/8/2009		2,277.50		0	Auto-Debit
FPRS DEPOSITORY ACCOUNT	P.O. Box 73307, Chicago IL 60673-7307	1/20/2009		12,891.62		0	Auto-Debit
FPRS DEPOSITORY ACCOUNT	P.O. Box 73307, Chicago IL 60673-7307	2/4/2009		21,913.98		0	Auto-Debit
FPRS DEPOSITORY ACCOUNT	P.O. Box 73307, Chicago IL 60673-7307	2/19/2009		13,000.57		0	Auto-Debit
FUNG, ERIC	REDACTED	1/15/2009		346.29		0	Direct Deposit
FUNG, ERIC	REDACTED	2/27/2009		2,822.69		0	Direct Deposit
GADOL, NANCY	301 Molton Ave. San Carlos CA 94070	2/13/2009		3,375.00		0	Check
GLOBAL CROSSING CONFEREN	Dept. 518, Denver CO 80291-0518	1/29/2009		583.71		0	Check
GLOBAL CROSSING CONFEREN	Dept. 518, Denver CO 80291-0518	2/13/2009		107.65		0	Check
GLOBAL CROSSING CONFEREN	Dept. 518, Denver CO 80291-0518	3/13/2009		103.64		0	Check
GOUFFRANT, CECILE	280 41st Street, Oakland CA 94611	1/29/2009		2,100.00		0	Check
GOUFFRANT, CECILE	280 41st Street, Oakland CA 94611	2/27/2009		1,050.00		0	Check
HAMILTON, JOHN F.	REDACTED	3/25/2009		5,000.00		0	Check
HARPER, MARIBETH R.	REDACTED	1/29/2009		236.25		0	Check
HARRIS, PAUL C.	3022 184th PI. SE, Bothell WA 98012	2/13/2009		1,125.00		0	Check
HYMAN, PHELPS & MCNAMARA	700 13th Street, Suite 1200, Washington DC 20005	1/29/2009		8,100.00		0	Check
HYMAN, PHELPS & MCNAMARA	700 13th Street, Suite 1200, Washington DC 20005	2/27/2009		840		0	Check
IMAGINE CENTER L.P.	911 Ranch Rd 620 North Suite 100, Lakeway TX 78734	1/8/2009		240		0	Check
IRON MOUNTAIN	P.O. BOX 601002, Los Angeles CA 90060-1002	1/29/2009		665.02		0	Check
IRON MOUNTAIN	P.O. BOX 601002, Los Angeles CA 90060-1002	2/13/2009		370.66		0	Check

VENDOR NAME	ADDRESS	Payment Date	Amount Paid		Amount Still Owing		Payment Method
IRON MOUNTAIN	P.O. BOX 601002, Los Angeles CA 90060-1002	3/13/2009		290.72		0	Check
JOHNS HOPKINS UNIVERSITY	JHU CENTRAL LOCKBOX, Bank of America, 12529 Collections Center Drive, Chicago IL 60693	1/29/2009		42,915.00		0	Check
JOHNS HOPKINS UNIVERSITY	JHU CENTRAL LOCKBOX, Bank of America, 12529 Collections Center Drive, Chicago IL 60693	1/30/2009		50,000.00		0	Check
JOHNS HOPKINS UNIVERSITY	JHU CENTRAL LOCKBOX, Bank of America, 12529 Collections Center Drive, Chicago IL 60693	2/13/2009		40,000.00		0	Check
JONES, JAMES V.	REDACTED	2/13/2009		4,071.13		0	Check
LAND ROVER CAPITAL GROUP	Department #193901, P.O. BOX 55000, Detroit MI 48255-1939	1/8/2009		1,363.77		0	Check
LAND ROVER CAPITAL GROUP	Department #193901, P.O. BOX 55000, Detroit MI 48255-1939	1/29/2009		1,363.77		0	Check
LAND ROVER CAPITAL GROUP	Department #193901, P.O. BOX 55000, Detroit MI 48255-1939	2/27/2009		1,363.77		0	Check
LANDESS, TINA M.	REDACTED	1/21/2009		1,600.00		0	Check
LANDESS, TINA M.	REDACTED	1/21/2009		1,600.00		0	Check
MESSAGELABS, INC.	512 Seventh Avenue 6th Floor, New York NY 10018	1/29/2009		337.5		0	Check
MOE, RHONDA	1022 Ocean Ln,Imperial Beach CA 91932	1/29/2009		1,235.00		0	Check
MOE, RHONDA	1023 Ocean Ln,Imperial Beach CA 91932	2/13/2009		390		0	Check
MONTGOMERY PROFESSIONAL	File #031052, P.O. BOX 60000, San Francisco CA 94160	1/8/2009		7,830.00		0	Check
MONTGOMERY PROFESSIONAL	File #031052, P.O. BOX 60000, San Francisco CA 94160	1/29/2009		12,060.00		0	Check
MONTGOMERY PROFESSIONAL	File #031052, P.O. BOX 60000, San Francisco CA 94160	2/13/2009		13,140.00		0	Check
MONTGOMERY PROFESSIONAL	File #031052, P.O. BOX 60000, San Francisco CA 94160	2/27/2009		5,760.00		0	Check
MONTGOMERY PROFESSIONAL	File #031052, P.O. BOX 60000, San Francisco CA 94160	3/17/2009		8,640.00		0	Check
NAIR & CO	Whitefriars, Lewins Mead, Bristol BS1 2NT, UK	2/10/2009		17,000.00		0	Wire Transfer
NAIR & CO	Whitefriars, Lewins Mead, Bristol BS1 2NT, UK	2/27/2009		20,000.00		0	Wire Transfer
NAIR & CO	Whitefriars, Lewins Mead, Bristol BS1 2NT, UK	3/9/2009		7,000.00		0	Wire Transfer
NATIONAL ONCOLOGY ALLIAN	750 Lindaro Street, Suite 350, San Rafael CA 94901	1/8/2009		25,000.00		0	Check
NELDA WELLS SPEARS	TRAVIS CNTY TAX ASSESSOR-COL, 5501 AIRPORT BLVD, P.O. BOX 149326, Austin TX 78714-9326	1/29/2009		65.3		0	Check
OFFICE DEPOT	P.O. Box 70001, Los Angeles CA90074-0001	1/29/2009		195.36		0	Check
OFFICE DEPOT	P.O. Box 70001, Los Angeles CA90074-0001	2/13/2009		39.11		0	Check
P G & E	Box 997300, Sacramento CA 95899-7300	1/29/2009		1,217.77		0	Check
P G & E	Box 997300, Sacramento CA 95899-7300	2/13/2009		1,341.67		0	Check
PAGE, GAIL	REDACTED	1/15/2009		707.62		0	Direct Deposit
PAGE, GAIL	REDACTED	2/27/2009		812.72		0	Direct Deposit
PALLIS, KATHERINE C.	87 Encantado Loop, Santa Fe NM 87508	1/29/2009		5,524.20		0	Check
PAUL, HASTINGS, JANOFSKY	55 Second Street, 24th Floor, San Francisco CA 94105-3441	1/8/2009		48,000.00		0	Check
PAUL, HASTINGS, JANOFSKY	55 Second Street, 24th Floor, San Francisco CA 94105-3441	2/6/2009		50,663.23		0	Check
PAUL, HASTINGS, JANOFSKY	55 Second Street, 24th Floor, San Francisco CA 94105-3441	2/13/2009		11,501.25		0	Check
PAUL, HASTINGS, JANOFSKY	55 Second Street, 24th Floor, San Francisco CA 94105-3441	2/27/2009		15,000.00		0	Check
PAUL, HASTINGS, JANOFSKY	55 Second Street, 24th Floor, San Francisco CA 94105-3441	3/13/2009		5,000.00		0	Check
PAUL, HASTINGS, JANOFSKY	55 Second Street, 24th Floor, San Francisco CA 94105-3441	3/25/2009		170,000.00		0	Wire Transfer
PITNEY BOWES GLOBAL	P.O. Box 856460, Louisville KY 40285-6460	3/13/2009		931.96		0	Check
PR NEWSWIRE	G.P.O. BOX 5897, New York NY 10087-5897	1/29/2009		1,060.50		0	Check
PRAXAIR DISTRIBUTION, IN	Dept LA 21511, Pasadena CA 91185-1511	1/29/2009		52.19		0	Check
PRAXAIR DISTRIBUTION, IN	Dept LA 21511, Pasadena CA 91185-1511	3/13/2009		26.46		0	Check
PRECISIONMED INC.	132 N. Acacia Avenue, Solana Beach CA 92075	1/8/2009		4,341.00		0	Check
PRECISIONMED INC.	132 N. Acacia Avenue, Solana Beach CA 92075	2/27/2009		5,000.00		0	Check
PRICEWATERHOUSECOOPERS L	P.O. Box 31001-0068, Pasadena CA 91110-0068	2/13/2009		7,675.00		0	Check
PRICEWATERHOUSECOOPERS L	P.O. Box 31001-0068, Pasadena CA 91110-0068	3/13/2009		5,000.00		0	Check
PRINCIPAL LIFE GROUP	P.O. BOX 14513, Des Moines IA 50306-3513	1/15/2009		1,004.26		0	Check
PRINCIPAL LIFE GROUP	P.O. BOX 14513, Des Moines IA 50306-3513	2/27/2009		1,071.90		0	Check
PRINCIPAL LIFE INSURANCE	P.O. BOX 10372, Des Moines IA 50306-3513	1/15/2009		1,203.70		0	Check
PRINCIPAL LIFE INSURANCE	P.O. BOX 10372, Des Moines IA 50306-3513	2/13/2009		1,203.70		0	Check
PRINCIPAL LIFE INSURANCE	P.O. BOX 10372, Des Moines IA 50306-3513	2/13/2009		812.65		0	Check

VENDOR NAME	ADDRESS	Payment Date	Amount Paid		Amount Still Owing		Payment Method
PRINCIPAL LIFE INSURANCE	P.O. BOX 10372, Des Moines IA 50306-3513	2/27/2009		608.66		0	Check
PROCESSWORKS	250 N. Patrick Blvd Suite 125, Brookfield WI 53045	1/29/2009		1,479.95		0	Check
PROCESSWORKS INC.	P.O.Box 712748, Cincinnati OH 45271-2748	1/15/2009		604		0	Check
PROCESSWORKS INC.	P.O.Box 712748, Cincinnati OH 45271-2748	2/13/2009		50		0	Check
PROCESSWORKS INC.	P.O.Box 712748, Cincinnati OH 45271-2748	3/13/2009		50		0	Check
PROLOGIS LIMITED PARTNER	4545 Airport Way, Denver CO 80239	1/29/2009		9,076.06		0	Check
PROLOGIS LIMITED PARTNER	4545 Airport Way, Denver CO 80239	2/27/2009		9,076.06		0	Check
PROLOGIS LIMITED PARTNER	4545 Airport Way, Denver CO 80239	3/13/2009		9,076.06		0	Check
PUBLIC STORAGE	24211-FREMONT/ALBRAE, 42101 Albrae Street, Fremont CA 94538-3123	1/29/2009		257		0	Check
PUBLIC STORAGE, INC.	1096 FAIR OAKS AVENUE, SUNNYVALE CA 94089	2/27/2009		255		0	Check
PUBLIC STORAGE, INC.	1096 FAIR OAKS AVENUE, SUNNYVALE CA 94089	3/13/2009		255		0	Check
PURCHASE POWER	P.O. BOX 856042, Louisville KY 40285-6042	1/8/2009		206.99		0	Check
QUEST DIAGNOSTICS, INC.	P.O. Box 5001, Collegeville PA 19426	1/5/2009		34,931.51		0	Wire Transfer
QUEST DIAGNOSTICS, INC.	P.O. Box 5001, Collegeville PA 19426	2/11/2009		31,849.31		0	Wire Transfer
QUINN EMANUEL URQUHART	865 South Figueroa Street 10th Floor, Los Angeles CA 90017	1/8/2009		18,060.89		0	Check
QUINN EMANUEL URQUHART	865 South Figueroa Street 10th Floor, Los Angeles CA 90017	2/27/2009		1,079.36		0	Check
SCHULMAN ASSOCIATES	4290 Glendale-Milford Rd. Cincinnati OH 45242	1/29/2009		1,475.00		0	Check
SHORTER, SIMON	REDACTED	1/15/2009		227.28		0	Direct Deposit
SHORTER, SIMON	REDACTED	2/27/2009		343.97		0	Direct Deposit
SHORTER, SIMON	REDACTED	3/13/2009		155.11		0	Direct Deposit
SHORTER, SIMON	REDACTED	3/31/2009		44.99		0	Direct Deposit
SIGMA-ALDRICH, INC.	P.O. BOX 535182, Atlanta GA 30353-5182	3/13/2009		108.13		0	Check
STANFORD UNIVERSITY	Department #44439, P.O. BOX 44000, San Francisco CA 94144-4439	1/29/2009		1,216.00		0	Check
STERICYCLE INC.	P.O. Box 9001589, Louisville KY 40290-1589	1/29/2009		1,001.22		0	Check
STERICYCLE INC.	P.O. Box 9001589, Louisville KY 40290-1589	2/13/2009		500.61		0	Check
STERICYCLE INC.	P.O. Box 9001589, Louisville KY 40290-1589	3/13/2009		500.61		0	Check
TESTORFF, CHARLOTTE	1841 Alburn Place, El Dorado Hills CA 95762	1/21/2009		3,000.00		0	Check
TESTORFF, CHARLOTTE	1841 Alburn Place, El Dorado Hills CA 95762	1/29/2009		3,000.00		0	Check
TESTORFF, CHARLOTTE	1841 Alburn Place, El Dorado Hills CA 95762	3/25/2009		1,500.00		0	Check
THOMSON FINANCIAL LLC	195 Broadway 7th Floor, New York NY 10007	2/13/2009		3,551.00		0	Check
TOWNSEND & TOWNSEND ET A	TWO EMBARCADERO CENTER 8TH FLOOR, SAN FRANCISCO CA 94111-3834	1/8/2009		3,101.74		0	Check
US BANK	60 Livingston Avenue, Saint Paul MN 55107	1/5/2009		15,762.05		0	Wire Transfer
VISION SERVICE PLAN — (C	P.O. BOX 45210, San Francisco CA 94145-5210	1/15/2009		104.85		0	Check
VISION SERVICE PLAN — (C	P.O. BOX 45210, San Francisco CA 94145-5210	1/29/2009		87.48		0	Check
VISION SERVICE PLAN — (C	P.O. BOX 45210, San Francisco CA 94145-5210	2/27/2009		87.48		0	Check
Vo, Kristy	REDACTED	1/29/2009		2,640.00		0	Check
Vo, Kristy	REDACTED	2/27/2009		1,320.00		0	Check
VWR INTERNATIONAL INC.	P.O. BOX 31001-1257, Pasadena CA 91110-1257	1/29/2009		403.58		0	Check
Wells Fargo of CA Ins. S	Dept. 33457 PO Box 39000, San Francisco CA 94139	3/13/2009		6,123.25		0	Check
WELLS FARGO SHAREOWNER S	P.O. Box 64875, St. Paul MN 55164-0875	2/13/2009		1,407.00		0	Check
WOMBLE CARLYLE SANDRIDGE	222 Delaware Avenue, Suite 1501 Wilmington, DE 19801	3/27/2009		30,000.00		0	Wire Transfer
YIP, CHRISTINE I.	REDACTED	3/13/2009		1,850.28		0	Direct Deposit
YIP, CHRISTINE I.	REDACTED	3/31/2009		28.98		0	Direct Deposit
ZHANG, DR. ZHEN	14104 Big Branch Drive, Dayton MD 21036	1/29/2009		332.96		0	Check
Report Total				1,148,345.32

Form 7, question 3-c

Name	Address	Relationship	Date of Payment	Total Amount Paid		Amount Still Owing		Payment Method
John Hamilton	REDACTED	Director	$10,000 on 11/21/08, $5,000 on 3/25/09		15,000.00		0	Check
Gail Page	REDACTED	Director/President & CEO	3/15/08, 3/31/08, 4/15/08, 4/30/08, 5/15/08, 5/31/08, 6/15/08, 6/30/08, 7/15/08, 7/31/08, 8/15/08, 8/31/08, 9/15/08, 9/30/08, 10/15/08, 10/31/08, 11/15/08, 11/30/08, 12/15/08, 12/31/08, 1/15/09, 1/31/09, 2/15/09, 2/28/09, 3/15/09, 3/27/09		471,568.88		0	Semi-monthly Payroll Direct Deposit
Eric Fung	REDACTED	VP & Chief Science Officer	3/15/08, 3/31/08, 4/15/08, 4/30/08, 5/15/08, 5/31/08, 6/15/08, 6/30/08, 7/15/08, 7/31/08, 8/15/08, 8/31/08, 9/15/08, 9/30/08, 10/15/08, 10/31/08, 11/15/08, 11/30/08, 12/15/08, 12/31/08, 1/15/09, 1/31/09, 2/15/09, 2/28/09, 3/15/09, 3/19/09		250,520.22		0	Semi-monthly Payroll Direct Deposit
Simon Shorter	REDACTED	VP of Business Development	3/15/08, 3/31/08, 4/15/08, 4/30/08, 5/15/08, 5/31/08, 6/15/08, 6/30/08, 7/15/08, 7/31/08, 8/15/08, 8/31/08, 9/15/08, 9/30/08, 10/15/08, 10/31/08, 11/15/08, 11/30/08, 12/15/08, 12/31/08, 1/15/09, 1/31/09, 2/15/09, 2/28/09, 3/15/09, 3/27/09		225,515.00		0	Semi-monthly Payroll Direct Deposit
Qun Zhou	REDACTED	Interim CFO & Corporate Controller	3/15/08, 3/31/08, 4/15/08, 4/30/08, 5/15/08, 5/31/08, 6/15/08, 6/30/08, 7/15/08, 7/31/08, 8/15/08, 8/31/08, 9/15/08, 9/30/08, 10/15/08, 10/31/08, 11/15/08, 11/30/08, 12/15/08, 12/31/08, 1/15/09, 1/31/09, 2/15/09, 2/28/09, 3/15/09, 3/27/09		171,684.40		0	Semi-monthly Payroll Direct Deposit

Form 7, question 4-a

Parties of Litigation involving Vermillion

Case	Plaintiff	Defendant	Nature of Proceeding	Case #	Court	Plaintiff Contact	Address	Tel	Fax
MAS Litigation	Molecular Analytical Systems	Vermillion Bio-Rad	MAS alleges that Vermillion is in breach of its license agreement with MAS relating to SELDI technology	H032845	Court of Appeal of the State of California, Sixth Appellate District	Steve Ellenberg Law Offices of Steven A. Ellenberg Defendant Contact for MAS case Melissa Baily Quinn Emanuel Urquhart Oliver & Hedges, LLP	125 South Market St. Suite 1001 San Jose, CA 95113 50 California Street, 22nd Floor San Francisco, CA 94111	408-998-8500 ext 202 (415) 875-6336	408-998-8503 (415) 875-6700
OPCO Litigation	Vermillion Inc	Oppenheimer & Co	Vermillion charges OPCO for mismanagement of Vermillion funds in OPCO account	09-00486	FINRA Dispute Resolution	Scott J. Link Richard L. Stone Ackerman, Link & Sartory, P.A. Defendant Contact for OPCO case David Bartholomew Palmer, Lombardi & Donohue, LLP	222 Lakeview Avenue Suite 1250 — Esperante West Palm Beach, FL 33401 888 West 6th Street 12th Floor Los Angeles, CA 90017	561-838-4100 (213) 688-0430	561-838-5305

Form 7, question 18-b

Foreign Subsidiaries

	Vermillion
Name of Entity	Ownership			Description
Ciphergen Biosystems GmbH ( Germany )		100	%	Entity was set up as the sales organization for ProteinChip systems when the company was still Ciphergen Biosystems. Entity had no operation activities since late 2006 after the company sold the Protein Chip tool business to Bio-Rad. Entity is in the final stage of liquidation at the time of filing.
Ciphergen Biosystems S.r.l ( Italy )		100	%	Same as CB GmbH
Ciphergen Biosystems EURL ( France)		100	%	Same as CB GmbH
Ciphergen (Beijing) Biosystems Co., Ltd. ( China )		100	%	Same as CB GmbH
Ciphergen Biosystems Ltd. (UK)		100	%	Already Liquidated
Ciphergen Biosystems A/S ( Denmark )		100	%	Already Liquidated
Ciphergen Biosystems AG ( Switzerland )		100	%	Already Liquidated
Ciphergen Biosystems KK ( Japan )		100	%	Entity was set up as the sales organization for ProteinChip systems when the company was still Ciphergen Biosystems. Entity had no operation activities since late 2006 after the company sold the Protein Chip tool business to Bio-Rad.
Ciphergen Biosystems International Inc.		100	%	Germany, France, Italy subsidiaries operates under CBII
Ciphergen Technologies Inc		100	%	Inactive US company
Illumesys Pacific Inc		100	%	Inactive US company

Form 7, question 23

Name	Address	Relationship	Date	Purpose	Stock Options	Grant Price
James Burns	REDACTED	Director	06/11/08	Annual Grant	18,000	$2.04
			10/28/08	Grant in lieu of Cash Payment	12,500	$0.75
Kenneth Conway	REDACTED	Director	06/11/08	Annual Grant	20,500	$2.04
			10/28/08	Grant in lieu of Cash Payment	12,500	$0.75
Rajen Dalal	REDACTED	Director	06/11/08	Annual Grant	20,500	$2.04
			10/28/08	Grant in lieu of Cash Payment	12,500	$0.75
John Hamilton	REDACTED	Director	06/11/08	New member Grant	30,000	$2.04
James Rathmann	REDACTED	Chairman of the Board	06/11/08	Annual Grant	28,000	$2.04
			10/28/08	Grant in lieu of Cash Payment	12,500	$0.75
John Young	REDACTED	Director	06/11/08	Annual Grant	18,000	$2.04
			10/28/08	Grant in lieu of Cash Payment	12,500	$0.75
Gail Page	REDACTED	Director/President & CEO	07/18/08	Annual Grant	125,000	$2.30
Eric Fung	REDACTED	VP & Chief Science Officer	07/18/08	Annual Grant	40,000	$2.30
Simon Shorter	REDACTED	VP of Business Development	07/18/08	Annual Grant	20,000	$2.30
Qun Zhou	REDACTED	Interim CFO & Corporate Controller	07/18/08	Annual Grant	10,000	$2.30

B6 Summary (Form 6 — Summary) (12/07)

United States Bankruptcy Court
District of Delaware

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)	Chapter	11

SUMMARY OF SCHEDULES

Indicate as to each schedule whether that schedule is attached and state the number of pages in each. Report the totals from Schedules A, B, D, E, F, I, and J in the boxes provided. Add the amounts from Schedules A and B to determine the total amount of the debtor’s assets. Add the amounts of all claims from Schedules D, E, and F to determine the total amount of the debtor’s liabilities. Individual debtors also must complete the “Statistical Summary of Certain Liabilities and Related Data” if they file a case under chapter 7,11, or 13.

	ATTACHED	NO. OF
NAME OF SCHEDULE	(YES/NO)	SHEETS	ASSETS		LIABILITIES		OTHER
A — Real Property	Yes		$	0.00
B — Personal Property	Yes		$	1,229,353.95
C — Property Claimed as Exempt	No
D — Creditors Holding Secured Claims	Yes				$	10,000,000.00
E — Creditors Holding Unsecured Priority Claims (Total of Claims on Schedule E)	Yes				$	0.00
F — Creditors Holding Unsecured Nonpriority Claims	Yes				$	21,749,642.25
G — Executory Contracts and Unexpired Leases	Yes
H — Codebtors	Yes
I — Current Income of Individual Debtor(s)	No						$	N/A
J — Current Expenditures of Individual Debtor(s)	No						$	N/A
TOTAL			$	1,229,353.95	$	31,749,642.35

United States Bankruptcy Court
District of Delaware

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)	Chapter	11

STATISTICAL SUMMARY OF CERTAIN LIABILITIES AND RELATED DATA (28 U.S.C. § 159)

     If you are an individual debtor whose debts are primarily consumer debts, as defined in § 101(8) of the Bankruptcy Code (11 U.S.C. § 101(8)), filing a case under chapter 7, 11 or 13, you must report all information requested below.

     þ Check this box if you are an individual debtor whose debts are NOT primarily consumer debts. You are not required to report any information here.

B6A (Official Form 6A) (12/07)

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)

SCHEDULE A — REAL PROPERTY

     Except as directed below, list all real property in which the debtor has any legal, equitable, or future interest, including all property owned as a co-tenant, community property, or in which the debtor has a life estate. Include any property in which the debtor holds rights and powers exercisable for the debtor’s own benefit. If the debtor is married, state whether the husband, wife, both, or the marital community own the property by placing an “H,” “W,” “J,” or “C” in the column labeled “Husband, Wife, Joint, or Community.” If the debtor holds no interest in real property, write “None” under “Description and Location of Property.”

     Do not include interests in executory contracts and unexpired leases on this schedule. List them in Schedule G — Executory Contracts and Unexpired Leases.

     If an entity claims to have a lien or hold a secured interest in any property, state the amount of the secured claim. See Schedule D. If no entity claims to hold a secured interest in the property, write “none” in the column labeled “Amount of Secured Claim.”

     If the debtor is an individual or if a joint petition is filed, state the amount of any exemption claimed in the property only in Schedule C — Property Claimed as Exempt.

				CURRENT VALUE
				OF DEBTOR’S
			HUSBAND,	INTEREST IN
			WIFE,	PROPERTY, WITHOUT
DESCRIPTION AND			JOINT,	DEDUCTING ANY		AMOUNT OF
LOCATION OF	NATURE OF DEBTOR’S		OR	SECURED CLAIM		SECURED
PROPERTY	INTEREST IN PROPERTY		COMMUNITY	OR EXEMPTION		CLAIM
-NONE-
			Total:	$	0.00
		(Report also on Summary of Schedules)

Sheet 1 of 1 total sheets in Schedule of Real Property
Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037	Best Case Bankruptcy

B6B (Official Form 6B) (12/07)
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY

     Except as directed below, list all personal property of the debtor of whatever kind. If the debtor has no property in one or more of the categories, place an ‘X’ in the appropriate position in the column labeled ‘None’. If additional space is needed in any category, attach a separate sheet properly identified with the case name, case number, and the number of the category. If the debtor is married, state whether the husband, wife, both, or the marital community own the property by placing an ‘H,’ ‘W,’ ‘J,’ or ‘C’ in the column labeled ‘HWJC.’ If the debtor is an individual or a joint petition is filed, state the amount of any exemptions claimed only in Schedule C — Property Claimed as Exempt.

     Do not list interests in executory contracts and unexpired leases on this schedule. List them in Schedule G — Executory Contracts and Unexpired Leases.

If the property is being held for the debtor by someone else, state that person’s name and address under ‘Description and Location of Property.’ If the property is being held for a minor child, simply state the child’s initials and the name and address of the child’s parent or guardian, such as ‘A.B., a minor child, by John Doe, guardian.’ Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007 (m).

				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
1. Cash on hand.	X
2. Checking, savings or other financial accounts, certificates of deposit or shares in banks, savings and loan, thrift, building and loan, and homestead associations, or credit unions, brokerage houses, or cooperatives.		As of 3/31/09 Silicon Valley Bank Oppenheimer - Money market Oppenheimer - Investment		$ $	610,214.31 3,701.57 (Book value $1m)
3. Security deposits with public utilities, telephone companies, landlords, and others.		LC for Landlord - SVB		$	100,000
4. Household goods and furnishings, including audio, video, and computer equipment.	X
		Subtotal (Total on this page)		$	713,915.88

Footnote:

(1)

Page 1 of 7

B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
5. Books; pictures and other art objects; antiques; stamp, coin, record, tape, compact disc, and other collections or collectibles.	X
6. Wearing apparel.	X
7. Furs and jewelry.	X
8. Firearms and sports, photographic, and other hobby equipment.	X
9. Interests in insurance policies. Name insurance company of each policy and itemize surrender or refund value of each.	X
10. Annuities. Itemize and name each issuer.	X
		Subtotal (Total on this page)		$	0

Footnote:

(2)

Page 2 of  7

B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

					CURRENT VALUE OF
					DEBTOR’S INTEREST IN
					PROPERTY, WITHOUT
					DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC		CLAIM OR EXEMPTION
11. Interests in an education IRA as defined in 26 U.S.C. § 530(b)(1) or under a qualified State tuition plan as defined in 26 U.S.C. § 529(b)(1). Give particulars. (File separately the record(s) of any such interest(s). 11 U.S.C. § 521(c).)	X
12. Interests in IRA, ERISA, Keogh, or other pension or profit sharing plans. Give particulars.	X
13. Stock and interests in incorporated and unincorporated businesses. Itemize.		Ciphergen Biosystems International Inc. ( CBII) Ciphergen Technologies Inc Illumesys Pacific Inc			100% owned subsidiary of Vermillion, set up for international sales for tool business already sold in late 2006 100% owned subsidiary of Vermillion, inactive Same as above
		Ciphergen Biosystems GmbH ( Germany )			100% owned by CBII, in process of liquidation
		Ciphergen Biosystems S.r.l ( Italy )			Same as GmbH
		Ciphergen Biosystems EURL ( France)			Same as GmbH
		Ciphergen (Beijing) Biosystems Co., Ltd. ( China )			100% owned subsidiary of Vermillion, in process of liquidation
		Ciphergen Biosystems KK ( Japan )			100% owned subsidiary of Vermillion,
14. Interests in partnerships or joint ventures. Itemize.	X
15. Government and corporate bonds and other negotiable and nonnegotiable instruments.	X
		Subtotal (Total on this page)		$	0

Page 3 of  7

B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
16. Accounts Receivable.	X
17. Alimony, maintenance, support, and property settlements to which the debtor is or may be entitled. Give particulars.	X
18. Other liquidated debts owed to debtor including tax refunds. Give particulars.	X
19. Equitable or future interests, life estates, and rights or powers exercisable for the benefit of the debtor other than those listed in Schedule A — Real Property.	X
20. Contingent and noncontingent interests in estate of a decedent, death benefit plan, life insurance policy, or trust.	X
21. Other contingent and unliquidated claims of every nature, including tax refunds, counterclaims of the debtor, and rights to setoff claims. Give estimated value of each.		Vermilion vs Oppenheimer & Co. Vermillion charges OPCO for mismanagement of Vermillion funds in OPCO account		unknown
		Subtotal (Total on this page)		$	0

Page 4 of  7

B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
22. Patents, copyrights, and other intellectual property. Give particulars.		See Exhibit 1
23. Licenses, franchises, and other general intangibles. Give particulars.		See Exhibit 2
24. Customer lists or other compilations containing personally identifiable information (as defined in 11 U.S.C. § 101 (41A)) provided to the debtor by individuals in connection with obtaining a product or service from the debtor primarily for personal, family, or household purposes.	X
25. Automobiles, trucks, trailers, and other vehicles and accessories.	X
26. Boats, motors, and accessories.	X
27. Aircraft and accessories.	X
		Subtotal (Total on this page)		$	0

Page 5 of 7

B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
28. Office equipment, furnishings, and supplies.		See Exhibit 3
29. Machinery, fixtures, equipment, and supplies used in business.		See Exhibit 3		As of 3/31/09, book value of $515,438.07
30. Inventory.	X
31. Animals.	X
32. Crops — growing or harvested. Give particulars.	X
33. Farming equipment and implements.	X
		Subtotal (Total on this page)		$	515,438.07

Page 6 of 7

B6B (Official Form 6B) (12/07) — Cont.
In re: Vermillion, Inc.	Case No. 09-11091 (CSS)

SCHEDULE B — PERSONAL PROPERTY
(Continuation Sheet)

				CURRENT VALUE OF
				DEBTOR’S INTEREST IN
				PROPERTY, WITHOUT
				DEDUCTING ANY SECURED
TYPE OF PROPERTY	NONE	DESCRIPTION AND LOCATION OF PROPERTY	HWJC	CLAIM OR EXEMPTION
34. Farm supplies, chemicals, and feed.	X
35. Other personal property of any kind not already listed. Itemize.	X
		Subtotal (Total on this page)		$	0
		Total		$	1,229,353.95

(Include amounts from any continuation
sheets attached. Report total also on
Summary of Schedules.)

Footnote:

(3)

Page 7 of 7

In re: Vermillion Inc. Case No. 09-11091

Schedule B — Exhibit 1

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

1

016866-008110 US

US

National Phase of PCT/US02/28152

10/487,978

Feb 27, 2004

Aug 30, 2001

METHOD OF DIAGNOSING NEPHROTIC SYNDROME

Naohisa TOMOSUGI

ISSUED

US 2005-0260678 A1

Nov 24, 2005

7,297,556

Nov 20, 2007

Dec 24, 2023

2

016866-011550 EP

EP

National Phase of PCT/US2004/37994

04810948.2

Nov 06, 2004

Nov 07, 2003

BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, James Norton McGUIRE, Anja Hviid SIMONSEN, Kaj BLENNOW, and Vladimir N. PODUST

PENDING

EP 1694816 A2

Aug 30, 2006

Nov 06, 2024

3

016866-011550 JP

JP

National Phase of PCT/US2004/37994

2006-538558

Nov 06, 2004

Nov 07, 2003

BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, James Norton McGUIRE, Anja Hviid SIMONSEN, Kaj BLENNOW, and Vladimir N. PODUST

PENDING

Nov 06, 2024

4

016866-011550 US

US

Claims Priority from 60/518,360, 60/526,753, 60/546,423 (012600), 60/547,250, 60/558,896 (012610), 60/572,617, and 60/586,503

10/982,545

Nov 06, 2004

Nov 07, 2003

BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, James Norton McGUIRE, Anja Hviid SIMONSEN, Kaj BLENNOW, and Vladimir N. PODUST

PENDING

US 2005-0244890 A1

Nov 03, 2005

Nov 06, 2024

5

016866-015110 AU

AU

National Phase of PCT/US2005/18728

2005253081

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING — TTC to Req Exam in late Oct 2008

May 26, 2025

6

016866-015110 CA

CA

National Phase of PCT/US2005/18728

2568976

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

7

016866-015110 CN

CN

National Phase of PCT/US2005/18728

200580026416.x

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

CN 101002084A

Jul 18, 2007

May 26, 2025

8

016866-015110 EP

EP

National Phase of PCT/US2005/18728

05753615.3

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

EP 1756554 A1

Feb 28, 2007

May 26, 2025

9

016866-015110 HK

HK

Based on EP 05753615.3

07109214.4

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

10

016866-015110 JP

JP

National Phase of PCT/US2005/18728

2007-515387

May 26, 2005

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

11

016866-015110 US

US

National Phase of PCT/US2005/18728

11/597,667

Nov 22, 2006

Jun 03, 2004

BIOMARKERS FOR PERIPHERAL ARTERY DISEASE

Eric T. FUNG, John P. COOKE, Xiao-Ying MENG, Tai-Tung YIP, and Fujun ZHANG

PENDING

May 26, 2025

Page 1 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

12

016866-018010 EP

EP

Claims Priority from PCT/US2006/13727

06749933.5

Apr 11, 2006

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING — Seq List filed in Jun 2008

Apr 11, 2026

13

016866-018010 HK

HK

Claims Priority from PCT/US2006/13727

Apr 11, 2006

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING

Apr 11, 2026

14

016866-018010 JP

JP

Claims Priority from PCT/US2006/13727

2008-507718

Apr 11, 2006

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING

Apr 11, 2026

15

016866-018010 US

US

Claims Priority from PCT/US2006/13727

11/911,962

Oct 18, 2007

Apr 19, 2005

SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir PODUST, and Anja Hviid SIMONSEN

PENDING — Seq List filed in Jun 2008; awaiting first OA

Apr 11, 2026

16

016866-018110 EP

EP

National Phase of PCT/US2006/23044

06784840.8

Jun 13, 2006

Jun 16, 2005

FRAGMENT OF NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING

WO 2006/138325 A2

Dec 28, 2006

Jun 13, 2026

17

016866-018110 HK

HK

National Phase of PCT/US2006/23044

08104640.8

Jun 13, 2006

Jun 16, 2005

FRAGMENT OF NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING

WO 2006/138325 A2

Dec 28, 2006

Jun 13, 2026

18

016866-018110 JP

JP

National Phase of PCT/US2006/23044

2008-517032

Jun 13, 2006

Jun 16, 2005

FRAGMENT OF NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING

WO 2006/138325 A2

Dec 28, 2006

Jun 13, 2026

19

016866-018110 US

US

Claims Priority from 60/691,637(018100), CIP of PCT/US06/13727 (018010), and CIP of 10/982,545 (011550)

11/452,477

Jun 13, 2006

Jul 08, 2004

NEUROSECRETORY PROTEIN VGF AS A BIOMARKER FOR ALZHEIMER’S DISEASE

Huw Alun DAVIES, Kaj BLENNOW, James McGUIRE, Vladimir N. PODUST, and Anja Hviid SIMONSEN

PENDING — Resp to first OA filed in Jun 2008

US 2007-015221 A1

Jan 18, 2007

Nov 06, 2024

20

016866-018710 PC

WO

Claims Priority from 60/779,246

PCT/US2007/63078

Mar 01, 2007

Mar 03, 2006

METHOD FOR QUANTIFYING AN ANALYTE IN A BIOLOGICAL SAMPLE USING MASS SPECTROMETRY

Lee O. LOMAS and Egisto BOSCHETTI

PENDING; enters national phase on 9/3/08

WO 2007/103734 A2

Dec 06, 2007

Sep 03, 2008

21

016866-018820 PC

WO

Claims Priority from 60/781,403 and 60/863,951

PCT/US2007/006276

Mar 12, 2007

Mar 11, 2006

BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE

John COOKE, Eric T. FUNG, and Eiichiro KIMURA

PENDING; enters national phase on 9/11/08

WO 2007/106466 A2

Sep 20, 2007

Sep 11, 2008

22

016866-018820 US

US

Claims Priority from 60/781,403 and 60/863,951

11/685,146

Mar 12, 2007

Mar 11, 2006

BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE

John COOKE, Eric T. FUNG, and Eiichiro KIMURA

PENDING

Mar 12, 2027

Page 2 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

23

016866-019900 PC

WO

Claims Priority from 60/863,951

PCT/US2007/82730

Oct 26, 2007

Nov 01, 2006

A PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew WILSON

PENDING; enters national phase on 5/1/09

May 01, 2009

24

016866-019900 US

US

Claims Priority from 60/863,951

11/925,678

Oct 26, 2007

Nov 01, 2006

A PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew M. WILSON

PENDING

Oct 26, 2027

25

016866-019910 PC

WO

Claims Priority from 60/863,951

PCT/US2007/83377

Nov 01, 2007

Nov 01, 2006

PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew WILSON

PENDING; enters national phase on 5/1/09

May 01, 2009

26

016866-019910 US

US

Claims Priority from 60/863,951

11/934,008

Nov 01, 2007

Nov 01, 2006

PANEL OF BIOMARKERS FOR PERIPHERAL ARTERIAL DISEASE

Eric T. FUNG, John COOKE, Fujun ZHANG, and Andrew M. WILSON

PENDING

Nov 01, 2027

27

S06-406 STAN524

60946681

Jun 27, 2007

B2m and CRP for PAD

John Cooke and Andrew Wilson

PENDING

28

021996-000200 CA (Biosite)

CA

National Phase of PCT/US2004/12067

2522709

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

CA 2522709 AA

Nov 04, 2004

Apr 19, 2024

29

021996-000200 EP (Biosite)

EP

National Phase of PCT/US2004/12067

04750349.5

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

EP 01616181 A2

Jan 18, 2006

Apr 19, 2024

30

021996-000200 JP (Biosite)

JP

National Phase of PCT/US2004/12067

2006-513130

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

JP 2006-527190

Nov 30, 2006

Apr 19, 2024

31

021996-000200 US (Biosite)

US

CIP of 10/419,059 (filed Apr 17, 2003 by Biosite) and 60/466,358 (CIPH-0002)

10/827,919

Apr 19, 2004

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

Granted

US 2005-064511 A1

Mar 24, 2005

Issued

Apr 17, 2023

32

021996-000210 US (Biosite)

US

DIV of 10/827,919

12/013,606

Jan 14, 2007

Apr 17, 2003

POLYPEPTIDES RELATED TO NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE

Kenneth F. BUECHLER, Eric T. FUNG, and Tai-Tung YIP

PENDING

Apr 17, 2023

33

035394-001610 CN

CN

National Phase of PCT/US03/10489

03809631.5

Oct 29, 2004

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

CN 1649613 A

Aug 03, 2005

Apr 07, 2023

34

035394-001610 EP

EP

National Phase of PCT/US03/10489

03746616.6

Apr 07, 2003

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

EP 1496928

Jan 19, 2005

Apr 07, 2023

35

035394-001610 HK

HK

Validated from EP 03746616.6

05105696.1

Apr 07, 2003

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

Apr 07, 2023

Page 3 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

36

035394-001610 JP

JP

National Phase of PCT/US03/10489

2003-583463

Oct 06, 2004

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

JP 2005-522677

Jul 28, 2005

Apr 07, 2023

37

035394-001610 US

US

National Phase of PCT/US03/10489

10/508,781

Sep 23, 2004

Apr 08, 2002

SERUM BIOMARKERS IN HEPATOCELLULAR CARCINOMA

Tai-Tung YIP, Terence POON, Philip JOHNSON, Victor F. YIP, Christine L. YIP, and Anthony CHAN

PENDING

US 2006-084059 A1

Apr 20, 2006

Apr 07, 2023

38

035394-001910 EP

EP

National Phase of PCT/US2003/36120

03783358.9

Nov 13, 2003

Nov 14, 2002

BIOMARKERS FOR INTRA-AMNIOTIC INFLAMMATION

Irina BUHIMSCHI and Robert CHRISTNER

PENDING

EP 0 1578205 A2

Sep 28, 2005

Nov 13, 2023

39

035394-001910 US

US

National Phase of PCT/US2003/36120

10/534,694

Jan 17, 2006

Nov 14, 2002

BIOMARKERS FOR INTRA-AMNIOTIC INFLAMMATION

Irina A. BUHIMSCHI and Robert CHRISTNER

PENDING

US 2006-127962 A1

Jun 15, 2006

Nov 13, 2023

40

035394-002210 EP

EP

National Phase of PCT/US2003/36118

03783356.3

Nov 13, 2003

Feb 05, 2003

NON-INVASIVE ASSESSMENT OF INTRA-AMNIOTIC ENVIRONMENT

Irina A. BUHIMSCHI, Robert CHRISTNER, Catalin S. BUHIMSCHI, and Carl P. WEINER

PENDING

EP 01590664 A1

Nov 02, 2005

Nov 13, 2023

41

035394-002210 US

US

National Phase of PCT/US2003/36118

10/541,793

Apr 24, 2006

Feb 05, 2003

NON-INVASIVE ASSESSMENT OF INTRA-AMNIOTIC ENVIRONMENT

Irina A. BUHIMSCHI, Robert CHRISTNER, Catalin S. BUHIMSCHI, and Carl P. WEINER

PENDING

US 2006-0240495 A1

Oct 26, 2006

Nov 13, 2023

42

035394-002410 US

US

National Phase of PCT/US2004/17624

10/559,687

May 11, 2006

Jun 06, 2003

SERUM BIOMARKERS IN ISCHAEMIC HEART DISEASE

Jian (“Jane”) DING and Lee O. LOMAS

PENDING

US 2006-0257946 A1

Nov 16, 2006

Jun 04, 2024

43

035394-003810 EP

EP

National Phase of PCT/US2006/023954

Jun 20, 2006

Jun 21, 2005

BIOMARKERS FOR BREAST CANCER

Anthony GONÇALVES, Jean-Paul BORG, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Jun 20, 2026

44

035394-003810 US

US

National Phase of PCT/US2006/023954

11/917,766

Dec 16, 2007

Jun 21, 2005

BIOMARKERS FOR BREAST CANCER

Anthony GONÇALVES, Jean-Paul BORG, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Jun 20, 2026

45

035394-004310 US (formerly OSU-000110 US)

US

ORIGINAL FILING

11/711,946

Feb 27, 2007

Feb 27, 2006

PROCESS TO DETERMINE ENZYME ACTIVITY

Haifeng WU, Ming JIN, Michael BISSELL and Spero CATALAND

PENDING

Feb 27, 2027

46

EAPD-56792 US (71699) (JHU)

US

National Phase of PCT/US03/00531

10/500,838

Feb 02, 2005

Jan 07, 2002

BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, and Alex Jaideep RAI

PENDING

US 2005-214760 A1

Sep 29, 2005

Jan 07, 2023

47

EAPD-57203 CA (71699) (JHU)

CA

National Phase of PCT/US03/06850

2,478,036

Mar 06, 2003

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

Mar 06, 2023

48

EAPD-57203 EP (71699) (JHU)

EP

National Phase of PCT/US03/06850

03713930.0

Mar 06, 2003

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

EP 1585962

Oct 19, 2005

Mar 06, 2023

49

EAPD-57203 JP (71699) (JHU)

JP

National Phase of PCT/US03/06850

2003-575071

Mar 06, 2003

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

JP 2006-508326

Mar 09, 2006

Mar 06, 2023

50

EAPD-57203 US (71699) (JHU)

US

National Phase of PCT/US03/06850

10/506,725

Sep 04, 2004

Mar 06, 2002

USE OF BIOMARKERS TO DETECT BREAST CANCER

Daniel W. CHAN, Zhen ZHANG, and Jinong LI

PENDING

US 2005-170352 A1

Aug 04, 2005

Mar 06, 2023

51

EAPD-57222 EP (71699) (JHU)

EP

National Phase of PCT/US2003/12729

03724209.6

Oct 25, 2004

Apr 26, 2002

IDENTIFICATION OF BIOMARKERS FOR DETECTING PROSTATE CANCER

Daniel W. CHAN, Jinong LI, and Zhen ZHANG

PENDING

Apr 25, 2023

Page 4 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

52

EAPD-57222 US (71699) (JHU)

US

National Phase of PCT/US03/12729

10/512,731

Oct 26, 2004

Apr 26, 2002

IDENTIFICATION OF BIOMARKERS FOR DETECTING PROSTATE CANCER

Daniel W. CHAN, Jinong LI, and Zhen ZHANG

PENDING

US 2005-176011 A1

Aug 11, 2005

Apr 25, 2023

53

EAPD-58368 AU (71699) (JHU)

AU

National Phase of PCT/US2003/024659

2003256858

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

AU 03257207

Feb 23, 2004

Aug 05, 2023

54

EAPD-58368 CA (71699) (JHU)

CA

National Phase of PCT/US2003/024659

2493817

Jan 27, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

55

EAPD-58368 CN (71699) (JHU)

CN

National Phase of PCT/US2003/024659

03819042.7

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

CN 1675372 A

Sep 28, 2005

Aug 05, 2023

56

EAPD-58368 EP (71699) (JHU)

EP

National Phase of PCT/US2003/024659

03767259.9

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

EP 1540010

Jun 15, 2005

Aug 05, 2023

57

EAPD-58368 HK (71699) (JHU)

HK

Validated from EP 03767259.9

05111072.3

Dec 05, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

HK 1076489 A

Jan 20, 2006

Aug 05, 2023

58

EAPD-58368 IL (71699) (JHU)

IL

National Phase of PCT/US2003/024659

166118

Jan 03, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

59

EAPD-58368 JP (71699) (JHU)

JP

National Phase of PCT/US2003/024659

2005-506102

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

60

EAPD-58368 KR (71699) (JHU)

KR

National Phase of PCT/US2003/24659

10-2005-7001536

Jan 27, 2005

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

61

EAPD-58368 US (71699) (JHU)

US

Claims Priority from 60/401,837, 60/441,727, and 60/460,342

10/635,308

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

US 2005-059013 A1

Mar 17, 2005

Aug 05, 2023

62

EAPD-58368-DIV NZ (71699) (JHU)

NZ

DIV of 538236

562912

Aug 05, 2003

Aug 06, 2002

USE OF BIOMARKERS FOR DETECTING OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG, and Xiao-Ying MENG

PENDING

Aug 05, 2023

63

EAPD-61154 AU (71699) (JHU)

AU

National Phase of PCT/US05/10783

2005-230445

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

Mar 31, 2025

64

EAPD-61154 CA (71699) (JHU)

CA

National Phase of PCT/US05/10783

2,559,911

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

Mar 31, 2025

65

EAPD-61154 CN (71699) (JHU)

CN

National Phase of PCT/US05/10783

200580017610.1

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

CN 101023349 A

Aug 22, 2007

Mar 31, 2025

66

EAPD-61154 EP (71699) (JHU)

EP

National Phase of PCT/US05/10783

05740120

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

EP 1756566 A2

Feb 28, 2007

Mar 31, 2025

67

EAPD-61154 JP (71699) (JHU)

JP

National Phase of PCT/US05/10783

2007-506525

Mar 31, 2005

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

2007-531883 A

Nov 08, 2007

Mar 31, 2025

Page 5 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

68

EAPD-61154 US (71699) (JHU)

US

National Phase of PCT/US05/10783

10/594,874

Sep 28, 2006

Mar 31, 2004

BIOMARKERS FOR OVARIAN CANCER

Daniel W. CHAN, Zhen ZHANG, Eric T. FUNG , and Xiao-Ying MENG

PENDING

Mar 31, 2025

69

EAPD-61849 AU (71699) (JHU)

AU

National Phase of PCT/US05/33168

2005287074

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

70

EAPD-61849 CA (71699) (JHU)

CA

National Phase of PCT/US05/33168

2,580,494

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

71

EAPD-61849 CN (71699) (JHU)

CN

National Phase of PCT/US05/33168

200580039464.2

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

72

EAPD-61849 EP (71699) (JHU)

EP

National Phase of PCT/US05/33168

05800204.9

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

EP 1802764 A2

Jul 04, 2007

Sep 16, 2025

73

EAPD-61849 MX (71699) (JHU)

MX

National Phase of PCT/US05/33168

MX/a/2007/003003

Sep 16, 2005

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

74

EAPD-61849 US (71699) (JHU)

US

National Phase of PCT/US05/33168

11/662,830

Mar 13, 2007

Sep 17, 2004

BIOMARKERS FOR BREAST CANCER

Jinong LI, Carolyn Nicole WHITE, Zhen ZHANG, Daniel W. CHAN, Eric Thomas FUNG, and Xiao-Ying MENG

PENDING

Sep 16, 2025

75

EAPD-62959 AU (71699) (JHU)

AU

National Phase of PCT/US2006/08578

2006223374

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

AU 6223374 AA

Sep 21, 2006

Mar 10, 2026

76

EAPD-62959 CA (71699) (JHU)

CA

National Phase of PCT/US2006/08578

2,602,088

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

2,602,088 AA

Sep 21, 2006

Mar 10, 2026

77

EAPD-62959 CN (71699) (JHU)

CN

National Phase of PCT/US2006/08578

2006-80007808.6

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

78

EAPD-62959 EP (71699) (JHU)

EP

National Phase of PCT/US2006/08578

06737729.1

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

EP 1 869 462

Dec 26, 2007

Mar 10, 2026

79

EAPD-62959 IL (71699) (JHU)

IL

National Phase of PCT/US2006/08578

185496

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

Page 6 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

80

EAPD-62959 JP (71699) (JHU)

JP

National Phase of PCT/US2006/08578

2008-500963

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

81

EAPD-62959 KR (71699) (JHU)

KR

National Phase of PCT/US2006/08578

10-2007-7023307

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

82

EAPD-62959 MX (71699) (JHU)

MX

National Phase of PCT/US2006/08578

MX/a/2007/011024

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

83

EAPD-62959 NZ (71699) (JHU)

NZ

National Phase of PCT/US2006/08578

560976

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

Mar 10, 2026

84

EAPD-62959 US (71699) (JHU)

US

Claims Priority from 60/662,090

11/373,833

Mar 10, 2006

Mar 11, 2005

BIOMARKERS FOR OVARIAN CANCER AND ENDOMETRIAL CANCER: HEPCIDIN

Eric T. FUNG, Robert C. BAST, Daniel W. CHAN, Jin SONG, Vladimir PODUST, and Zhen ZHANG

PENDING

US 2007-0054329 A1

Mar 08, 2007

Mar 10, 2026

85

EAPD-63133 CA (71699) (JHU)

CA

National Phase of PCT/US2006/020643

2,608,522

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

86

EAPD-63133 CN (71699) (JHU)

CN

National Phase of PCT/US2006/020643

2006-80026379.7

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

87

EAPD-63133 EP (71699) (JHU)

EP

National Phase of PCT/US2006/020643

06771418.8

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

88

EAPD-63133 MX (71699) (JHU)

MX

National Phase of PCT/US2006/020643

MX/A/2007/014863

May 25, 2006

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

89

EAPD-63133 US (71699) (JHU)

US

National Phase of PCT/US2006/020643

11/920,906

Nov 21, 2007

May 26, 2005

BIOMARKERS FOR BREAST CANCER

Jinong LI, Saraswati SUKUMAR, and Daniel W. CHAN

PENDING

May 25, 2026

90

EAPD-63630 AU (52903) (VRML)

AU

National Phase of PCT/US2006/024677

2006261904

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

91

EAPD-63630 CA (52903) (VRML)

CA

National Phase of PCT/US2006/024677

2,611,524

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

92

EAPD-63630 EP (52903) (VRML)

EP

National Phase of PCT/US2006/024677

06785526.2

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

EP 1 904 852

Apr 02, 2008

Jun 23, 2026

93

EAPD-63630 IL (52903) (VRML)

IL

National Phase of PCT/US2006/024677

187899

Dec 04, 2007

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

94

EAPD-63630 MX (52903) (VRML)

MX

National Phase of PCT/US2006/024677

MX/a/2008/000098

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

95

EAPD-63630 US (52903) (VRML)

US

National Phase of PCT/US2006/024677

11/922,621

Dec 20, 2007

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN

Eric T. FUNG, Enrique DALMASSO, Valdimir PODUST, and Zheng WANG

PENDING

Jun 23, 2026

Page 7 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

96

EAPD-63631 AU (71699) (JHU)

AU

National Phase of PCT/US2006/024269

2006262182

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

97

EAPD-63631 CA (71699) (JHU)

CA

National Phase of PCT/US2006/024269

2,611,340

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

98

EAPD-63631 CN (71699) (JHU)

CN

National Phase of PCT/US2006/024269

2006-80029695.x

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

99

EAPD-63631 EP (71699) (JHU)

EP

National Phase of PCT/US2006/024269

06785323.4

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

100

EAPD-63631 IL (71699) (JHU)

IL

National Phase of PCT/US2006/024269

187867

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

101

EAPD-63631 JP (71699) (JHU)

JP

National Phase of PCT/US2006/024269

2008-518376

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

102

EAPD-63631 MX (71699) (JHU)

MX

National Phase of PCT/US2006/024269

MX/a/2008/000090

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER: CTAP3-RELATED PROTEINS

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

Jun 21, 2026

103

EAPD-63631 US (71699) (JHU)

US

Claims Priority from 60/693,324

11/473,280

Jun 21, 2006

Jun 22, 2005

BIOMARKER FOR OVARIAN CANCER

Zhen ZHANG, Daniel Wanyui CHAN, Eric T. FUNG, Zheng WANG, and Fujun ZHANG

PENDING

US 2007-0172902 A1

Jul 26, 2007

Jun 21, 2026

104

EAPD-64161 AU (71699) (JHU)

AU

Natl phase of PCT/US/2006/036538

2006-292212

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

105

EAPD-64161 CN (71699) (JHU)

CN

Natl phase of PCT/US/2006/036538

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

106

EAPD-64161 EP (71699) (JHU)

EP

Natl phase of PCT/US/2006/036538

06803875.1

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

1934603

Jun 25, 208

Sep 19, 2026

107

EAPD-64161 JP (71699) (JHU)

JP

Natl phase of PCT/US/2006/036538

Sep 19, 2006

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

108

EAPD-64161 US (71699) (JHU)

US

Natl phase of PCT/US/2006/036538

11/922,000

Mar 12, 2008

Sep 19, 2005

BIOMARKER FOR PROSTATE CANCER

Zhen ZHANG, Daniel W. CHAN, and Carolyn ROSENZWEIG

PENDING; enters national phase by 3/19/08

Sep 19, 2026

109

EAPD-66375 PC (71699) (JHU)

WO

Claims Priority from 60/849,506

PCT/US2007/021483

Oct 04, 2007

Oct 04, 2006

ALGORITHIMS FOR MULTIVARIANT MODELS TO COMBINE A PANEL OF BIOMARKERS FOR ASSESSING THE RISK OF DEVELOPING OVARIAN CANCER

Zhen ZHANG

PENDING; enters national phase by 4/4/09

Apr 04, 2009

Page 8 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

110

EAPD-66453 P2 (52903) (VRML)

US

ORIGINAL FILING

60/998,728

Oct 12, 2007

Oct 12, 2007

PROGNOSTIC BIOMARKER IN PATIENTS WITH OVARIAN CANCER

Eric T. FUNG

PENDING

Oct 12, 2008

111

EAPD-66453 PC (52903) (VRML)

WO

Claims Priority from 60/851,520

PCT/US2007/021867

Oct 12, 2007

Oct 13, 2006

PROGNOSTIC BIOMARKER IN PATIENTS WITH OVARIAN CANCER

Eric T. FUNG

PENDING; enters national phase by 4/13/09

Apr 13, 2009

112

EAPD-67896 P2 (52903) (VRML)

US

Second Provisonal, but doesn’t claim priority to 60/920,274; HOWEVER, both US regular and WO claim priority to both

61/034,469

Mar 06, 2008

Mar 06, 2008

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Robert C. BAST, Vladimir PODUST, and Charlotte CLARK

PENDING; regular and PCT applications due 3/5/09

Mar 06, 2008

113

EAPD-67896 PC (52903) (VRML)

WO

Claims priority to 60/920,274 and 61/034,469

PCT/US/2008/004088

Mar 27, 2008

Mar 27, 2007

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Robert C. BAST, Vladimir PODUST, and Charlotte CLARK

PENDING; enters national phase by 9/26/09

Sep 27, 2009

114

EAPD-67896 US (52903) (VRML)

US

Claims priority to 60/920,274 and 61/034,469

12/079,592

Mar 27, 2008

Mar 27, 2007

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Robert C. BAST, Vladimir PODUST, and Charlotte CLARK

PENDING

Mar 27, 2028

115

EAPD-68838 CA (52903) (VRML)

CA

National Phase of PCT/US2006/024693

2,611,173

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

116

EAPD-68838 CN (52903) (VRML)

CN

National Phase of PCT/US2006/024693

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

117

EAPD-68838 EP (52903) (VRML)

EP

National Phase of PCT/US2006/024693

06773938.3

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

118

EAPD-68838 JP (52903) (VRML)

JP

National Phase of PCT/US2006/024693

2008-51847

Jun 23, 2006

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

119

EAPD-68838 US (52903) (VRML)

US

National Phase of PCT/US2006/024693

11/922,652

Dec 20, 2007

Jun 24, 2005

BIOMARKERS FOR OVARIAN CANCER

Eric T. FUNG, Frederick Rand UELAND, J.R. van NAGELL, Jr., Paul Duane DEPRIEST, and Andre Thomas BARON

PENDING

Jun 23, 2026

120

EAPD-68840 PC (52903) (VRML)

WO

Based on 60/908,670

PCT/US2008/04089

Mar 27, 2008

Mar 28, 2007

METHODS FOR DIAGNOSING OVARIAN CANCER

Eric T. FUNG, Tai-Tung YIP, Vladimir PODUST, Mats BRÄNNSTRÖM, Karin SUNDFELDT, and Bjorg KRISJANSDOTTIR

PENDING; enters national phase by 9/27/09

Sep 28, 2009

Page 9 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

121

EAPD-68840 US (52903) (VRML)

US

Based on 60/908,670

12/079,588

Mar 27, 2008

Mar 28, 2007

METHODS FOR DIAGNOSING OVARIAN CANCER

Eric T. FUNG, Tai-Tung YIP, Vladimir PODUST, Mats BRÄNNSTRÖM, Karin SUNDFELDT, and Bjorg KRISJANSDOTTIR

PENDING

Mar 27, 2028

122

EAPD-69585 P (52903) (VRML)

US

ORIGINAL FILING

60/983,378

Oct 29, 2007

Oct 29, 2007

METHODS FOR DIAGNOSING OVARIAN CANCER

Eric T. FUNG, Charlotte CLARK, Robert C. BAST, and Kevin COOMBES

PENDING; regular and PCT applications due 10/28/08

Oct 29, 2008

123

NCVC-000110 JP

JP

National Phase of PCT/JP02/10816

Oct 18, 2002

Oct 18, 2002

SUBSTRATES SPECIFIC TO VON WILLEBRAND FACTOR CLEAVING PROTEASE AND METHOD OF ASSAYING THE ACTIVITY

Toshiyuki MIYATA and Koichi KOKAME

ISSUED

JP 3944586

Oct 18, 2022

124

NCVC-000110 US

US

National Phase of PCT/JP02/10816

10/531,427

Apr 15, 2005

Oct 18, 2002

SUBSTRATES SPECIFIC TO VON WILLEBRAND FACTOR CLEAVING PROTEASE AND METHOD OF ASSAYING THE ACTIVITY

Toshiyuki MIYATA and Koichi KOKAME

PENDING

US 2007-0065895 A1

Mar 22, 2007

Oct 18, 2022

125

VRML-0021 US

US

National Phase of PCT/US05/00548 (14)

10/586,075

Jul 14, 2006

Jan 16, 2004

SPECIFIC DETECTION OF TROPONIN AND MODIFIED FORMS OF TROPONIN

Tai-Tung YIP and Eric T. FUNG

PENDING

Jan 07, 2025

126

VRML-0023 PC

WO

Claims Priority from 60/749,449

PCT/US2006/61954

Dec 12, 2006

Dec 12, 2005

BIOMARKERS FOR BABESIA

Momar NDAO, Brian WARD, Peter KRAUSE, Mark DUNCAN, Mike EDWARDS, and Terrence William SPITHILL

PENDING; enters national phase by 6/12/08

WO 2007/070809

Jun 21, 2007

Jun 12, 2008

127

VRML-0030 BR (formerly 016866-012130 BR)

BR

National Phase of PCT/US2004/040990

PI 0417231-0

Jun 02, 2006

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

Dec 06, 2024

128

VRML-0031 CA (formerly 016866-012130 CA)

CA

National Phase of PCT/US2004/040990

2547861

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

Dec 06, 2024

129

VRML-0032 EP (formerly 016866-012130 EP)

EP

National Phase of PCT/US2004/040990

04813321.9

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

EP 1718763 A2

Nov 08, 2006

Dec 06, 2024

130

VRML-0033 MX (formerly 016866-012130 MX

MX

National Phase of PCT/US2004/040990

PA/a/2006/006231

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

Dec 06, 2024

Page 10 of 11

Earliest Priority Date -

Filing Date - date of

ie provisional filing

filing specific

date (for publication,

application (nat’l phase,

request for

Status/Expected

Vermillion File No.

Ctry

Genealogy

Application No.

div, con, etc.)

examination, etc.)

Title

Inventors

Actions

Publication #

Published

Patent No.

Issued

Expires

131

VRML-0034 US (formerly 016866-012130 US)

US

Claims Priority from 60/527,153, 60/565,093, and 60/625,519

11/006,119

Dec 06, 2004

Dec 05, 2003

SERUM BIOMARKERS FOR CHAGAS DISEASE

Momar NDAO, Brian WARD, Rebecca E. CAFFREY, Terence William SPITHILL, Hongshan LI, Vladimir PODUST, and Regis PERICHON

PENDING

US 2005-260691 A1

Nov 24, 2005

Dec 06, 2024

132

VRML-0035 P

US

ORIGINAL FILING

60/985,611

Nov 05, 2007

Nov 05, 2007

BIOMARKERS FOR LEISHMANIASIS

Momar NDAO, Brian WARD, and Naomi ARONSON

PENDING; regular and PCT applications due by Nov 4, 2008

Nov 05, 2008

Page 11 of 11

Schedule B — Exhibit 2 to the Statement of Financial Affairs and Schedules of Assets and Liabilities containing information about licenses, franchises, and other general intangibles, as filed with the U.S. Bankruptcy Court of Delaware, is available through the Federal Court filing system PACER at http://pacer.psc.uscourts.gov/ in the Company’s document section.

In re: Vermillion, Inc.	Case No. 09-11091
Schedule B — Exhibit 3
Plant, Property, and Equipment
Detail Listing
March 31, 2009

System		Asset			Acquisition				Acquisition		Accumulated
Number		Tag			Date	Account		Description	Value		Depreciation		Net Book Value
	20		01011		01Sep97		1610	Centrifuge — Sorvall Super 21		14,252.50		14,252.50		0.00
	103		01777		27Mar00		1610	ST-H750 Rotor with Buckets		7,134.34		7,134.34		0.00
	146		01174		25May00		1610	Biomek 2000 Workstation		79,630.11		79,630.11		0.00
	269		01173		21Dec00		1610	Eppendorf Centrifuge 5417R		5,136.20		5,136.20		0.00
	297		01171		31Jan01		1610	Triple Swinging Door Refrigerator		5,694.47		5,694.47		0.00
	349		01021		30Apr01		1610	Balance PSLIP# 7638161-0		3,505.13		3,505.13		0.00
	352		01146		30Apr01		1610	XL1010 Sonicator with 1/2" Horn		5,646.28		5,646.28		0.00
	373		01148		30Jun01		1610	Model 5416 Feezer- 86 VWR-Revco		6,909.13		6,909.13		0.00
	415		01151		30Sep01		1610	Biomek 2000 Workstation		79,569.79		79,569.79		0.00
	416		01181		30Sep01		1610	Biomek 2000 Workstation w/Autoloader PAL03126		83,911.56		83,911.56		0.00
	501		01357		31Mar02		1610	Refrigerator, GLS Door, 72 Cubic Ft		4,503.53		4,503.53		0.00
	542		01847		07May02		1610	DPC Shaker Integ Kit/BMK 2000		3,274.32		3,274.32		0.00
	741		02150		14Jan03		1610	Freezer, UPRT, Val		8,427.77		8,427.77		0.00
	766		02077		26Feb03		1610	Micromix 5 Shaker		2,122.31		2,122.31		0.00
	780		02149		20Mar03		1610	Biological Safey Cabinet Class II A2		8,265.56		8,265.56		0.00
	934		02195	(?)	31Aug03		1610	NRE Tooling Charge for WIOS Wafter, 5"x5"		12,000.00		12,000.00		0.00
	977		02186		01Dec03		1610	Retrofit kits		24,059.65		24,059.65		0.00
	1,045		02115		23Mar04		1610	SPBSIIc		42,395.30		42,395.30		0.00
	1,067		02189		31Mar04		1610	DPC Micromix 5 Shaker		2,215.36		2,215.36		0.00
	1,084		02438		28Apr04		1610	Biomek 2000 Integration Package (Shaker)		5,585.70		5,585.70		0.00
	1,086		02110		28Apr04		1610	Biomek 2000 Integration Package (Shaker) Micromix 5		5,585.70		5,585.70		0.00
	1,200		02350		05Jan05		1610	FREEZER		8,775.00		7,166.25		1,608.75
	1,201		02351		05Jan05		1610	FREEZER		8,775.00		7,166.25		1,608.75
	1,210		02359		31Mar05		1610	QSTAR XL Mass Spectrometer		357,619.45		268,214.59		89,404.86
	1,215		02369		08Apr05		1610	PCS4000, PROTEINCHIP READER		47,407.55		47,407.55		0.00
	1,216		02370		08Apr05		1610	PCS4000		47,407.55		47,407.55		0.00
	1,219		02436		16Jun05		1610	Tandem MS Interface only QSTAR/Z200-0003		21,987.28		21,987.28		0.00
	1,241				31Oct05		1610	PCS4000 SN: 5E1151E		49,824.93		49,824.93		0.00
	1,258		02421		31Jan06		1610	BioDot AD1800 SN: AD1610		34,730.00		21,995.67		12,734.33
	1,264		02418		31Jan06		1610	PCS 4000 SN: 5I1170E		76,453.27		76,453.27		0.00
	1,268				12Apr06		1610	PCS4000 SN: 5K1182E		46,359.01		45,071.25		1,287.76
	1,285		02475		09Aug06		1610	PCS4000 SN: 6A1196E		47,631.29		41,015.84		6,615.45
	1,286		2463		10Aug06		1610	PCS4000 SN: 6C1198E		38,839.51		33,445.12		5,394.39
	1,288				10Aug06		1610	PCS4000 SN: 6A1190E		46,201.25		39,784.41		6,416.84
	1,290				10Oct06		1610	PBS11C SN: 4C637TC		37,159.84		29,934.31		7,225.53
	1,292		2476		31Oct06		1610	EVO 150 w/MCA Package with work station		108,879.39		52,625.04		56,254.35
	1,309				15Mar07		1610	Assy(refurbished), laser module		17,293.42		12,009.31		5,284.11
	1,312				01Nov04		1610	PCS4000		44,173.43		44,173.43		0.00
	1,317				15Jun07		1610	Assy(refurbished), laser module-reduction in price FA#1309		-1,151.92		-703.95		-447.97
	1,318		02467		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74
	1,319				14Sep07		1610	PCS 4000, LASER MODULE		16,185.69		8,542.44		7,643.25
	1,320		02468		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74
	1,322		02466		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74
	1,323		02469		31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.61		32,995.87		36,877.74

System		Asset		Acquisition				Acquisition		Accumulated
Number		Tag		Date	Account		Description	Value		Depreciation		Net Book Value
	1,324		02470	31Oct07		1610	PCS 4000 SELDI Enterprise edition, w/Barcode scanner, data mgr&doc package		69,873.62		32,995.88		36,877.74
	1,325		02471	03Oct07		1610	Scotsman model AFE400AE-1H flake ice machine		3,741.00		1,122.30		2,618.70
	1,326		02472	31Oct07		1610	Demo instrument freedom EVO 200 SN 491		100,565.48		47,489.25		53,076.23
	1,334		N/A	02Dec08		1610	BN II Nephelometer, #07235		47,562.50		2,378.12		45,184.38
									1,965,612.69		1,479,314.28		486,298.41
	163		01636	31Jul00		1620	HP Laser Jet 4050TN Printer		2,896.76		2,896.76		0.00
	164		01637	31Jul00		1620	HP Laser Jet 4050TN Printer		2,896.76		2,896.76		0.00
	165		01638	31Jul00		1620	HP Laserjet 4050TN Printer and Accessories		2,896.76		2,896.76		0.00
	250		01394	30Nov00		1620	Laptop — Dell Lattitude C600 Laptops		4,250.14		4,250.14		0.00
	290		01259	31Jan01		1620	Laptop — Lattitude C600 700 MHZ		2,674.01		2,674.01		0.00
	407		01705	12Sep01		1620	Infocus LP130 Prem Digital Projector		4,476.05		4,476.05		0.00
	503		2394	31Mar02		1620	PowerEdge 2550, Pentium, 1.4 GHz, 512K Cache Server		4,587.95		4,587.95		0.00
	504		01812	31Mar02		1620	244131, 3CO-3C17700-US, 3COM Switches		5,027.96		5,027.96		0.00
	555		01857	02May02		1620	Avocent DSR2161 2/U DIG-1/U LOCAL 16 KVM Hardware		4,699.65		4,699.65		0.00
	606		2391	13Jun02		1620	PowerEdge 1650, Pentium III-T, 1.4GHz, 512K Cache, Base Server		5,383.31		5,383.31		0.00
	608		2392	13Jun02		1620	PowerEdge, 1650, Pentium III-T, 1.4GHz, 512K Cache, Base Server		5,383.32		5,383.32		0.00
	610		02435	19Jun02		1620	PowerEdge 2650, 2.2 GHz/512K Cache Xeon Server File 01		4,209.07		4,209.07		0.00
	660		01411	07Aug02		1620	Back Up System — PowerVault 128T, 5U, Rack, 1 Drive, LTO		10,654.57		10,654.57		0.00
	700		2393	23Oct02		1620	PowerEdge 1650, Pentium, III-T, 1.4GHz, 512K Cache Base Server		5,095.04		5,095.04		0.00
	747		02060	15Jan03		1620	PowerEdge 2650, 1.8GHz/512K Server		4,587.95		4,587.95		0.00
	767		02126-1	26Feb03		1620	Infocus LP790HB Projector 3300 Lumen XGA		5,454.17		5,454.17		0.00
	915		01942	25Sep03		1620	Laptop — Latitude D400, 1.70GHz, Pen M.		3,098.11		3,098.11		0.00
	917		01943	25Sep03		1620	Laptop -Latitude D400, 1.70GHz, PEN M., 12.1 XGA, NIC		3,098.11		3,098.11		0.00
	975		02276	31Dec03		1620	HP Color Laser Jet Printer — 5500DN		3,926.18		3,926.18		0.00
	999		02300	30Jan04		1620	PowerEdge 2650, 3.2GHz/1MB Cache/533MHz FSB Xeon		6,993.03		6,993.03		0.00
	1,000		02301	30Jan04		1620	PowerEdge 2650, 3.2GHz/1MB Cache/533MHz FSB Xeon		6,993.03		6,993.03		0.00
	1,004		02245	28Jan04		1620	Laptop — Latitude D400, 1.70GHz, Pen M.		2,807.55		2,807.55		0.00
	1,008		02304	19Jan04		1620	Apple PM G5/1.8 160GB 512M		4,831.20		4,831.20		0.00
	1,033		02122	12Feb04		1620	Dell Workgroup Laser Printer W5300n		2,087.09		2,087.09		0.00
	1,049		02228	25Mar04		1620	Laptop — Latitude D400, 1.70GHz, PEN M., 12.1XGA		2,795.82		2,795.82		0.00
	1,050		02303	30Mar04		1620	Gateway 840 Storage Enclosure		7,532.05		7,532.05		0.00
	1,058		2263	30Mar04		1620	Firewall Hardware — CISCO PIX 515E Chassis Fail Over		2,828.99		2,828.99		0.00
	1,071		02223	09Apr04		1620	Laptop — Latitude D400, 1.70GHz, PEN M., 12.1 XGA		2,794.59		2,794.59		0.00
	1,121		2299	25Jun04		1620	IT Hardware — Power VAult 136T, LTO-2		26,799.80		26,799.80		0.00
	1,135		2336	14Jul04		1620	PSS 100E Dual Controller		29,729.17		29,729.17		0.00
	1,173		02338	01Nov04		1620	Server — Fre VM03 Poweredge 2650		15,069.43		15,069.43		0.00
	1,185		02339	11Nov04		1620	HP Procurve Switch — Network Equipment		5,167.18		5,167.18		0.00
	1,266		2428	19Feb06		1620	Laptop Sony TX650P		2,542.86		2,542.86		0.00
	1,269		2430	13Apr06		1620	Dell PowerEdge 1850 S/T 1CSCR91		4,292.72		4,173.48		119.24
	1,270		2429	13Apr06		1620	Dell PowerEdge 1850 S/T FYTCR91		6,085.14		5,916.10		169.04
	1,271		2431	30Apr06		1620	Cisco Pix 515E Chassis Failover		2,557.32		2,344.21		213.11
	1,295			27Dec06		1620	Latitude D420 ST: JZB96C1		2,084.74		1,563.54		521.20
									219,287.58		218,264.99		1,022.59
	359		N/A	01May01		1621	5-User MAS200 Licenses		6,480.00		6,480.00		0.00
	472		N/A	21Feb02		1621	MAS Window Work Order Processing & MAS90 MRP Software		4,726.88		4,726.88		0.00
	605		N/A	17Jun02		1621	5-User License for MAS200		6,495.00		6,495.00		0.00
	679		02009	10Sep02		1621	TN-2224B 24-Port Digital 2W-Ref Software		2,830.84		2,830.84		0.00
	722		N/A	30Nov02		1621	Prophix Software for Budget		20,357.07		20,357.07		0.00
	748		N/A	16Jan03		1621	5 User License MAS200 CS		6,507.00		6,507.00		0.00
	872		N/A	08May03		1621	5 User License MAS200 CS		6,495.00		6,495.00		0.00
	932		N/A	30Sep03		1621	MCF SAV CUP 251-500 Software		4,391.16		4,391.16		0.00
	933		N/A	30Sep03		1621	MCL ACS UPG PERP 251-500 Software		6,448.45		6,448.45		0.00

System		Asset		Acquisition				Acquisition		Accumulated
Number		Tag		Date	Account		Description	Value		Depreciation		Net Book Value
	1,005		N/A	21Jan04		1621	VMWARE GSX SERVER 2 CPU V2.5 WIN EMA Software		3,088.37		3,088.37		0.00
	1,038		N/A	28Feb04		1621	VMWARE GSX Server CPU V2.5 Win EMA Software		2,853.00		2,853.00		0.00
	1,107	NA		31May04		1621	Windows Svr Std English SA MVL Licenses		121,687.07		121,687.07		0.00
	1,175			01Nov04		1621	Titanium SQL Software		3,750.00		3,750.00		0.00
	1,272			31May06		1621	SBE BES TO ENTPR BES 4.1 UPGRADE		2,773.77		2,619.68		154.09
									198,883.61		198,729.52		154.09
	331		01477	31Mar01		1630	HON File Cabinets		3,152.06		3,152.06		0.00
	354		01477-A	30Apr01		1630	HON File Cabinets for Accounting		4,281.72		4,281.72		0.00
	357		01477-B	30Apr01		1630	HON File Cabinets for Accounting		6,410.46		6,410.46		0.00
	518		N/A	01Mar02		1630	3 Creative Wood 72" Credenzas		3,989.41		3,989.41		0.00
	805		N/A	30Apr03		1630	13 8X8 Cubicles and 7 10X12 Cubicles		7,169.60		7,169.60		0.00
	1,294			02Dec06		1630	Lateral 3 drawer 43" Fire Resistant		2,565.41		1,154.43		1,410.98
	1,304			20Feb07		1630	Desk/Credenza		2,347.28		978.03		1,369.25
	1,305			02Feb07		1630	Lateral 4 drawer 43" fire resistant with lock & key		2,695.91		1,168.22		1,527.69
	1,328		02474	07Jan08		1630	Lateral 4 drawer 43" fire resistant with lock & key		2,689.39		672.35		2,017.04
									35,301.24		28,976.28		6,324.96
	1,329		N/A	30Jun08		1640	Electrical Installation		10,550.00		3,956.25		6,593.75
	1,330		N/A	30Jun08		1640	Voice and Data Install		11,887.00		4,457.62		7,429.38
	1,331		N/A	30Jun08		1640	PBX Install		8,709.48		3,266.05		5,443.43
	1,332		N/A	30Jun08		1640	Cubicle Design Service: 12 8x8 and 6 10x12		4,041.00		1,515.37		2,525.63
	1,333		N/A	28Aug08		1640	PBX Install SYSNO 1331-Reduction in Price-Refund		-500.00		-145.83		-354.17
									34,687.48		13,049.46		21,638.02
	443		02111	30Nov01		1650	PBS-II		39,014.19		39,014.19		0.00
	807		02109	22Apr03		1650	Biomek 2000 Workstation		49,217.70		49,217.70		0.00
	884		02251	30Jun03		1650	Autoloader PBSII+3C500TC		3,976.13		3,976.13		0.00
	956		02113	30Nov03		1650	Server		2,385.32		2,385.32		0.00
	1,068		02259	31Mar04		1650	Biomek 2000 w/ProteinChip		46,010.00		46,010.00		0.00
	1,179		02348	01Nov04		1650	PCS4000		41,748.72		41,748.72		0.00
	1,180		02349	01Nov04		1650	PCS4000		41,748.72		41,748.72		0.00
	1,192		02404	31Dec04		1650	Biomek 2000 w/ ProteinChip Biomarker		46,762.50		46,762.50		0.00
	1,296		02456	31Dec06		1650	Protein Chip System PCS 4000		39,587.57		39,587.57		0.00
	1,299		02458	31Dec06		1650	Protein Chip System PCS 4000		43,176.27		43,176.27		0.00
	1,300		02459	31Dec06		1650	Protein Chip System PCS 4000		43,176.27		43,176.27		0.00
	1,301		02461	31Dec06		1650	Biomek 2000 w/ ProteinChip Biomarker		43,000.00		43,000.00		0.00
	1,302		02462	31Dec06		1650	Biomek 2000 w/ ProteinChip Biomarker		43,000.00		43,000.00		0.00
	1,303			31Dec06		1650	Autoloader		3,443.94		3,443.94		0.00
	1,310			01Mar07		1650	Sales tax for Dec06 inventory trf #1296,1297,1299,1300,1301,1302,1303		22,624.03		22,624.03		0.00
									508,871.36		508,871.36		0.00
							Grand Total:		2,962,643.96		2,447,205.89		515,438.07

B6D (Official Form 6D) (12/07)

In re	Vermillion, Inc.	Case No.	09-11091
	Debtor(s)

SCHEDULE D — CREDITORS HOLDING SECURED CLAIMS

     State the name, mailing address, including zip code, and last four digits of any account number of all entities holding claims secured by property of the debtor as of the date of filing of the petition. The complete account number of any account the debtor has with the creditor is useful to the trustee and the creditor and may be provided if the debtor chooses to do so. List creditors holding all types of secured interests such as judgment liens, garnishments, statutory liens, mortgages, deeds of trust, and other security interests.

     List creditors in alphabetical order to the extent practicable. If a minor child is the creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed R. Bankr. P. 1007(m). If all secured creditors will not fit on this page, use the continuation sheet provided.

     If any entity other than a spouse in a joint case may be jointly liable on a claim, place an “X” in the column labeled “Codebtor,” include the entity on the appropriate schedule of creditors, and complete Schedule H — Codebtors. If a joint petition is filed, state whether the husband, wife, both of them, or the marital community may be liable on each claim by placing an “H,” “W,” “J,” or “C” in the column labeled “Husband, Wife, Joint, or Community.”

     If the claim is contingent, place an “X” in the column labeled “Contingent.” If the claim is unliquidated, place an “X” in the column labeled “Unliquidated.” If the claim is disputed, place an “X” in the column labeled “Disputed.” (You may need to place an “X” in more than one of these three columns).

     Total the columns labeled “Amount of Claim Without Deducting Value of Collateral” and “Unsecured Portion, if Any” in the boxes labeled “Total(s)” on the last sheet of the completed schedule. Report the total from the column labeled “Amount of Claim Without Deducting Value of Collateral” also on the Summary of Schedules and, if the debtor is an individual with primarily consumer debts, report the total from the column labeled “Unsecured Portion, if Any” on the Statistical Summary of Certain Liabilities and Related Data.

     o Check this box if debtor has no creditors holding secured claims to report on this Schedule D.

		Husband, Wife, Joint or Community
CREDITOR’S NAME AND			DATE CLAIM WAS INCURRED,
MAILING ADDRESS			NATURE OF LIEN, AND					AMOUNT OF CLAIM
INCLUDING ZIP CODE AND			DESCRIPTION AND VALUE					WITHOUT	UNSECURED
AN ACCOUNT NUMBER			OF PROPERTY					DEDUCTING VALUE	PORTION,
(See Instructions Above)	CODEBTOR	HWJC	SUBJECT TO LIEN		CONTINGENT	UNLIQUIDATED	DISPUTED	OF COLLATERAL	IF ANY
ACCOUNT NO.
Quest Diagnostics, Inc. 3 Giralda Farms Madison, NJ 07940		NA	Research and development Loan. Credit Agreement entered on July 22, 2005
			VALUE	$0.00				$10,000,000.00	$	10,000,000.00
			Total(s)					$10,000,000.00	$	10,000,000.00
			(Use only on last page)					(Report also on Summary of Schedules)	If applicable, report also on Statistical Summary of Certain Liabilities and Related Data)

Sheet 1 of 1 total sheets in Schedule of Creditors Holding Secured Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6E (Official Form 6E) (12/07)
In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)

SCHEDULE E — CREDITORS HOLDING UNSECURED PRIORITY CLAIMS

     A complete list of claims entitled to priority, listed separately by type of priority, is to be set forth on the sheets provided. Only holders of unsecured claims entitled to priority should be listed in this schedule. In the boxes provided on the attached sheets, state the name, mailing address, including zip code, and last four digits of the account number, if any, of all entities holding priority claims against the debtor or the property of the debtor, as of the date of the filing of the petition. Use a separate continuation sheet for each type of priority and label each with the type of priority.

     The complete account number of any account the debtor has with the creditor is useful to the trustee and the creditor and may be provided it he debtor chooses to do so. If a minor child is a creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m).

     If any entity other than a spouse in a joint case may be jointly liable on a claim, place an “X” in the column labeled “Codebtor,” include the entity on the appropriate schedule of creditors, and complete Schedule H-Codebtors. If a joint petition is filed, state whether the husband, wife, both of them, or the marital community may be liable on each claim by placing an “H,” “W,” “J,” or “C” in the column labeled “Husband, Wife, Joint, or Community.” If the claim is contingent, place an “X” in the column labeled “Contingent.” If the claim is unliquidated, place an “X” in the column labeled “Unliquidated.” If the claim is disputed, place an “X” in the column labeled “Disputed.” (You may need to place an “X” in more than one of these three columns.)

     Report the total of claims listed on each sheet in the box labeled “Subtotals” on each sheet. Report the total of all claims listed on this Schedule E in the box labeled “Total” on the last sheet of the completed schedule. Report this total also on the Summary of Schedules.

     Report the total of amounts entitled to priority listed on each sheet in the box labeled “Subtotals” on each sheet. Report the total of all amounts entitled to priority listed on this Schedule E in the box labeled “Totals” on the last sheet of the completed schedule. Individual debtors with primarily consumer debts report this total also on the Statistical Summary of Certain Liabilities and Related Data.

     Report the total of amounts not entitled to priority listed on each sheet in the box labeled “Subtotals” on each sheet. Report the total of all amounts not entitled to priority listed on this Schedule E in the box labeled “Totals” on the last sheet of the completed schedule. Individual debtors with primarily consumer debts report this total also on the Statistical Summary of Certain Liabilities and Related Data.

     Check this box if debtor has no creditors holding unsecured priority claims to report on this Schedule E.

TYPES OF PRIORITY CLAIMS (Check the appropriate box(es) below if claims in that category are listed on the attached sheets)

o Domestic Support Obligations

     Claims for domestic support that are owed to or recoverable by a spouse, former spouse, or child of the debtor, or the parent, legal guardian, or responsible relative of such a child, or a governmental unit to whom such a domestic support claim has been assigned to the extent provided in 11 U.S.C. § 507(a)(1).

o Extensions of credit in an involuntary case

     Claims arising in the ordinary course of the debtor’s business or financial affairs after the commencement of the case but before the earlier of the appointment of a trustee or the order for relief. 11 U.S.C. § 507(a)(3).

þ Wages, salaries, and commissions

     Wages, salaries, and commissions, including vacation, severance, and sick leave pay owing to employees and commissions owing to qualifying independent sales representatives up to $10,950* per person earned within 180 days immediately preceding the filing of the original petition, or the cessation of business, whichever occurred first, to the extent provided in 11 U.S.C. § 507(a)(4).

Name	Address	Type	Amount
Gail Page	REDACTED	Severance	$	10,950
Simon Shorter	REDACTED	Severance	$	10,950
Qun Zhou	REDACTED	Severance	$	10,950
Sue Carruthers	REDACTED	Severance	$	5,447

Sheet 1 of 2 total sheets in Schedule of
Creditors Holding Unsecured Priority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6E (Official Form 6E) (12/07) — Cont.
In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)

SCHEDULE E — CREDITORS HOLDING UNSECURED PRIORITY CLAIMS
(Continuation Sheet)

o Contributions to employee benefit plans

     Money owed to employee benefit plans for services rendered within 180 days immediately preceding the filing of the original petition, or the cessation of business, whichever occurred first, to the extent provided in 11 U.S.C. § 507(a)(5).

o Certain farmers and fishermen

     Claims of certain farmers and fishermen, up to 5,400* per farmer or fisherman, against the debtor, as provided in 11 U.S.C. § 507(a)(6).

o Deposits by individuals

     Claims of individuals up to $2,425* for deposits for the purchase, lease, or rental of property or services for personal, family, or household use, that were not delivered or provided. 11 U.S.C. § 507(a)(7).

o Taxes and Certain Other Debts Owed to Governmental Units

     Taxes, customs duties, and penalties owing to federal, state, and local governmental units as set forth in 11 U.S.C. §507(a)(8).

o Commitments to Maintain the Capital of an Insured Depository Institution

     Claims based on commitments to the FDIC, RTC, Director of the Office of Thrift Supervision, Comptroller of the Currency, or Board of Governors of the Federal Reserve System, or their predecessors or successors, to maintain the capital of an insured depository institution. 11 U.S.C. § 507(a)(9).

o Claims for Death or Personal Injury While Debtor Was Intoxicated

     Claims for death or personal injury resulting from the operation of a motor vehicle or vessel while the debtor was intoxicated from using alcohol, a drug, or another substance. 11 U.S.C. § 507(a)(10).

* Amounts are subject to adjustment on April 1, 2010, and every three years thereafter with respect to cases commenced on or after the date of adjustment.

Sheet 2 of 2 total sheets in Schedule of
Creditors Holding Unsecured Priority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07)
In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS

     State the name, mailing address, including zip code, and last four digits of any account number of all entities holding unsecured claims without priority against the debtor, as of the date of filing of the petition. The complete account number of any account the debtor has with the creditor is useful to the trustee and the creditor and may be provided if the debtor chooses to do so. If a minor child is a creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m). Do not include claims listed in Schedules D and E. If all creditors will not fit on this page, use the continuation sheet provided.

     If any entity other than a spouse in a joint case may be jointly liable on a claim, place an “X” in the column labeled “Codebtor,” include the entity on the appropriate schedule of creditors, and complete Schedule H — Codebtors. If a joint petition is filed, state whether the husband, wife, both of them, or the marital community may be liable on each claim by placing an “H,” “W,” “J,” or “C” in the column labeled “Husband, Wife, Joint, or Community.”

     If the claim is contingent, place an “X” in the column labeled “Contingent.” If the claim is unliquidated, place an “X” in the column labeled “Unliquidated.” If the claim is disputed, place an “X” in the column labeled “Disputed.” (You may need to place an “X” in more than one of these three columns).

     Report the total of all claims listed on this schedule in the box labeled “Total” on the last sheet of the completed schedule. Report this total also on the Summary of Schedules and, if the debtor is an individual with primarily consumer debts, report this total also on the Statistical Summary of Certain Liabilities and Related Data.

o Check this box if debtor has no creditors holding secured claims to report on this Schedule F.

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Airesprings Inc. PO Box 7420 Van Nuys, CA 91409-7420		NA	Trade debt					4.71
American Express CPC Remittance Processing 2975W. Corporate Lakes Blvd. Weston, FL 33331		NA	Trade debt					1,043.47
Applied Clinical Intelligence 225 City Avenue Suite 15 Bala Cynwyd, PA 19004		NA	Trade debt					220,746.73
AT&T Payment Center Sacramento, CA 95887		NA	Trade debt					3,096.08

Sheet 1 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 37855 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Baker & McKenzie LLP One Prudential Plaza Ste #3500 130 East Randolph Drive Chicago, IL 60601		NA	Trade debt					2,438.17
Beckman Coulter, Inc. Dept. CH 10164 Palatine, IL 60055		NA	Trade debt			X		15,000.00
Bio-Rad Laboratories, Inc Life Science Group Dept. 9750 Los Angeles, CA 90084		NA	Trade debt			X		116,507.57
Bioreclamation P.O. Box 770 Hicksville, NY 11802		NA	Trade debt					6,557.62
Bowne of Los Angeles, Inc P.O. Box 79358 City of Industry, CA 91716		NA	Trade debt					1,805.00
Bruce & Co. Attn: Jeff Bruce 20 North Wacker Drive, Ste. 2414 Chicago, IL 60606		NA	4.5% Convertible Senior Notes					135,000.00
Bruce Fund Inc. Attn: Jeff Bruce 20 North Wacker Drive, Ste. 2414 Chicago, IL 60606		NA	7% Convertible Senior Notes					1,800,000.00

Sheet 2 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Certified Compliance Solutions Inc. 16787 Bernardo Center Drive #A-1 San Diego, CA 92128		NA	Trade debt					6,072.10
CIT Technologies P.O. Box 100706 Pasadena, CA 91189		NA	Trade debt					336.82
Computer Patent Annuities CPA House, 11-15 Seaton Place St. Helier, Jersey JE1 1BL Channel Islands, Great Britain		NA	Trade debt					4,911.76
Control Solutions Attn: Accounts Receivable 400 Amherst St. Suite 201 Nashua, NH 03063		NA	Trade debt					4,040.22
Deerfield International Limited Attn: Robert Olan 780 3rd Avenue 37th Floor New York, NY 10017		NA	7% Convertible Senior Notes					1,560,000.00
Deerfield Partners, L.P. Attn: Robert Olan 780 3rd Avenue 37th Floor New York, NY 10017		NA	7% Convertible Senior Notes					1,440,000.00
Deloitte Tax, LLP P.O. Box 2079 Carol Stream, IL 60132		NA	Trade debt					107,971.00

Sheet 3 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Edwards Angell Palmer & Dodge LLP P.O. Box 40956 Hartford, CT 06150		NA	Trade debt					132,318.60
ENDSIGHT 1440 Fourth Street, Suite B Berkeley, CA 94710		NA	Trade debt					10,125.00
E*Trade Financial Corporate Services Attn: Accounts Receivable P.O. Box 3512 Arlington, VA 22203		NA	Trade debt					8,396.62
Facilities Maintenances Svcs 266 Gifford Avenue San Jose, CA 95110		NA	Trade debt					329.00
Fedex ERS P.O. Box 371741 Pittsburgh, PA 15250		NA	Trade debt					246.36
Foley & Lardner 3000 K Street, N.W. Suite 500 Washington, DC 20007		NA	Trade debt					34,646.56
Gail Page REDACTED		NA	Severance					353,050.00

Sheet 4 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Global Cross Conferencing Dept 518 Denver, CO 80291		NA	Trade debt					178.70
Gouffrant, Cecile REDACTED		NA	Trade debt					1,425.00
Highbridge International LLC Attn: Eric Colandrea 9 W. 57th Street, 27th Floor New York, NY 10019		NA	7% Convertible Senior Notes					11,100,000.00
HSBC Bank USA P.O. Box 5875 Hicksville, NY 11802		NA	Trade debt					14,699.01
Hyman, Phelps & McNamara. P.C Attn: Accounting 700 13th Street, Suite 1200 Washington, DC 20005		NA	Trade debt					1,400.00
Iron Mountain P.O. Box 601002 Los Angeles, CA 90060-1002		NA	Trade debt					354.29
John Hopkins University Attn: Kim Nguyen John Hopkins Tec. Transfer 100 North Charles St., 5th Floor Baltimore, MD 21201		NA	Trade debt					323,260.00

Sheet 5 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Landrover Capital Dept 193901 P.O. Box 55000 Detroit, MI 48355-1939		NA	Trade debt					1,363.77
MD Anderson Cancer Center Attn: Susan Z. Murray Office of CME&Conference 1515 Holcombe Blvd. Houston, TX 77030		NA	Trade debt					28,000.00
Messagelabs, Inc 512 7th Ave, Six Floor New York, NY 10018		NA	Trade debt					337.5
Montgomery Professional Services Corp File # 031052 P.O. Box 60000 San Francisco, CA 94160		NA	Trade debt					5,760.00
Oaktree Capital Management L.P. Attn: Andrew Watts 333 South Grand Avenue 26th Floor
Los Angeles, CA 90071		NA	4.5% Convertible Senior Notes					2,365,000.00
Paul, Hastings, Janofsky 1117 S. California Ave Palo Alto, CA 94304		NA	Trade debt					159,639.18

Sheet 6 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
PG & E P. O. Box 997300 Sacramento, CA 95899		NA	Trade debt					1,368.71
Praxair Distribution, Inc Dept. LA 21511 Pasadena, CA 91185-1511		NA	Trade debt					24.28
Precision Med. Inc. 132 N. Acacia Avenue Solana Beach, CA 92075		NA	Trade debt					53,336.09
PricewaterhouseCoopers LLP P.O. Box 310001-0068 Pasadena, CA 91110		NA	Trade debt					45,000.00
Principal Life Group PLIC- SBD Grand Island P.O.Box 10372 Des Moines, IA 50306-0372		NA	Trade debt					197.63
PR. Newswire G.P.O. Box 5897 New York, NY 10087-5897		NA	Trade debt					1,732
Processworks Inc. P.O. Box 712748 Cincinatti, OH 45271-2748		NA	Trade debt					50.00

Sheet 7 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Professional Life and Casualty Attn: Jeff Bruce 20 North Wacker Drive, Ste. 2414
Chicago, IL 60606		NA	7% Convertible Senior Notes					600,000.00
Prologis Limited Partnership — I 4545 Airport Way Denver, CO 80239		NA	Trade debt					36.45
PurchasePower P.O. Box 856042 Louisville, Kentucky 40285		NA	Trade debt					206.99
Qun Zhou REDACTED		NA	Severance					71,450.00
Ross 3, Inc 30514 Knightong Drive Farmington hills, MI 48331		NA	Trade debt					5,500.00
Sigma-Aldrich Inc. P.O.Box 535182 Atlanta, GA 30353		NA	Trade debt					1,901.19
Simon Shorter REDACTED		NA	Severance					142,050.00

Sheet 8 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Sue Carruthers REDACTED		NA	Severance					25,057.00
ThinkPanmure, LLC 600 Montgomery Street 3rd Floor San Francisco, CA 94111		NA	Trade debt					77,814.76
Thomson Financial LLC 195 Broadway, 7th Floor New York, NY 10007		NA	Trade debt					2,949.00
Townsend and Townsend and Crew Two Embarcadero Center 8th Floor San Francisco, CA 94111		NA	Trade debt					90,947.56
U.S. Bank Attn: Paul Briggs CM 9705 PO Box 70870			Interest on the 4.5% and 7%
Saint Paul, MN 55170		NA	Convertible Senior Notes					633,750.00
Vision Service Plan ( CA) P.O. Box 45210 San Francisco, CA 94145		NA	Trade debt					52.74
VWR International Inc. P.O. Box 31001-1257 Pasadena, CA 91110		NA	Trade debt					25.86

Sheet 9 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6F (Official Form 6F) (12/07) — Cont.
In re	Vermillion, Inc.		Case No	09-11091
		Debtor(s)

SCHEDULE F — CREDITORS HOLDING UNSECURED NONPRIORITY CLAIMS
(Continuation Sheet)

		Husband,
		Wife, Joint , or
		Community
			DATE CLAIM WAS
CREDITOR’S NAME,			INCURRED AND
MAILING ADDRESS			CONSIDERATION FOR
INCLUDING ZIP CODE,			CLAIM.
AND ACCOUNT NUMBER			IF CLAIM IS SUBJECT TO				AMOUNT OF
(See instructions above.)	CODEBTOR	HWJC	SETOFF, SO STATE.	CONTINGENT	UNLIQUIDATED	DISPUTED	CLAIM
Wells Fargo Shareowner Services P.O. Box 64875 St. Paul, MN 55164		NA	Trade debt					1,404.16
			Total				$	21,749,642.25
See Exhibit for complete trade debt list			(Use only on last page of the completed Schedule F.) (Report also on Summary of Schedules and, if applicable, on the Statistical Summary of Certain Liabilities and Related Data.)

Sheet 10 of 10 total sheets in Schedule of Creditors
Holding Unsecured Nonpriority Claims

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6G (Official Form 6G) (12/07)

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)

SCHEDULE G — EXECUTORY CONTRACTS AND UNEXPIRED LEASES

     Describe all executory contracts of any nature and all unexpired leases of real or personal property. Include any timeshare interests. State nature of debtor’s interest in contract, i.e., “Purchaser,” “Agent,” etc. State whether debtor is the lessor or lessee of a lease. Provide the names and complete mailing addresses of all other parties to each lease or contract described. If a minor child is a party to one of the leases or contracts, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m).

Check this box if debtor has no executory contracts or unexpired leases.

NAME AND MAILING ADDRESS,	DESCRIPTION OF CONTRACT OR LEASE AND
INCLUDING ZIP CODE,	NATURE OF DEBTOR’S INTEREST. STATE
OF OTHER PARTIES TO LEASE OR CONTRACT.	WHETHER LEASE IS FOR NONRESIDENTIAL
	REAL PROPERTY. STATE CONTRACT
	NUMBER OF ANY GOVERNMENT CONTRACT.

See Schedule G- Exhibit 1

Sheet 1 of 1 total sheets in Schedule of
Executory Contracts and Unexpired Leases

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

Schedule G — Exhibit 1

PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
ACE Fire Underwriters Insurance Company	Vermillion, Inc.	Workers’ Compensation Insurance	PO Box 31083, Tampa FL 33631
ADP	Ciphergen Biosystems, Inc.	Service Level Agreement	820 N. McCarthy Blvd., Milpitas, CA 95035
Anthem Blue Cross	Vermillion, Inc.	Group Benefit Agreement	P.O. BOX 54630, Los Angeles CA 90054-0630
Applied Clinical Intelligence	Ciphergen Biosystems, Inc.	Consulting Agreement	225 City Avenue, Suite 15, Bala Cynwyd, PA 19004
AT&T Wireless	Ciphergen Biosystems, Inc.	Corporate Agreement to provide telephone services	P.O. BOX 5019, Carol Stream IL 60197-5019
Baker & McKenzie	Ciphergen Biosystems, Inc.	Engagement Letter	One Prudential Plaza, Suite 3500, 130 East Randolph Drive, Chicago, IL 50501-6384
Barkhurst, David	Vermillion, Inc.	Consulting Agreement	REDACTED
Bast, Robert C.	Ciphergen Biosystems, Inc.	Scientific Advisory Board and Diagnostics Consulting Agreement	14 Memorial Point Lane, Houston TX 77024
Baylor College of Medicine	Ciphergen Biosystems, Inc.	Consent Agreement	One Baylor Plaza, Houston, Texas 77030
Bio-Rad Laboratories, Inc.	Ciphergen Biosystems, Inc.	Asset Purchase Agreement	1000 Alfred Nobel Drive, Hercules, CA 04547
Bioreg Technologies, LLC (Rhonda Moe)	Ciphergen Biosystems, Inc.	Consulting Agreement	1022 Ocean Lane, Imperial Beach, CA 91932
Burns, James S.	Ciphergen Biosystems, Inc.	Indemnification Agreement	REDACTED
Carl, Marybeth	Vermillion, Inc.	Consulting Agreement	REDACTED
Carruthers, Susan	Vermillion, Inc.	Consulting Agreement	REDACTED
Certified Compliance Solutions, Inc.	Vermillion, Inc.	Consulting Agreement	16787 Bernardo Center Drive, Suite A-1, San Diego, CA 92128
Chan, Daniel	Ciphergen Biosystems, Inc.	Scientific Advisory Board and Diagnostics Consulting Agreement	REDACTED
Chavez, Jesus	Vermillion, Inc.	Consulting Agreement	REDACTED
Cintas	Ciphergen Biosystems, Inc.	Standard Uniform Rental Service Agreement	P.O. Box 633842, Cincinnati OH 45263-3842
CIT Technology Financing Services, Inc.	Ciphergen Biosystems, Inc.	Lease Agreement on Photocopier	P.O. Box 100706, Pasadena CA 91189-0706
Colorado Prevention Center	Vermillion, Inc.	Master Clinical Services Agreement	789 Shereman Street, Suite 200, Denver CO 80203
Computer Patent Annuities	Ciphergen Biosystems, Inc.	Patent renewal service	CPA House, 11-15 Seaton Place, St. Helier, Jersey JE1 lBL, Channel Islands
Cooke, John P.	Vermillion, Inc.	Consulting Agreement	REDACTED

Schedule G — Exhibit 1

PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
Copenhagen University Hospital	Ciphergen Biosystems, Inc.	Amendment 1 to Research and License Agreement Between Clinic of Gynecology and Clinic of Oncology, Rigshospitalet	Nørregade 10, DK-1165 Copenhagen Denmark
Copyright Clearance Center	Ciphergen Biosystems, Inc.	Copyright agreement	222 Rosewood Drive, Danvers MD 01923
Creech, William	Vermillion, Inc.	Consulting Agreement	REDACTED
E*Trade Financial	Ciphergen Biosystems, Inc.	Master Agreement	PO Box 3512, Arlington, VA 22203
EndSight	Ciphergen Biosystems, Inc.	Computer & Network Consulting Services	1440 Fourth Street, Suite B, Berkeley, CA 94710
Federal Insurance Company ( Chubb)	Vermillion, Inc.	Commercial General Liabiltiy Insurance Policy# 35326826	15 Mountain View Road, Warren, NJ 07059
Federal Insurance Company ( Chubb)	Vermillion, Inc.	Worldwide Umbrella Liability Insurance Policy#79217680	15 Mountain View Road, Warren, NJ 07059
Federal Insurance Company ( Chubb)	Vermillion, Inc.	Employment Practice liability Insurance Policy#81468061	15 Mountain View Road, Warren, NJ 07059
Federal Insurance Company ( Chubb)	Vermillion, Inc.	Commercial Automobile Insurance Policy#73240204	15 Mountain View Road, Warren, NJ 07059
Ford, Fiona	Vermillion, Inc.	Consulting Agreement	REDACTED
Harper, Maribeth	Vermillion, Inc.	Consulting Agreement	REDACTED
Health Discovery Corporation	Ciphergen Biosystems, Inc.	Consulting Agreement	2 East Bryan Street, Suite 601, Savannah GEORGIA, 31401
Iron Mountain	Ciphergen Biosystems, Inc.	Agreement for Storage of off-site materials	P.O. BOX 601002, Los Angeles CA 90060-1002
Johns Hopkins University	Molecular Analytical Systems, Inc.	Technology Transfer Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205
Johns Hopkins University	Vermillion, Inc.	Collaborative Agreement Extension	733 North Broadway, Suite 117, Baltimore, MD 21205
Johns Hopkins University	Ciphergen Biosystems, Inc.	Joint Defense Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205
Johns Hopkins University	Ciphergen Biosystems, Inc.	Label License Waiver to Dr. Cotter (replaces voided waiver dated May 27, 2005)	733 North Broadway, Suite 117, Baltimore, MD 21205
Johns Hopkins University	Ciphergen Biosystems, Inc.	Patent and License Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205
Johns Hopkins University, The University of Texas System, The University of Texas M. D. Anderson Cancer Center	Ciphergen Biosystems, Inc.	Research and License Agreement	733 North Broadway, Suite 117, Baltimore, MD 21205
Landess, Tina	Vermillion, Inc.	Consulting Agreement	REDACTED
Leda Consulting	Vermillion, Inc.	Business Development consulting agreement	280 41st Street, Oakland CA 94611
Malloy & Associates	Vermillion, Inc.	Consulting Agreement	354 Whites Landing, Long Beach, CA 90803

Schedule G — Exhibit 1

PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
MAS (Baylor College of Medicine)	Ciphergen Biosystems, Inc.	Agreement for the Provision of Executive Search and Consulting Services for CFO	101 First Street, Suite 478, Los Altos, CA 94022
MAS (Illiumesys Pacific)	Molecular Analytical Systems, Inc.	Technology Transfer Agreement	101 First Street, Suite 478, Los Altos, CA 94022
McKool Smith	Ciphergen Biosystems, Inc.	Engagement Agreement	300 Crescent Court, Suite 1500, Dallas, TX 75201
Medmarc Casualty Insurance Company	Vermillion, Inc.	Product Liability Insurance Policy#08CA380082	14280 Park Meadow Drive, Suite 300, Chantilly, VA 20151
Messagelabs	Ciphergen Biosystems, Inc.		512 Seventh Avenue, 6th Floor, NY NY 10018
Messagelabs	Ciphergen Biosystems, Inc.	Customer Agreement	512 Seventh Avenue, 6th Floor, NY NY 10018
Microsoft	Ciphergen Biosystems	Master Agreement	PO Box 810, Buffalo, NY 14207
Microsoft Business	Ciphergen Biosystems, Inc.	Volume Licensing	PO Box 810, Buffalo, NY 14207
Microsoft Select License	Ciphergen Biosystems, Inc.	Contract Agreement	PO Box 810, Buffalo, NY 14207
Molecular Analytical Systems, Inc.	Ciphergen Biosystems, Inc.	Contract Agreement	101 First Street, Suite 478, Los Altos, CA 94022
Morgan Stanley	Ciphergen Biosystems, Inc.	Settlement Agreement	2 Theatre Square, Suite 2/322 Orinda, CA 94563
Morgan Stanley	Ciphergen Biosystems, Inc.	Retirement Plan (401K) Non-Std PS Plan	2 Theatre Square, Suite 2/322 Orinda, CA 94563
Nair & Co.	Ciphergen Biosystems, Inc.	Termination of Administration Agreements	Whitefriars, Lewins Mead, Bristol BS1 2NT, UK
Navigators Insurance Co	Vermillion, Inc.	Directors & Officers Insurance Policy #NY08DOL601993IV	One Penn Plaza, New York, NY 10119
Ohio State University Research Foundation, The	Ciphergen Biosystems, Inc.	Exclusive Cfommercialization License Agreement	1960 Kenny Road, Columbus, OHIO 43210
Ohio State University Research Foundation, The	Ciphergen Biosystems, Inc.	Amendment 1 to Exclusive Commercialization License Agreement	1960 Kenny Road, Columbus, OHIO 43210
Oppenheimer & Co. Inc.	Ciphergen Biosystems, Inc.	Engagement letter — re fairness opinion on terms of sale of assets to Bio-Rad	125 Broad Street, New York, NY 10004
Oppenheimer & Co. Inc.	Ciphergen Biosystems, Inc.	Engagement letter — re Recapitalization and Convertible Promissory Notes	125 Broad Street, New York, NY 10004
Oppenheimer & Co. Inc.	Ciphergen Biosystems, Inc.	Letter entitled “Placement Agent Agreement” — to sell up to $25 Million of Common Stock and Warrants	125 Broad Street, New York, NY 10004
Oppenheimer & Co. Inc. — Individual Employees	Ciphergen Biosystems, Inc.	Letter re Warrants exercisable into 100,000 shares	125 Broad Street, New York, NY 10004
Page, Gail	Vermillion, Inc.	Consulting Agreement	REDACTED

Schedule G — Exhibit 1

PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
Page, Gail	Vermillion, Inc.	Severance Agreement	REDACTED
Pallis Communications, Inc. (Kathy C. Pallis)	Vermillion Inc.	Consulting Agreement	87 Encantado Loop, Santa Fe NM 87508
Paul Hastings Janowsky & Walker LLP	Ciphergen Biosystems, Inc.	Corporate Agreement to provide legal services	Five Palo Alto Square, Palo Alto, CA 94306
Praxair Distribution, Inc.	Abiotic Systems, Inc.	Consulting Agreement	Dept LA 21511, Pasadena CA 91185-1511
PrecisionMed International	Ciphergen Biosystems, Inc.	Product Supply Agreement	132 North Acacia Avenue, Solana Beach, CA 92075
PricewaterhouseCoopers	Ciphergen Biosystems, Inc.	Consulting Agreement	Ten Almaden Boulevard, Suite 1600, San Jose, CA 95113
PricewaterhouseCoopers	Ciphergen Biosystems, Ltd.	Engagement Letter	Ten Almaden Boulevard, Suite 1600, San Jose, CA 95113
Prologis Limited Partner	Vermillion, Inc.	Rental Agreement	4545 Airport Way, Denver CO 80239
Public Storage	Vermillion, Inc.	Storage Agreement	42101 Albrae Street, Fremont CA 94538-3123
Quest Diagnostics Incorporated	Ciphergen Biosystems, Inc.	Strategic Alliance Agreement	3 Giralda Farms, Madison, NJ 07940
Quinn Emannuel Urquihart Oliver & Hedges LLP	Vermillion, Inc.	Engagement Letter	50 California Street, 22nd Floor, San Francisco, CA 94111
Sage Software, Inc.	Ciphergen Biosystems, Inc.	Agreement for Accounting System (MAS 90)	PO Box 849887, Dallas, TX 75284-9887
Sheibani, Nadia	Ciphergen Biosystems, Inc.	Consulting Agreement	REDACTED
Shorter, Simon	Vermillion, Inc.	Consulting Agreement	REDACTED
Shorter, Simon	Vermillion, Inc.	Severance Agreement	REDACTED
Silicon Valley Bank	Ciphergen Biosystems, Inc.	Engagement Letter for Legal Services	3005 Tasman Drive, Santa Clara, CA 95054
Smith, Alan	Vermillion, Inc.	Consulting Agreement	REDACTED
Stanford University	Vermillion, Inc.	Exclusive License Agreement	Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305
Stericycle	Ciphergen Biosystems, Inc.	Fee Schedule Agreement	P.O. Box 9001589, Louisville KY 40290-1589
Testorff, Doug	Vermillion, Inc.	Consulting Agreement	REDACTED
Think Panmure	Vermillion, Inc.	Engagement Letter	600 Montgomery Street, 3rd Floor, San Francisco, CA 94111

Schedule G — Exhibit 1

PARTY A	PARTY B	NAME OF AGREEMENT	ADDRESS OF PARTY
Thomson Financial	Ciphergen Biosytems, Inc.	Corporate Services Client Agreement	195 Broadway, New York, NY 10007
Torres, Sarah Lyn	Ciphergen Biosystems, Inc.	Consulting Agreement	REDACTED
University of Kentucky	Ciphergen Biosystems, Inc.	Research and Collaboration Agreement	800 Rose Street, Lexington, Kentucky 40536
University of Texas M.D. Anderson Cancer Center, The	Vermillion, Inc.	Clinical Trial Site Agreement	1515 Holcombe Boulevard, Houston TX 77030
University of Texas M.D. Anderson Cancer Center, The	Ciphergen Biosystems, Inc.	Research and License Agreement	1515 Holcombe Boulevard, Houston TX 77030
University of Texas M.D. Anderson Cancer Center, The	Ciphergen Biosystems, Inc.	Research and License Agreement	1515 Holcombe Boulevard, Houston TX 77030
University of Texas M.D. Anderson Cancer Center, The	Ciphergen Biosystems, Inc.	Research and License Agreement	1515 Holcombe Boulevard, Houston TX 77030
University of Texas Medical Branch	Ciphergen Biosystems, Inc.	Research and License Agreement	301 University Boulevard, Galveston, TX 77555
Vo, Kristy	Vermillion, Inc.	Consulting Agreement	REDACTED
Wallen, William	Ciphergen Biosystems, Inc.	Extension of Term of Scientific Advisory Board & Diagnostic Consulting Agreement	IDEXX Laboratories, Inc. One Idexx Drive, Westbrook, Maine 04092
XL Specialty Insurance Company	Vermillion, Inc.	Excess Directors & Officers Insurance Policy #ELU10711308	Executive Offices, 70 Seaview Avenue, Stamford, CT 06902
Zhou Qun	Vermillion, Inc.	Consulting Agreement	REDACTED
Zhou Qun	Vermillion, Inc.	Severance Agreement	REDACTED

B6H (Official Form 6H) (12/07)

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)

SCHEDULE H — CODEBTORS

     Provide the information requested concerning any person or entity, other than a spouse in a joint case, that is also liable on any debts listed by the debtor in the schedules of creditors. Include all guarantors and co-signers. If the debtor resides or resided in a community property state, commonwealth, or territory (including Alaska, Arizona, California, Idaho, Louisiana, Nevada, New Mexico, Puerto Rico, Texas, Washington, or Wisconsin) within the eight years immediately preceding the commencement of this case, identify the name of the debtor’s spouse and of any former spouse who resides or resided with the debtor in the community property state, commonwealth, or territory. Include all names used by the nondebtor spouse during the eight years immediately preceding the commencement of this case. If a minor child is a codebtor or a creditor, state the child’s initials and the name and address of the child’s parent or guardian, such as “A.B., a minor child, by John Doe, guardian.” Do not disclose the child’s name. See, 11 U.S.C. §112 and Fed. R. Bankr. P. 1007(m).

þ Check this box if debtor has no codebtors.

NAME AND ADDRESS OF CODEBTOR NAME AND ADDRESS OF CREDITOR

Sheet 1 of 1 total sheets in Schedule of Codebtors

Software Copyright (c) 1996-2008 Best Case Solutions — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

B6 Declaration (Official Form 6-Declaration). (12/07)

United States Bankruptcy Court
District of Delaware

In re	Vermillion, Inc.		Case No.	09-11091
		Debtor(s)	Chapter	11

DECLARATION CONCERNING DEBTOR’S SCHEDULES

DECLARATION UNDER PENALTY OF PERJURY ON BEHALF OF CORPORATION OR PARTNERSHIP

     I, the Chair of the Board of Directors of the corporation named as debtor in this case, declare under penalty of perjury that I have read the foregoing summary and schedules, consisting of 45 sheets, and that they are true and correct to the best of my knowledge, information, and belief.

Date June 11, 2009	Signature	/s/ Gail S. Page
		Gail S. Page
		Executive Chairman of the Board of Directors

     Penalty for making a false statement or concealing property: Fine of up to $500,000 or imprisonment for up to 5 years or both.

18 U.S.C. §§ 152 and 3571.

Software Copyright (c) 1996-2006 Best Case Solutions, Inc. — Evanston, IL — (800) 492-8037 Best Case Bankruptcy

EX-99.3

Exhibit 99.3

Cash Budget for Vermillion, Inc. through December, 2009

Vermillion Inc

	April			May			June			July			August			September			October			November			December
	Actual			Actual			Forecast			Forecast			Forecast			Forecast			Forecast			Forecast			Forecast
Operating expense we believe is adequate to support the completion of FDA clearance
Employee and facility total		25,786			55,066			64,351			50,872			51,211			51,922			50,872			51,211			51,922
Outside service and other operating expenses		48,252			143,846			368,346			552,656			407,702			404,652			191,832			240,832			167,582
Total expenditures		74,038			198,913			432,697			603,528			458,912			456,573			242,703			292,042			219,503
Beginning Cash		642,969			568,930			370,018			1,237,321			633,793			174,881			1,018,308			775,604			483,562
DIP Financing								1,300,000									1,300,000
Cash Usage		(74,038	)		(198,913	)		(432,697	)		(603,528	)		(458,912	)		(456,573	)		(242,703	)		(292,042	)		(219,503	)
Ending Cash		568,930			370,018			1,237,321			633,793			174,881			1,018,308			775,604			483,562			264,058

Assumptions for this scenario:

- Two of the three current employees who are @ 80% will resume 100% work time in June.

- We will become current with all SEC reporting obligations, $650K expenses can be saved if company goes private.

- We will maintain consultant utilization as follows: 50% CSO service, and 50% of Gail, Taya and Sue’s time till July.

- Consultants will come back full time after FDA clearance to work on preparation of commercialization, quality system set up, and FDA inspection.

- If there is a buyout and change of control, D&O insurance will go up to 200% of current rate, cost will go up another 80k but the expense on Q2 and Q3 SEC reporting of 71k per quarter can be saved depending on timing.

Vermillion, Inc. Cash Budget through December 2009

Detail

Vermillion Inc

	April		May		June		July		August		September		October		November		December
	Actual		Actual		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast
Employee and Facility
Payroll including payroll taxes
Gillian		12,036		12,544		12,864		12,864		12,864		12,864		12,864		12,864		12,864
Christine		7,935		7,935		9,918		9,918		9,918		9,918		9,918		9,918		9,918
Vivian		5,816		5,816		7,270		7,270		7,270		7,270		7,270		7,270		7,270
Pre-BK employee 401k Contribution withdraw delayed by Fidelity						12,459
Medical Insurance
Gillian				2,720		1,360		1,360		1,360		1,360		1,360		1,360		1,360
Christine				2,828		1,403		1,403		1,403		1,403		1,403		1,403		1,403
Vivian				2,342		1,171		1,171		1,171		1,171		1,171		1,171		1,171
Rent & Utilities
Prologis — Rent & CAM				9,113		9,100		9,200		9,200		9,200		9,200		9,200		9,200
PG&E — Electricity				1,965		1,500		1,500		1,500		1,500		1,500		1,500		1,500
Allied Waste Management — waste collection				1,991		2,000		2,000		2,000		2,000		2,000		2,000		2,000
Stericycle — Bio waste collection per environmental law				501		500		500		500		500		500		500		500
Iron Mountain — tape backup, data storage				354		750		750		750		750		750		750		750
Cintas — recycle document collection to shred						140		70		70		70		70		70		70

Vermillion, Inc. Cash Budget through December 2009

	April		May		June		July		August		September		October		November		December
	Actual		Actual		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast
Facility Maintenance service — Janitory services				329		350		350		350		350		350		350		350
AT&T — T1, fax line, phone				2,464		1,600		1,600		1,600		1,600		1,600		1,600		1,600
AT&T — Blackberry service				2,778		360		360		360		360		360		360		360
Global Crossing — Conference call service provider				464		300		300		300		300		300		300		300
CIT technology — copier lease						1,050						1,050						1,050
Bay Alarm — alarm system				339						339						339
Public Storage — offsite storage for marketing booth, etc				583		255		255		255		255		255		255		255
Employee and Facility subtotal		25,786		55,066		64,351		50,872		51,211		51,922		50,872		51,211		51,922
Outside Services
Professional services supporting FDA submission
Biostatistical data analysis		34,300		52,600		58,600
Analytical performance testing site				22,710		11,500		11,500
Testing site						10,000		5,000		5,000
Technical writing for response, product insert				1,548		7,000		1,000
Regulatory consulting				4,760		2,000		1,000
Agreement/contracts drafting						200		200
Specimen Biorepository				5,000		5,000		5,000		5,000
Reagent provider						4,000
FDA contigency								50,000		50,000
Post- clearance quality system set up required by FDA										15,000		15,000		15,000
Access procedure for OVA1 software										15,000		15,000		15,000
Critical Vendor Pre-BK service payment						5,000

Vermillion, Inc. Cash Budget through December 2009

	April		May		June		July		August		September		October		November		December
	Actual		Actual		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast
Legal Management, IT, HR, Facility consulting
Endsight — IT service				8,000		4,000		4,000		4,000		4,000		4,000		4,000		4,000
Doug — facility, HR, 40 hours @ $87/h for Post-BK closure						870		870		870		870
PWC year end audit, 10k, proxy, Q1 - Q3 10Q						45,000		195,000		60,000		40,000				40,000
SEC consultant — 10k, proxy, three 10Qs						20,000		45,000		30,000		15,000				15,000
Financial printer,								25,000		25,000		6,000				6,000
SOX review								20,000								10,000
Legal review on SEC filings								20,000		20,000		10,000				10,000
General Legal — Paul Hastings						30,000		20,000		20,000		20,000		20,000		20,000		20,000
Ongoing patent cost						30,000		20,000		20,000		20,000		20,000		20,000		20,000
Claim Agent		10,000								10,000
US Trustee Charge				325		5,000						5,000						5,000
Chapter 11 legal cost						40,000		10,000		10,000		10,000		10,000		10,000		10,000
Gail —50% time consulting till July FDA clearance				32,760		19,717		19,717		39,433		39,433		39,433		39,433		39,433
CSO consultant — 50% till July						11,917		11,917		23,833		23,833		23,833		23,833		23,833
Taya — 50% time consulting till July				13,020		8,938		8,938		17,875		17,875		17,875		17,875		17,875
Sue — 50% time consulting till July				4,892		6,175		6,175		12,350		12,350		12,350		12,350		12,350
Rene — 16 hours@$90/h per month for consolidation work						2,880		1,440		1,440		1,440		1,440		1,440		1,440
Incentive Bonus ( 10k Gillian, 5k Vivian, Christine)								20,000

Vermillion, Inc. Cash Budget through December 2009

	April		May			June		July		August		September		October		November		December
	Actual		Actual			Forecast		Forecast		Forecast		Forecast		Forecast		Forecast		Forecast
Other operating expenses
Wells Fargo — transfer agent service							3,000		1,500		1,500		1,500		1,500		1,500		1,500
SVB — bank and wire fee		752		615			800		800		800		800		800		800		800
Fidelity — 401k plan							750						750						750
PR Newswire — press release etc							1,000				1,000				1,000				1,000
Bowne — SEC filing, 8K etc							1,000				1,000				1,000				1,000
Office Depot — office supplies							300		300		300		300		300		300		300
Fedex — shipping							800		800		800		800		800		800		800
T&E — Gail and BOD travelling							3,000		3,000		3,000		3,000		3,000		3,000		3,000
E* Trade — ESPP and Stock option plan							5,000		2,500		2,500		2,500		2,500		2,500		2,500
California State Franchise tax		3,200
Delaware Franchise tax first quarter payment							12,900				0						0
Workers’ Comp insurance premium due May 2009				2,091
Commercial Liability and Product liability insurance premium									30,000
D&O Insurance — 120% of current rate with no change of control													127,200
Foreign Subsidiary liquidation project							10,000		10,000		10,000		10,000
Other Misc				(4,474	)		2,000		2,000		2,000		2,000		2,000		2,000		2,000
Cash usage on critical operations		74,038		198,913			432,697		603,528		458,912		456,573		242,703		292,042		219,503

Vermillion, Inc. Cash Budget through December 2009

Unaudited Information

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Monthly Operating Report, which was not prepared for the purpose of providing the basis for an investment decision relating to any of the securities of the Company. The Monthly Operating Report is limited in scope, covers a limited time period and has been prepared solely for the purpose of the Company’s compliance with the monthly reporting requirements of the Bankruptcy Court.  The financial information in the Monthly Operating Report was not audited or reviewed by independent registered accountants and is not presented in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), is in a format prescribed by applicable bankruptcy laws and is subject to future adjustment and reconciliation.  There can be no assurance that, from the perspective of an investor or potential investor in the Company’s securities, the Monthly Operating Report is complete.  The Monthly Operating Report also contains information for periods which may be shorter or otherwise different from those contained in reports required pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such information is likely not indicative of Company’s financial condition or operating results for the period that would be reflected in the periodic reports pursuant to the Exchange Act.  The Monthly Operating Reports do not include footnotes that would ordinarily be contained in the financial statements in our quarterly and annual reports pursuant to the Exchange Act.  In addition, the income tax provision in the Monthly Operating Reports is difficult to ascertain as a result of many factors, including, among other things, our inability to predict taxable income that may be generated as a result of any cancellation of indebtedness that might occur as a result of the bankruptcy proceeding involving the Company.  Results set forth in the Monthly Operating Reports should not be viewed as indicative of future results.

Forward-Looking Statements

Certain matters discussed in this Cash Budget contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. These forward-looking statements may relate to, among other things, expectations of the business environment in which the Company operates, projections of future performance and projections of future expenses. These forward-looking statements are based upon current management expectations and may therefore involve risks and uncertainties. These forward-looking statements are only estimates of the anticipated cash and expenses of the Company, and of the operating requirements of the Company through December, 2009. The Company’s actual expenses may be affected by a wide range of factors, including, but not limited to: anticipated expenses may significantly increase; unanticipated or unforeseen expenses may arise; changes to FDA regulations, and any delay by or failure of the FDA to approve any of the Company’s diagnostic tests submitted to the FDA may result in unanticipated expenses; the overall financial situation and needs of the Company or its research could change; the Company’s Chapter 11 filing may disrupt and distract management, resulting in unanticipated expenses or increases to estimated expenses; the Company’s Chapter 11 filing could end in litigation, which could increase costs significantly; the creditors’ committee could contest the plan of reorganization which could increase costs; and unanticipated litigation unrelated to the Chapter 11 filing could arise and could result in increased expenses. The Company’s actual results or performance may differ materially from those suggested, expressed, or implied by forward-looking statements due to a wide range of factors, and although the Company believes that its expectations and beliefs are based on reasonable assumptions, it can give no assurance that its goals will be achieved. The Company disclaims any obligation to subsequently revise or update any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.